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Burkholderia pseudomallei, a gram-negative soil bacterium, is the causative 
agent of melioidosis. It is intrinsically resistant to a wide range of antimicrobial agents 
including β-lactams, aminoglycosides, macrolides, and polymyxins. Most antibiotic 
efflux transporters in gram-negative bacteria belong to the resistance-nodulation-cell 
division (RND) superfamily of transporters, which have a tripartite structure that 
spanning the inner and outer membranes and periplasmic space, thus facilitating the 
direct passage of the substrate from the cytoplasm into the external medium. More 
than 8 putative operons encoding RND efflux pumps are present in the sequenced B. 
pseudomallei genome. The B. pseudomallei operon encoding BpeAB-OprB and BpeR 
was identified from a genomic library of B. pseudomallei ATCC23343 using the B. 
cepacia ceoA and ceoB probes prior to the completion of genome sequence of B. 
pseudomallei K96243 by the Sanger Institute in 2003.  
In a limited study, BpeAB-OprB was detected in the majority of B. 
pseudomallei isolated from patients, animal and soil. A bpeAB deletion mutant and a 
bpeR null mutant were derived from a virulent clinical isolate, KHW. Comparison of 
the minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations 
(MBC) of antimicrobials between the wild type parent and its isogenic mutant 
derivatives revealed that the B. pseudomallei BpeAB-OprB pump is responsible for 
the efflux of the aminoglycosides gentamicin and streptomycin, the macrolide 
erythromycin, as well as acriflavine. Resistance was restored by complementation in 
trans using a multicopy plasmid carrying wild-type bpeAB.  
BpeR, a member of the TetR family, functions as a repressor of the bpeAB-
oprB operon. In bpeR mutant, bpeA expression was increased as detected by RT-PCR. 
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The MIC values for streptomycin, erythromycin and gentamicin, respectively, were 2-
, 4- and 16-fold higher in the bpeR mutant when compared to the wild type. The 
expression of bpeAB-oprB was 3.5-fold higher in the bpeR mutant compared to wild 
type, and consequently resulted in relatively higher MIC and MBC values for the 
antibiotic substrates. Interestingly, over-expression of bpeR in both KHW and bpeR 
null mutant resulted in complete inhibition of bpeA expression and thus increased 
their susceptibilities to all three antibiotics significantly.  
bpeABpromoter-lacZ and bpeRpromoter-lacZ fusions were constructed for studies on 
transcriptional expression. The expression of bpeAB-oprB was growth phase-
dependent whilst that of bpeR was inducible upon entry into stationary phase. 
Expression of bpeAB-lacZ was induced in the presence of exogenous acyl-homoserine 
lactones, i.e., C8-HSL and C10-HSL; and the extracellular production of acyl 
homoserine lactones was significantly reduced in the absence of BpeAB-OprB 
function. Interestingly, the expression of bpsI, an acyl homoserine lactone synthase 
which was under positive feedback regulation, was also much reduced in the bpeAB 
mutant. Subsequent reversed phase HPLC analyses revealed the involvement of 
BpeAB-OprB in the active efflux of C8-HSL.  
BpeAB-OprB seemed to function as a metabolic relief valve to alleviate the 
toxic intermediates of methylthioadenosine (MTA) and spermidine metabolism, as 
both compounds induced bpeAB expression and showed bacteriostatic effects on B. 
pseudomallei. BpeAB-OprB positively regulated the extracellular production of the 
putative virulence determinants, phospholipase C and siderophore. Additionally, 
BpeAB-OprB function was required for optimal biofilm formation and was required 
for bacterial virulence as demonstrated using cell invasion and killing assays. Thus, 
the inhibition of BpeAB-OprB would be potentially beneficial for therapeutic 
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intervention of meliodosis as it would (1) increase the susceptibility of B. 
pseudomallei to antibiotics commonly used to treat suspected cases of community-
acquired sepsis; and (2) attenuate virulence via its negative effect on B. pseudomallei 
quorum sensing and expression of quorum sensing-regulated virulence factors such as 
phospholipase C and siderophore; (c) reduce biofilm formation. However, the 
screening of the broad-spectrum efflux pump inhibitor MC-207,110 and several 
adenosine analogues did not identify any compound that could potentiate the 
susceptibility of B. pseudomallei to erythromycin.  
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1.1. Multi-drug resistance in gram-negative bacteria 
Bacterial infections are becoming more challenging to treat, as a result of the 
emergence of multi-drug resistant pathogenic bacteria. According to worldwide 
surveillance studies, multi-drug resistance (MDR) is increasingly prevalent. Antibiotic 
resistance of bacterial pathogens is a fast emerging global crisis and an understanding 
of the underlying resistance mechanisms is paramount for the design and development 
of new therapeutic strategies. Multi-drug efflux in gram-negative pathogen is 
increasingly recognized as an important cause of multi-drug resistance. Indeed, Li and 
colleagues (Li et al., 2004) recently reported that all but 2 of 33 experimental anti-
microbials recovered from a screen of a limited compound library were substrates for 
efflux by the endogenous multi-drug efflux system of E. coli, homologues of which 
are present in virtually all gram-negative bacteria (Poole, 2004).  
Although the development and use of antibiotics has been one of the most 
important steps towards controlling infectious diseases in the 20th century, the 
subsequent appearance and spread of antibiotic resistance in pathogenic organisms 
have made many currently available antibiotics ineffective (Neu, 1992). To 
successfully fight the increasing numbers of drug-resistant and multi-drug resistant 
bacteria, extensive knowledge of the molecular mechanisms underlying microbial 
antibiotic resistance is required.  
Gram-negative bacteria are generally more resistant to anti-microbials than 
gram-positive bacteria, and this has long been explained by the presence, in the 
former, of the outer-membrane permeability barrier, which limits access of the anti-
microbial agent to their targets in the bacterial cell. However, drug resistance in gram-
negative bacteria is mainly attributed to synergy between reduced drug intake and 
active drug efflux. Whereas in some cases resistance to anti-bacterial drugs is intrinsic 
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to bacteria, in most cases this phenomenon has arisen due to the antibiotic pressure, 
and has been acquired by many organisms (Nikaido, 2003).  
Mechanisms that confer resistance to antibiotics include: 
alteration/modification of the target site (Lambert, 2005), degradation of the antibiotic 
molecule (Wright, 2005) and reduction of effective intracellular antibiotic 
concentration as a result of decreased permeability and energy-dependent (or active) 
efflux (Kumar and Schweizer, 2005). Resistance genes are either carried on the 
chromosomes of wild-type bacteria or on elements of extrachromosomal, sometimes 
extraneous origins, such as resistance plasmids and transposons. 
The toxic effects of antibiotics and other drugs may be overcome through 
enzymatic alterations of drugs involved in the production of enzymes that inactivate 
antibiotics by hydrolysis or by the formation of inactive derivatives (Davies, 1994). 
Well-known examples are β-lactamases (Bush et al., 1995) and enzymes that 
phosphorylate, adenylate, or acetylate aminoglycosides (Shaw et al., 1993). Within 
the B. pseudomallei genome, 7 genes encoding β-lactamases have been identified 
(Holden et al., 2004). Functionally, the most important of these is the class 2e β-
lactamase BPS-1, encoded by the gene blaA, which hydrolyses most cephalosporins 
but is readily inhibited by clavulanate (Livermore et al., 1987; Cheung et al., 2002). 
Acquired resistance to β-lactams while on treatment is mostly associated with 
mutations in the blaA gene (Tribuddharat et al., 2003). Overexpression of the class D 
β-lactamases, OXA-42 and OXA-43, may also be responsible for ceftazidime 
resistance in some isolates (Niumsup and Wuthiekanun, 2002).  
The second mechanism of resistance is target alteration. Cellular targets can be 
altered by mutation or enzymatic modification in such a way that the affinity of the 
antibiotic for the target is reduced. In E. coli, a mutational substitution of a glycine for 
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a tryptophan at amino acid position 30 of the enzyme dihydrofolate reductase (DHFR) 
was thought to relate to the observed 3-fold increase in the Ki for trimethoprim 
(Huovinen et al., 1995). A third, more general mechanism of resistance is the 
inhibition of drug entry into the cell. Due to the low permeability of the outer 
membrane of gram-negative bacteria (Nikaido, 1989), drug diffusion across the cell 
envelope is reduced. The permeability of the outer membrane can be further 
decreased by the loss of porins (Nikaido, 1994). These barriers, however, cannot 
prevent the drugs from exerting their toxic action once they have entered the cell, and 
the active efflux of drugs (the 4th mechanism) is essential to ensure significant levels 
of drug resistance (Levy, 1992). 
Efflux pumps are transporter proteins involved in the extrusion of toxic 
substrates (including virtually all classes of clinically relevant antibiotics) from within 
cells into the external environment. Broadly specific efflux systems which are able to 
accommodate a variety of unrelated anti-microbial agents, including antibiotics, 
biocides, dyes, detergent, fatty acids, organic solvents, and acyl-homoserine lactones 
(acyl-HSLs), are responsible for much of the intrinsic multi-drug resistance in gram-
negative bacteria (Poole, 2001b). In the prokaryotic kingdom there are five major 
families of efflux transporters (Figure 1): major facilitator (MFS), multi-drug and 
toxic efflux (MATE), resistance-nodulation-division (RND), small multi-drug 
resistance (SMR) and ABC (ATP binding cassette). All these systems utilize the 
proton motive force as an energy source and hence are inhibited by carbonyl cyanide 
m-chlorophenylhydrazone (CCCP) (Van Bambeke et al., 2000), apart from the ABC 





Figure 1. Schematic illustration of the main types of bacterial drug efflux pumps. 
Illustrated are S. aureus NorA, a member of the major facilitator superfamily (MFS); 
E. coli EmrE, a member of the small multi-drug resistance (SMR) superfamily; V. 
parahaemolyticus NorM, a member of the multi-drug and toxic compound extrusion 
(MATE) superfamily; E. coli AcrAB–TolC, a member of the resistance-nodulation-
cell division (RND) superfamily; and L. lactis LmrA, a member of the ATP-binding 
cassette (ABC) superfamily. All pumps extrude the substrate chemically unaltered 
and in an energy-dependent manner, using either an ion gradient (proton or Na+) or 
ATP. Although the drug is in many instances pumped from the cytoplasm (as depicted 
here), there is increasing evidence that RND pumps can also acquire substrates either 
directly from the periplasm or from the outer leaflet of the cytoplasmic membrane. 
(Reproduced with permission from ScienceDirect, Elsevier B.V.) 
 
Most of the efflux transporters that mediate resistance to clinically relevant 
antibiotics belong to the RND superfamily of transporters (Saier et al., 1998). RND 
components are predicted to span the cytoplasmic membrane 12 times with 
substantial periplasmic loops occurring between helices 1 and 2, and 7 and 8. Such a 





MexD (Gotoh et al., 1999) RND components of the MexAB-OprM and MexCD-OprJ 
multi-drug efflux systems in P. aeruginosa. The inner membrane component of RND 
efflux pumps is responsible for the recognition of the molecule to be effluxed 
(Zgurskaya and Nikaido, 1999b). Recent studies conclusively showed that the two 
large periplasmic loops (about 300 amino acid residues each) of RND pumps contain 
the amino acid residues responsible for substrate recognition (Mao et al., 2002; 
Tikhonova et al., 2002; Eda et al., 2003). These studies were performed using 
chimeric constructs of different RND pump proteins from E. coli and P. aeruginosa. 
It was observed that the chimeric protein containing the periplasmic loops of one 
protein retained the substrate specificity of that particular protein. 
Multi-drug transporters belonging to the RND family interact with a 
membrane fusion protein (MFP) and an outer membrane protein to allow drug 
transport across both the inner and outer membrane of gram-negative bacteria (Figure 
2). The MFP proteins are thought to induce fusion of the inner and outer membranes 
(Dinh et al., 1994; Saier et al., 1994) or form a channel-like structure that spans the 
periplasmic space (Zgurskaya and Nikaido, 1999a). The outer membrane protein is 
believed to form a channel connected with the other 2 components to allow the export 




Figure 2. The Resistance-Nodulation-Division (RND) efflux pump in gram-
negative bacteria. Drug molecules penetrate across the outer membrane and once in 
the periplasm, amphiphilic drugs partition spontaneously into the cytoplasmic 
membrane, then are captured by an RND-type transporter, such as MexB in P. 
aeruginosa, and are pumped back into the medium by a multi-subunit complex that 
also contains a membrane fusion protein such as MexA, and an outer membrane 
channel such as OprM (Reproduced with permission from ScienceDirect, Elsevier 
B.V.) 
 
1.2. Regulation of RND efflux systems  
The understanding of the environmental conditions involved in regulation of 
RND pump expression is an integral part of the drug discovery efforts aimed at 
overcoming efflux as a contributing factor to antibiotic resistance. These 
environmental conditions may yield clues as to the physiological function of the 
respective efflux components and thus facilitate design of inhibitory compounds. 
Furthermore, the regulators themselves may be attractive drug targets, especially in 
those cases where specific ligands can be identified.  
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Multi-drug transporter genes are frequently subjected to both local and global 
regulation. Transcriptional regulatory proteins control expression of the majority of 
the bacterial drug transporter genes. Multi-drug transporter gene regulation has been 
pursued not only for its innate scientific interest, but also because the identification of 
physiologically relevant effectors may provide insight into the cellular roles of multi-
drug transporters. Well-characterized proteins with a demonstrated role in controlling 
the expression of drug efflux genes encompass examples of both repressors and 
activators of target gene transcription, a process that can occur at either the local or 
global level. Multi-drug transporter genes are subjected to very complex 
transcriptional networks, and as more data become available this may be more 
generally true. For instance, expression of the E. coli acrAB locus can be elevated by 
the MarA, Rob and Sox global activators, modulated by the local AcrR repressor (Ma 
et al., 1996; Alekshun and Levy, 1997) and is also affected by the quorum sensor 
regulator SdiA (Rahmati et al., 2002). 
In general, the confirmed regulators of bacterial drug transporter genes belong 
to one of five regulatory protein families, the AraC, MarR, MerR, LysR and TetR 
families (Grkovic et al, 2002). The assignment of these regulatory proteins to their 
respective families is based solely on similarities detected within their DNA-binding 
domains, which typically constitute only one third of each polypeptide. Like the 
majority of bacterial activators and repressors, the drug transport regulators identified 
to date all possess helix-turn-helix (HTH) DNA-binding motifs, which are embedded 
in larger DNA-binding domains that form a number of different structural 
environments (Pabo and Sauer, 1992).  
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1.2.1. Local regulators 
Many pump component-encoding operons contain a physically linked 
regulatory gene. For example, E. coli acrR is transcribed divergently from the acrAB 
genes and encodes a repressor of the TetR repressor family. AcrR is known to repress 
both its own and acrAB transcription, probably in a similar fashion as TetR represses 
tetA expression (Saenger et al., 2000) (Figure 3). It appears though that the main role 
of AcrR is to prevent the overexpression of acrAB, as its repression of acrAB is leaky 
and allows for its constitutive basal expression. Many other local repressors of multi-
drug efflux pumps belong to the TetR family, e.g., AcrS (AcrEF, E. coli) (Ma et al., 
1994), MexL (MexJK, P. aeruginosa) (Chuanchuen et al., 2002), MexZ (MexXY, P. 
aeruginosa) (Westbrock-Wadman et al., 1999) and SmeT (SmeDEF, S. maltophila) 
(Zhang et al., 2001) 
 
Figure 3. Schematic description of local gene regulation by TetR. Tet repressor 
(TetR, depicted as grey spheres) binds as a homodimer to operators tetO1 and tetO2. 
Tetracycline (open triangle) diffuses into the (bacterial) cell and forms a complex 
(black triangles) with a divalent cation (Mg2+). If the complex binds to TetR, it 
enforces conformational change and the complexes release the operators so that 
transcription of genes tetR and tetA can now proceed (wavy lines represent mRNA). 
(Reproduced with permission from WILEY-VCH Verlag GmbH) 
  
28
1.2.2. Global regulators 
 
Expression of various efflux pumps is also controlled by different global 
regulators, with the best studied example being the AcrAB–TolC system of E. coli. So 
far, several global transcriptional activators, including MarA, SoxS and Rob, are 
known to be involved in the regulation of expression of this system (Figure 4). The 
mar (multiple antibiotic resistance) locus consists of the marRAB operon and the 
divergently transcribed marC, both being expressed from a central operator/promoter 
region, marO (Alekshun and Levy, 1997). MarR function as a repressor and MarA an 
activator, but the functions of MarB and MarC remain unknown. MarA is a member 
of the AraC family of transcriptional activators, and activates its own transcription as 
well as a large number of other genes, including acrAB, tolC and micF. MicF is an 
antisense RNA that down-regulates the expression of ompF, a gene encoding an OMP 
channel that is responsible for entry of various antibiotics (Delihas and Forst, 2001). 
Lower OmpF levels combined with overexpression of AcrAB–TolC provide E. coli 
with a highly effective mechanism by which MarA can coordinate a response to the 
presence of anti-microbials. Overall, MarA activates expression of the mar regulon, 
including acrAB, tolC and marRAB, while MarR represses the mar regulon by 
repressing the synthesis of MarA.  
Elevated levels of SoxS and Rob, two MarA homologues, activate the 
transcription of acrAB, tolC and micF. SoxS is the effector of the soxRS global 
superoxide response (sox) regulon and Rob is a protein binding to the E. coli 
chromosomal origin of replication (White et al., 1997). SoxS is only expressed after 
conversion of the transcriptional activator SoxR into an active form by superoxide-
generating agents (Nunoshiba et al., 1992) (Martin and Rosner, 1997). Unlike MarA 
and SoxS, Rob is synthesized constitutively and activates its target genes only after 
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the binding of inducers, such as medium-chain fatty acids and bile salts (Rosenberg et 
al., 2003).  
 
 
Figure 4. Major features of local and global regulation of E. coli AcrAB–TolC 
expression. The acrAB operon is negatively regulated by a local repressor (AcrR). 
acrAB, tolC and the antisense regulatory RNA micF are positively regulated by 
several activators (MarA, SoxS and Rob). The levels of MarA and SoxS are 
themselves regulated by the repressors MarR and SoxR, respectively. The activity of 
Rob is modulated by metabolites, such as bile salts and fatty acids. The micF 
transcript inhibits translation of the ompF porin mRNA, thus lowering expression of 
this outer membrane porin and reducing outer membrane permeability for many 
drugs. At the same time, all three activators increase expression of AcrA, AcrB and 
TolC, leading to increased drug efflux. (-) and (+) indicate negative and positive 





The LysR family of transcriptional regulators was first reported by Henikoff et 
al in 1988 (Henikoff et al., 1988). LysR-type transcriptional regulators (LTTRs) may 
be the most common type of positive regulators in prokaryotes. LTTRs regulate very 
diverse genes and functions (Schell, 1993). Some LTTRs control multiple, unlinked 
target genes or regulons. For example, OxyR in E. coli responds to oxidative stress 
and induce expression of proteins required for the removal of reactive oxygen species 
but it also regulates genes involved in phage restriction and aggregation (Farr and 
Kigoma, 1991). Some other LTTRs are themselves regulated by other genes forming 
complex regulatory networks. For example, Nac transcriptionally activates hut 
(encoding histidase), put (encoding proline utilization), and ure (encoding urease), but 
represses gdh (encoding glutamate dehydrogenase) in response to nitrogen limitaion 
in K. aerogenes (Bender, 1991).  
 
1.3. RND efflux systems in P. aeruginosa 
The best-studied members of RND pumps are the AcrAB–TolC system of E. 
coli (Ma et al., 1993; Ma et al., 1995) and the MexAB–OprM system of P. 
aeruginosa (Poole et al., 1993b) that are known to efflux antibiotics, heavy metals, 
dyes, detergents, solvents, plus many other substrates. These tripartite pumps span the 
entire gram-negative cell envelope and are thus uniquely suited to synergize with 
reduced outer membrane permeability (uptake) to impart drug resistance. 
P. aeruginosa, a close relative of B. pseudomallei, is a clinically opportunistic 
pathogen characterized by relatively high intrinsic resistance to a variety of anti-
microbial agents. This property is now recognized to result from the synergy between 
low outer membrane permeability and at least 7 RND efflux systems (Schweizer, 
2003). The known substrates of these systems are summarized in Table 1.  
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Table 1: Substrates of characterized P. aeruginosa efflux pumps 
Efflux pump Substrates Reference 
MexAB-OprM β-lactams, β-lactam inhibitors, 
fluoroquinolones, tetracycline, 
chloramphenicol, novobiocin, macrolides, 
trimethoprim, ethidium bromide, SDS, acylated 
homoserine lactones 
 
(Poole et al., 
1993b) 
MexCD-OprJ β-lactams, fluoroquinolones, tetracycline, 
chloramphenicol, novobiocin, macrolides, 
trimethoprim, acriflavin, aromatic 
hydrocarbons 
 
(Poole et al., 
1996a; Poole, 
2001a) 
MexEF-OprN Fluoroquinolones, chloramphenicol, 
trimethoprim, aromatic hydrocarbons 
(Kohler et al., 
2001; Poole, 
2001a) 
MexGHI-OpmD Vanadium, acylated homoserine lactones? (Aendekerk et 
al., 2002) 
MexJK-OprM Tetracycline, erythromycin (Chuanchuen et 
al., 2002) 
MexXY-OprM Fluoroquinolones, erythromycin, tetracycline, 
aminoglycosides 
(Westbrock-
Wadman et al., 
1999) 
MexVW-OprM Fluoroquinolones, tetracycline, 
chloramphenicol, erythromycin, 
Ethidium bromide, acriflavine. 
(Li et al., 2003) 
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These Mex pumps share a similar genetic organization but differ in substrate 
specificity and regulation. The mexAB-oprM operon was first thought to play a role in 
the export of siderophore pyoverdine (Poole et al., 1993a). Further characterization of 
the operon, however, showed that over-expression of MexAB-OprM increased the 
resistance of P. aeruginosa to various antibiotics such as tetracycline, 
chloramphenicol, ciprofloxacin etc. (Poole et al., 1993b). A direct assay of drug 
accumulation showed that MexAB-OprM pumps out various antibacterial agents in an 
energy-dependent fashion (Li et al., 1995). This efflux system was also thought to 
pump out quorum sensing related homoserine lactone PAI-1 (Evans et al., 1998). The 
examination of P. aeruginosa strains showed widely different levels of intrinsic 
resistance suggested the presence of more than one endogenous multi-drug efflux 
system (Li et al., 1994). Similar to MexAB-OprM, MexEF-OprN expression 
correlates inversely with the production of the virulence factor pyocyanin (Kohler et 
al., 1997). In contrast to MexAB-OprM and MexCD-OprJ, MexEF-OprN does not 
confer resistance to β-lactams (Gotoh et al., 1995; Kohler et al., 1997). The effects of 
simultaneous expression of these efflux pumps on antibiotic resistance were 
investigated.  It was shown that simultaneous overexpression of pairs of multi-
component efflux pumps provided additive effects on drug resistance (Lee et al., 
2000). 
Each of the operons encoding the four RND pump complexes encodes its own 
transcriptional regulator (either a repressor or an activator) upstream to the operon 
(Figure 5). Most of these regulatory proteins do not share significant homology to one 
another, but appear to belong to four distinct families of regulatory proteins (Grkovic 
et al., 2002). The regulation of the mexAB-oprM operon is the best-characterized 
example; the divergently encoded MexR, a member of the MarR family of proteins, 
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acts as a repressor of transcription of mexAB-oprM (Li et al., 1995; Poole et al., 
1996b). In addition to the control of transcription from the mexA promoter (P2mexA), 
MexR also autoregulates its own expression by repressing the mexR promoter (PmexR) 
(Evans et al., 2001). Initially, it was proposed that a second promoter (P1 mexA) might 
be responsible for the relatively high constitutive level of mexAB-oprM expression. 
However, S1 mapping and reporter gene fusions showed that P1 mexA was not a 
functional promoter (Sa'nchez et al., 2002). A large number of mutant strains that 
contain alterations to the mexR coding region and produce an inactive MexR repressor 
have been described; all of these mutations result in overproduction of the MexAB-
OprM pump complex and enhanced efflux of a broad range of antibiotics, such as β-
lactams, fluoroquinolones, tetracycline, and chloramphenicol (Li and Poole, 1999). 
Not surprisingly, clinical isolates that overexpress the MexAB–OprM system often 
carry mutations in the mexR gene (Saito et al., 1999; Adewoye et al., 2002).  
Expression of mexCD–oprJ is regulated by the NfxB repressor encoded by a 
gene located upstream of the mexCD–oprJ operon (Poole et al., 1996a). P. aeruginosa 
isolates from cystic fibrosis patients, which expressed MexCD–OprJ as a consequence 
of long-term ciprofloxacin exposure were shown to harbour mutations in nfxB (Jalal et 
al., 2000). MexT, a member of the LysR family of transcriptional regulators, is an 
activator of mexEF–oprN transcription (Kohler et al., 1997; Kohler et al., 1999) and 
thus mechanistically unique when compared to other P. aeruginosa RND operons 
whose expression is usually negatively regulated. The mexT gene is located upstream 
of and transcribed in the same direction as the mexEF–oprN genes. Overexpression of 
mexT induces the expression of mexEF–oprN, and decreases the expression of the 
oprD outer membrane channel (Masuda et al., 2001). MexXY appears to be regulated 
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by MexZ, which is homologous to the repressor protein AmrR in B. pseudomallei 















Figure 5. Genetic organization of the RND efflux pumps in P. aeruginosa. Each 
operon contains genes (grey arrows) that encode a drug efflux complex and is 
regulated by the product of an upstream gene (black arrow), which either represses (-) 
or activates (+) operon expression. A schematic representation of the MexAB-OprM 
tripartite complex, which efflux drugs simultaneously across both the cytoplasmic 
(CM) and outer (OM) membranes, is also shown. MexB, the RND component of the 
pump complex, transports drugs across the cytoplasmic membrane in exchange for 





Global regulation of efflux pump expression is also evident from instances 
where interplay between different pumps is seen within P. aeruginosa that 
simultaneously expressed the MexAB–OprM and MexXY systems, thus broadening 
the resistance profile, which is of great advantage in a clinical setting (Llanes et al., 
2004). This indicates a very tight coordination in the regulation of expression of 
efflux pumps with overlapping substrate profiles. There is also mounting evidence 
that mex gene expression in P. aeruginosa is also controlled by a number of global 
regulators. For instance, expression of MexGHI–OpmD is governed by the quorum 
sensing regulatory circuits (Aendekerk et al., 2002). Secondly, some clinical isolates 
express MexAB–OprM, although they do not contain mexR mutations, thus the 
regulation of mexAB–oprM is quite complex and other regulators besides MexR are 
involved (Srikumar and Poole, 2000; Beinlich et al., 2001). MexAB–oprM over-
expressing mutants may be grouped as nalB-type mutants, which contain mutations in 
mexR, or nalC-type mutants which do not have mutations in mexR. Recently, it was 
found that nalC mutants contain mutations in PA3721, another transcriptional 
regulator of the TetR family (Cao et al., 2004). PA3721 functions as a repressor of the 
two yet uncharacterized genes comprising the PA3719–PA3720 operon. Over-
expression of PA3719 alone is sufficient for expression of the nalC phenotype, with 
PA3719 directly or indirectly impacting mexAB–oprM expression. Recently, nalD-
type mutants expressing mexAB–oprM without mutations in either mexR or 




1.4. Physiological functions of bacterial multi-drug 
transporters 
The physiological functions of the different RND pumps are still a topic of 
debate. The broad range-specificity of RND pumps which makes possible the efflux 
of structurally unrelated toxic compounds might either be the primary physiological 
function of multi-drug transporters or merely a fortuitous side effect of its primary 
role in the transport of an unidentified specific physiological substrate (Neyfahk, 
1997). It was originally believed that these pumps evolved in gram-negative bacteria 
as a defense mechanism to counter the effects of environmental anti-microbials or 
other toxins. However, with phylogenetic studies pointing to the presence of RND 
homologs in gram-positive bacteria, archaea and even human, it is now widely 
believed that these proteins are members of an ancient family of proteins with 
representation in all major kingdoms (Tseng et al., 1999). 
The most convincing evidence for the involvement of multi-drug transporters 
in chemoprotection comes from the analysis of the mechanisms regulating expression 
of E. coli multi-drug transporter, AcrAB. The gene expression of acrAB can be 
induced by the ubiquitous plant products salicylate and naphthoquinones (Miller and 
Sulavik, 1996). Thus, it is plausible that one of the functions of these pumps is to 
prepare bacteria for attack from multiple toxins elicited by either living or 
decomposing plants. Furthermore, acrAB is also induced in response to stress 
conditions (Ma et al., 1996), bile salts (Thanassi et al., 1997), and organic solvents 
(White et al., 1997), suggesting that multi-drug transporters play a role in protection 
of the membrane integrity or energy state of the cell. The AcrAB pump of E. coli has 
a high affinity for bile salts, and acrAB knockout strains are hypersusceptible to bile 
salts (Thanassi et al., 1997). Since the natural habitat of E. coli is the enteric tract, 
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which is rich in bile salts, its efflux would be a protective mechanism. It is also 
possible that bacterial efflux pumps may be involved in the removal of metabolic by-
products, thus buffering the organism against surges in pools of potentially toxic 
metabolites (Helling et al., 2002).  
There is also evidence that RND pumps might be involved in the efflux of 
signal molecules required for bacterial cell-to-cell signalling (quorum sensing). SdiA, 
a quorum-sensing regulator from E. coli, controls multi-drug resistance by positively 
regulating the AcrAB pump (Rahmati et al., 2002). Finally, the AcrAB–TolC pump 
seemed to be involved in the transport of the calcium-channel components in the E. 
coli membrane (Jones et al., 2003). In P. aeruginosa, the physiological role of only 
the MexGHI-OpmD pump, which extrudes heavy metals, is known (Aendekerk et al., 
2002). Other P. aeruginosa RND pumps may play an active role in cellular 
metabolism although direct evidence for this is not available. For example, strains 
hyper-expressing and/or lacking MexAB-OprM, MexEF-OprN and MexGHI-OpmD 
either exhibited altered levels of extra-cellular acyl-homoserine lactones (HSLs) or 
other phenotypes tied to quorum sensing (Evans et al., 1998; Kohler et al., 2001; 
Aendekerk et al., 2002). Therefore, these systems may play a role in the efflux of 
quorum sensing molecules or their metabolic precursors, and thus play an important 
role in quorum sensing signal homeostasis (Schweizer, 2003). MexAB–OprM was 
shown to play a role in the invasiveness of P. aeruginosa in mouse models (Hirakata 
et al., 2002), thus MexAB-OprM is involved in the pathogenicity of this organism. 
In Bacillus subtilis, Blt, a member of the major facilitator superfamily of 
transporters, effluxes from cells a number of toxic molecules, such as fluoroquinolone 
antibiotics, ethidium, rhodamine, tetraphenylphosphonium, acridine dyes, puromycin, 
doxorubicin, etc (Ahmed et al., 1995). BltD is also shown to efflux the polyamine 
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spermidine (Woolridge et al., 1997). Over-expression of Blt led to 2-fold decrease in 
the amount of intracellular spermidine and a 4-fold increase in the efflux of 
spermidine into the culture medium. It has also been proposed that physiological 
functions unrelated to antibiotic resistance can actually foster persistence of resistant 
determinants in bacteria (Barbossa and Levy, 2000). For example, a plasmid carrying 
both the chloramphenicol-resistance gene and tetracycline-resistance gene conferred 
beneficial fitness effects on E. coli. In the study, the plasmid was introduced into a 
naïve, plasmid-free E. coli host and into an E. coli host that had previously borne the 
same plasmid for 500 generations under antibiotic selective pressure. In the absence 
of antibiotics, the naïve host did not grow as well as the adapted host and this survival 
advantage was attributed to the tetracycline-resistance gene. Although it was unclear 
what the specific benefits of the antibiotic-resistance gene conferred on the host, the 
data suggests that its presence had a beneficial role on the survival of the host 
bacterium, which might be the maintenance of pH homeostasis in E. coli as reviewed 
by Krulwich (Krulwich et al., 2005). This indication of a role in alkali tolerance is 
supported by the alkali sensitivity of an mdf multi-drug-efflux pump deletion strain 
(Lewinson et al., 2004). The sensitivity of deletion mutants to alkaline conditions 
indicates that Mdf efflux pump is involved in bacterial pH homeostasis, a property 
that is essential for all forms of life coping with fluctuating and/or a wide range of 
external pH values (~5.5 – 9.0) to protect the integrity and activity of cytoplasmic 
proteins (Padan et al., 1981; Booth, 1985).  
 
1.5. Inhibitors of multi-drug efflux pumps 
Today, many important pathogens are resistant to multiple anti-microbial 
classes, covering most, sometimes all, clinically useable anti-microbials, and 
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infections caused by these so-called multi-drug resistant organisms are costly to treat 
and treatment increasingly prone to failure (Deshpande et al., 2004). Early approaches 
to bacterial antibiotic resistance involved the discovery and development of new 
antibiotics, often of new classes, an approach that later gave way to chemical 
modification of existing agents to increase potency and/or overcome/bypass 
resistance. However, novel anti-microbial classes unaffected by existing resistance 
became harder to come by and existing resistance mechanisms adapted to the 
antibiotic modifications designed to overcome them. Thus, as in the pre-antibiotic era, 
infectious disease remains today a major determinant of human morbidity and 
mortality. 
Multi-drug transporters are a serious problem in the treatment of patients with 
hospital-or community-acquired infectious disease as they confer resistance to various 
antibiotics employed (Putman et al., 2000a). To restrain the evolution of antibiotic 
resistance, the dependence and abuse of antibiotic usage must be reduced. One 
approach is to search for antibiotics with novel modes of action, which will not face 
previously selected resistance determinants. The failures encountered with antibiotics 
designed to specifically resist inactivating enzymes such as β-lactamases showed that 
this is likely to be overcome quickly by the bacteria. Obtaining specific and potent 
inhibitors of antibiotic transporters, therefore appears today as an important objective 
in anti-infective chemotherapy. The identification and development of resistance-
blocking agents, to allow existing antibiotics to remain effective, became urgent. With 
the demonstrated importance of RND transporters in the development of clinically 
significant anti-microbial resistance in many gram-negative bacteria, these efflux 
pumps play an important role in the drug discovery process and are considered bona 
fide drug targets for the development of combination therapies (Lomovsakya and 
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Watkins, 2001b; Lomovsakya and Watkins, 2001a; Lomovskaya et al., 2001). 
Inhibition of these pumps may be achieved at different levels: by inhibiting drug 
binding to the inner membrane pumps, by inhibiting the interactions of different 
components of a multi-component pump, by targeting the regulatory networks that 
control the expression of efflux pumps, or by targeting the energy source of pumps 
with the use of carbonyl cyanide m-chlorophenylhydrazone (CCCP), that dissipates 
the proton motive force within bacterial cells.  
Over the past decade, a series of efflux pump inhibitors (EPIs) have been 
identified. The first broad-spectrum RND pump inhibitor, MC-207,110 (phenylalanyl-
arginyl-h-naphthylamide), potentiated the activity of levofloxacin against wild-type P. 
aeruginosa 8-fold and against a MexAB–OprM overexpressing strain 64-fold (Renau 
et al., 1999; Lomovskaya et al., 2001; Kriengkauykiat et al., 2005). Several improved 
EPIs exhibited antibiotic potentiation activity for P. aeruginosa strains expressing 
MexAB–OprM, MexCD–OprJ and MexEF–OprN, and for E. coli expressing AcrAB–
TolC (Lomovsakya and Watkins, 2001b; Renau et al., 2001). Importantly, EPIs 
dramatically reduced the emergence of spontaneously levofloxacin-resistant bacteria 
and were effective in animal models of P. aeruginosa infections ((Lomovskaya et al., 
2001). Similar compounds have been shown to inhibit efflux pumps in E. aerogenes 
(Mallea et al., 2002) and Campylobacter (Mamelli et al., 2003). It is believed that 
these compounds act by inhibiting the specific binding sites of antibiotics within the 
pump molecule (Lomovsakya and Watkins, 2001a). Benastatins obtained from 
fermentation of an actinomycete are another group of compounds that were found to 
be active against P. aeruginosa expressing MexAB–OprM (Lee et al., 2001). Several 
inhibitors of the multi-drug transporters NorA and PmrA have also been shown to 
increase the activity of fluoroquinolones against Staphylococcus aureus and S. 
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pneumoniae respectively (Aeschlimann et al., 1999; Markham, 1999). Furthermore, 
these inhibitors dramatically suppress the in vitro emergence of resistant strains.  
 
1.6. Burkholderia pseudomallei – the causative agent of 
melioidosis 
Burkholderia (Pseudomonas) pseudomallei was first described in 1912 by 
Whitmore and Krishnasawami in Rangoon, Burma (Whitmore and Krishnaswami, 
1912). B. pseudomallei is an environmental saprophyte found in wet soils, rice 
paddies and stagnant waters. The common route of infection is via inhalation of 
contaminated dust or when contaminated soil comes in contact with abraded skin 
(Brett and Woods, 2000). B. pseudomallei  is visualized as a gram-negative bacillus 
with bipolar staining and is vacuolated and slender and has rounded ends. It is a 
resilient organism that is capable of surviving hostile environmental conditions, 
including prolonged nutrient deficiency (Wuthiekanun et al., 1995), antiseptic and 
detergent solutions (Gal et al., 2004), acidic environments (pH 4.5 for up to 70 days) 
(Dejsirilert et al., 1991), and a wide temperature range (24oC to 32oC) and 
dehydration (soil water content of less than 10% for up to 70 days) (Tong et al., 1996; 
Chen et al., 2003), but not exposure to UV light (Tong et al., 1996). It is likely that 
harsh environment conditions may confer a selective advantage for the growth of B. 
pseudomallei (Cheng and Currie, 2005).   
B. pseudomallei is very well adapted to its many hosts, producing proteases 
(Sexton et al., 1994; Lee and Liu, 2000), phospholipase C (Korbsrisate et al., 1999), 
and hemolysin, lecithinase, and lipase (Ashdown and Koehler, 1990). These antigens 
are probably secreted via the general secretory pathway (type II secretion system) 
(DeShazer et al., 1999) and their exact roles in pathogenesis are unclear. Transposon 
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mutations in the general secretory pathway, resulting in a failure to secrete protease, 
lipase, or lecithinase, do not appear to result in an attenuation of virulence in an 
animal model (Brett and Woods, 2000). A largely unexplored area has been the role 
of iron metabolism in determining virulence in B. pseudomallei. It is known that a 
siderophore, malleobactin, is produced by B. pseudomallei and is efficient at 
acquiring iron at acidic pH (Yang et al., 1993). In other organisms, such as Vibrio 
parahaemolyticus, iron-restricted conditions result in the induction of siderophore 
production with increased virulence (Dai et al., 1992).  
Previous study in our laboratory showed that B. pseudomallei is capable of 
forming biofilms (Song, 2003). Biofilm is defined as a microbially derived sessile 
community characterized by cells that are attached to a substratum or interface or to 
each other, are embedded in a matrix of extracellular polymeric substances that they 
have produced and exhibit an altered phenotype with respect to growth rate and gene 
transcription (Harshey, 1994; Donlan and Costerton, 2002). Biofilm development 
initiates when bacteria change from a planktonic existence to a lifestyle in which the 
microorganisms are firmly attached to biotic or abiotic surfaces. This transition is 
believed to be regulated in part by the nutritional status of the environment. After the 
initial attachment to the substratum, cells are thought to undergo a programme of 
physiological changes, which results in a highly structured sessile microbial 
community. One prominent feature of bacteria in biofilms is their dramatic increased 
resistance to antibiotics. In fact, when cells exist in a biofilm, they can become 10-
1000 times more resistant to the effects of anti-microbial agents (Nickel et al., 1985; 
Evans and Holmes, 1987; Gristina et al., 1987; Prosser et al., 1987). The development 
cycle of biofilm is completed when planktonic cells are shed from the biofilm into the 
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Melioidosis is an infection caused by the gram-negative bacterium 
Burkholderia pseudomallei, and is an important cause of community-acquired sepsis 
in Southeast Asia and northern Australia (White, 2003). Adults who are infected 
usually have an underlying predisposing condition, such as diabetes mellitus 
(Suputtamongkol et al., 1999). Symptoms of infection include fever, internal 
abscesses or inflamed joints, cough, gastrointestinal discomfort and diarrhoea. The 
disease may manifest itself as an acute, subacute or chronic form of illness (Dance, 
1991). In N.E. Thailand where the disease is endemic, overall mortality of infected 
individuals is 51% (White, 2003).  In the acute form of the disease, death usually 
occurs within 48 h as a result of septic shock. The infection may also remain dormant 
and become active after months, years or decades when host is immuno-compromised 
by drugs (e.g. steroids) or disease (diabetes mellitus, chronic renal failure, retrovirus 
infections, haematological malignancies, collagen vascular disease) or social 
deprivation (alcoholism, drug abuse, occupational exposure) (Currie et al., 1993). The 
factors that provoke the reactivation of latent pathogen probably are environmental 
variables, stress and immunity status (Johnson and Ali, 1990; Thummakul et al., 
1999).  
In Singapore, melioidosis is a notifiable communicable disease and an average 
of 60 cases are reported each year (MOH, Communicable Diseases Surveillance in 
Singapore, 1995 - 2004).  Eighty-four cases were reported from January to September 
2004, with a mortality rate of 32.1% (Orellana, 2004). The infection was reported by 
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the Sydney Morning Herald (September 17, 2004) as being worse than Severe Acute 
Respiratory Syndrome (SARS), which had a mortality rate of 13%. B. pseudomallei is 
now classified as a potential agent for bioterrorism by the Centers for Disease Control 
and Prevention (www.cdc.gov). The US National Institute of Allergy and Infectious 
Diseases (NIAID) is strongly funding and encouraging microbiologists to study the 
bacterium and develop improved diagnostic tools, treatments and vaccines (Aldhous, 
2005).  
The acute form of infection often leads to high mortality and morbidity rates 
despite aggressive antibiotic therapy.  This is, in part, due to the inherent resistance of 
B. pseudomallei to a variety of antibiotics including β-lactams, aminoglycosides, 
macrolides and polymyxins (Eickhoff et al., 1970). Treatment of severe melioidosis 
includes a combination of cefoperazone-sulbactam plus co-trimoxazole or ceftazidime 
plus co-trimoxazole (Chetchotisakd et al., 2001). A high-dose intravenous ceftazidime 
regimen was shown to be superior to the conventional four-drug regimen 
(chloramphenicol, doxycycline, and trimethoprim-sulfamethoxazole) (Chaowagul, 
2000). Despite treatment with high-dose ceftazidime, severe melioidosis carries a 
mortality rate of 40% (Angus et al., 2000). Oral treatment using the four-drug 
regimen was given over 20 weeks for maintenance therapy, with chloramphenicol 
given only for the first 8 weeks. Despite this long antibiotic course, the rate of relapse 
is about 10%, which rises to nearly 30% if antibiotic treatment lasts for 8 weeks or 
less (Suputtamongkol et al., 1991; Chaowagul et al., 1993; Rajchanuvong et al., 1995; 
Chaowagul et al., 1999; Chaowagul, 2000; Currie et al., 2000). Risk of relapse is 
related to adherence to treatment and the initial extent of disease, but not to the 
underlying condition (Chaowagul et al., 1993). B. pseudomallei strains resistant to 
chloramphenicol, ceftazidime and polymyxin B are known to emerge during 
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maintenance therapy. The chloramphenicol-and ceftazidime-resistant B. pseudomallei 
strains were reported to be fully virulent and frequently showed cross-resistance to 
other anti-microbials such as tetracycline, sulfamethoxazole, trimethoprim, and 
ciprofloxacin (Dance et al., 1989). 
Burkholderia pseudomallei was formerly under genus Pseudomonas. Based on 
the 16S rRNA sequences, DNA-DNA homology values, cellular lipid and fatty acid 
composition, and phenotypic characteristics, B. pseudomallei was transferred to the 
new genus Burkholderia (Yabuuchi et al., 1992). The complete genome of B. 
pseudomallei, was composed of two chromosomes of 4.07 megabase pairs and 3.17 
megabase pairs, showing significant functional partitioning of genes between them 
(Holden et al., 2004). The large chromosome 1 encodes many of the core functions 
associated with central metabolism and cell growth, whereas the small chromosome 
carries more accessory functions associated with adaptation and survival in different 
niches. In silico genome analysis identified 8 putative RND efflux pumps in B. 
pseudomallei, of which 6 are located on chromosome 1, the remaining two on 
chromosome 2. 
In B. pseudomallei, AmrAB-OprA, an efflux system of the resistance-
nodulation division (RND) family, has been reported to be responsible for the efflux 
of aminoglycosides and macrolides (Moore et al., 1999).  A divergently transcribed 
repressor gene, amrR, which belongs to a TetR family protein, is proposed to be a 
transcriptional repressor of amrAB-oprA. However, the expression of the AmrAB-
OprA efflux system was not affected by the substrate streptomycin or by stress 
conditions such as 4% ethanol or 0.5% NaCl (Moore et al., 1999). RND efflux pumps 
have been described in other gram-negative bacteria, including AcrAB-TolC of 
Escherichia coli; the AcrAB homologue of Salmonella enterica serovar 
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Typhimurium; MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM of 
Pseudomonas aeruginosa; and CeoAB-OpcM of Burkholderia cepacia ((Poole, 
2001b). Additionally, many of these bacterial pathogens have several RND multi-drug 
efflux systems that render them resistant to a wide range of anti-microbials. When 
AmrAB-OprA was first identified in B. pseudomallei as an aminoglycoside and 
macrolide efflux pump, we asked if there too might also be other RND pumps in B. 
pseudomallei and, more importantly, if these pumps interact with one another.   
 
1.8. Objectives of present studies 
The successful treatment of melioidosis patients is difficult due to the inherent 
resistance of B. pseudomallei to a variety of antibiotics including β-lactams, 
aminoglycosides, macrolides, and polymyxins. The overall aim of this thesis is to 
characterize the role of B. pseudomallei RND multi-drug efflux pumps in antibiotic 
resistance. The identification of multiple putative RND efflux pumps in B. 
pseudomallei via in silico genome analysis suggests that these pumps may have 
important physiological roles - perhaps acting as metabolic relief valves as suggested 
by Van Dyk et al (Van Dyk et al., 2004). Treatment of E. coli with p-hydroxybenzoic 
acid (pHBA) resulted in up-regulation of aaeAB, encoding a protein of the AaeAB 
efflux protein family. pHBA is an intermediate of ubiquinone biosynthesis and thus 
would normally be expected to be present at very low concentrations in E. coli cells. 
However, an accumulation of PHBA to high levels in the cell disrupts its metabolic 
state and the expression of the efflux system is activated. The role of pHBA in normal 
E. coli metabolism and the highly regulated expression of the AaeAB efflux system 
suggest that its physiological role may be as a "metabolic relief valve" to alleviate 
toxic effects of imbalanced metabolism. By focussing on a RND pump, which shares 
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significant amino acid homology to the P. aeruginosa MexAB-OprM and E. coli 
AcrAB-TolC pumps, this thesis describes a study of the B. pseudomallei BpeAB-
OprB pump.   
 
Specific objectives of this thesis include: 
(i) Identification of the anti-microbial substrates of the B. pseudomallei BpeAB-
OprB pump by comparing anti-microbial susceptibility profiles of isogenic 
bpeAB  pump mutants with the parental wild-type B. pseudomallei  
(ii) Regulation of bpeAB-oprB expression by both local and global regulators  
(iii) Identification of physiological substrates of the BpeAB-OprB pump as the 
growth phase-dependent expression of bpeAB-oprB suggests that it might be 
involved in the regulation of the intracellular levels of a physiological substrate(s) 
or a cellular metabolite, which accumulates during stationary phase    
(iv) Elucidating the interaction between BpeAB-OprB and B. pseudomallei quorum 
sensing as evidence for such interaction has been provided for several RND 
pumps (Evans et al., 1998; Kohler et al., 2001; Aendekerk et al., 2002; Rahmati 
et al., 2002) 
(v) Screening chemical analogues of cellular metabolites that might function as 









Chapter 2: Materials and Methods 
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2.1. Bioinformatic tools 
 
The presence of RND pumps in B. pseudomallei, whose genome was 
completely sequenced by the Sanger institute (www.sanger.ac.uk) in May 2003, was 
analysed and annotated by homology and conserved domain search using a database 
created by Xie Chao (Xie, 2003). The prediction of transmembrane regions and 
orientations was done using TMPred (version 2) software 
(http://www.ch.embnet.org/software/TMPRED_form.html) (Hofmann and Stoffel, 
1993). The Neural Network Promoter Prediction at 
http://www.fruitfly.org/seq_tools/promoter.html was used for prediction of bacterial 
promoters. Multiple-sequence alignments of the translated amino acid sequences of B. 
pseudomallei ATCC 23343 bpeR-bpeAB-oprB with RND efflux pump components 
from other gram-negative bacteria were performed with the AlignX program in 
Vector NTI Suite 7 software (Informax Inc., Bethesda, Md.) and the BLASTX 
program (Altschul et al., 1997). The GenBank accession number for the B. 
pseudomallei KHW bpeAB-oprB DNA sequence is AY325270 (Appendix III).  
 
 
2.2. Bacterial strains and culture conditions  
The bacterial strains and plasmids used in this study are listed in Table 2. 
Unless otherwise stated, cultures were grown under aerobic conditions at 37°C in 
Luria-Bertani (LB) agar∗ or LB broth (Becton Dickinson, Cockeysville, Md.). The 
antibiotic concentrations used for E. coli, when it was used, were as follows: 
ampicillin, 50 µg/ml; gentamicin, 50 µg/ml; trimethoprim, 25 µg/ml; kanamycin, 10 
µg/ml; streptomycin, 50 µg/ml; chloramphenicol, 10 µg/ml; tetracycline, 5 µg/ml, for 
                                                
 
∗ Please refer to Appendix for recipes 
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A. tumefaciens: kanamycin, 50 µg/ml; tetracycline, 5 µg/ml and for B. pseudomallei: 
kanamycin, 200 µg/ml; trimethoprim, 100 µg/ml; tetracycline, 25 µg/ml. All 
antibiotics were purchased from Sigma (St Louis, Mo.). 
 
Table 2. Bacterial strains and plasmids used in this study 
Strain  Description 
Source or 
reference 
E. coli    
DH5αλpir λpir lysogen of DH5α for replication of 






Helper stain for triparental mating, supE44 
hsdS20(rBmB) recA13 ara-14 proA2 lacY1 
galK2 rpsL20 xyl-5 mtl-1; Cmr  
 




LE392 Permissive host strain for genomic library 
 
Promega 
JB525 Restriction-negative mutant derived from E. 
coli MC1000 harbouring plasmid pJBA132; 
Tcr 
 
Andersen et al., 
2001 
A. tumefaciens NT1 
(traR, tra::lacZ749) 
pTi58-cured derivative of A. tumefaciens C58, 
contains pAtC58, pJM749 and pSVB33 
 
Piper et al., 
1993 
B. pseudomallei    
ATCC23343 ATCC strain for genomic library generation ATCC 
KHW Wild-type parental strain, clinical isolate, 
KanS, TmpS, GenR 
 
Chua et al., 
2003 







KHW∆bpeAB complemented in trans with 
pUCP28TbpeAB; KanR, TmpR 
This study 
KHWbpeR::Km KHWbpeR::Km, derivative of KHW with 
bpeR inactivated by insertion of kanamycin 






KHWbpeR::Km complemented in trans with 









pGEM-T Vector for PCR cloning; AmpR 
 
Promega 





pUCP28T Broad-host range vector; incP oriT; pRO1600 
ori, TmpR 
 
West et al., 
1994 
pUCP28TbpeAB TmpR; 4.9 kb promoter-containing bpeAB 
PCR product ligated into SmaI site pUCP28T 
This study 
pUCP28TbpeR TmpR; 1.5 kb promoter-containing bpeR PCR 
product ligated into SmaI site pUCP28T 
 
This study 
pUTKm Source of kanamycin resistance cassette; 
oriR6K, mobRP4, KanR, AmpR 
 




pMC1403 pBR322-derived plasmid; source of promoter-




Mini-CTX1 Broad host range plasmid; oriT, TetR Hoang et al., 
2000 
pCYY Mini-CTX1 containing promoter-less lacZYA 
cassette from pMC1403 
 
This study 
pCYYbpeAB pCYY ligated to bpeAB promoter 
 
This study 
pCYYbpeR pCYY ligated to bpeR promoter 
 
This study 
pSYI pCYY carrying 1.2kbp bpsIpromoter-lacZ gene 
fusion; Tetr 
 
Song et al., 
2005 
pMC1403 pBR322-derived plasmid; source of promoter-





2.3. DNA and RNA manipulations 
Molecular biology techniques were performed as described by Sambrook et al 
(Sambrook and Russell, 2001). Restriction endonucleases and DNA-modifying 
enzymes were purchased from Promega Corp (Madison, WI. US). Conversion of 
DNA fragments with 3’ recessed or overhanging ends to blunt ends with T4 DNA 
polymerase was performed as described by the manufacturer (Promega). Briefly, 2 µg 
of DNA was made blunt-ended using 5 units of T4 DNA polymerase (Promega) and 
100 µM of dNTPs. Incubation was done at 37 oC for 5 minutes and the enzyme 
inactivated by heating the mixture at 75 oC for 10 minutes. DNA polymerase 




Genomic DNA was isolated according to the method described by Pitcher et al 
(Pitcher et al., 1989). Bacterial cells were harvested from 5 ml overnight broth 
cultures by centrifugation and resuspended in 100 µl sterile deionized water. Five 
hundred microliters of GES buffer was added and the mixture was gently mixed by 
inversion. The mixture was incubated at room temperature for 10 minutes before 
cooling on ice for 10 minutes. 250 µl of ice-cold 7.5M ammonium acetate solution 
was added and incubation on ice was done for another 10 minutes. Five hundred 
microliters of chloroform : pentanol (24:1) was added and the tube was centrifuged at 
14,300 g for 10 minutes. Seven hundred and thirty µl of ice cold isopropanol was 
added to the aqueous phase and DNA was pelletted at 6000 rpm for 1 minute. The 
DNA pellet was washed 5 times with ice-cold 70% (v/v) ethanol before drying the 
pellet under vacuum using Speedvac evaporator (Savant, Sunnyvale, CA, USA). DNA 
pellets were resuspended in 200 µl of sterile deionized water and stored at –20oC. 
Plasmids were purified from E. coli host strains by using Qiaprep Spin Miniprep 
kit (Qiagen, GmbH, Germany). Small scale purification of plasmid DNA using the 
commercial kit is based on the alkaline lysis method of Birnboim and Doly (Birnboim 
and Doly, 1979). A single bacterial colony of E. coli containing recombinant plasmid 
was inoculated into 5ml LB broth and incubated at 37˚C with shaking at 100 rpm 
about 16 h. The culture was centrifuged for 10 min at 3000 rpm at room temperature 
(Beckman Microfuge® Centrifuge, F241.5). The supernatant was then decanted and 
the pelleted bacterial cells were resuspended completely in 250µl of buffer P1 
containing RNase. 250 µl Buffer P2 was added and gently mixed by inverting the 
microtube a few times. Then 350 µl of buffer 3 was added and the tube was 
immediately mixed gently and thoroughly to avoid localized precipitation. This 
reaction mixture was centrifuged at 14,000g for 10 min at room temperature. After 
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centrifugation, the supernatant containing the plasmid was applied to the QIAprep 
column by decanting or pipetting and centrifuged at 14,000g for 2 min. After two 
times of centrifugation to completely collect the plasmid DNA on the column, the 
flow-throughs were discarded. The QIAprep spin column was washed by adding 
0.75ml of buffer PE and centrifuged at the same conditions. After the flow-throughs 
were discarded, the QIAprep column was centrifuged for an additional 1 min to 
remove residual wash buffer. Finally, the QIAprep column was placed in a clean 
1.5ml eppendorf tube and the plasmid DNA was eluted by adding 50µl SDW to the 
centre of the column and let stand for 1 min followed by centrifugation for 1 min. 
Plasmids were introduced into E. coli by electroporation using a Gene Pulser 
(BioRad, Richmond, CA, USA) DNA fragments were separated on 0.7-1.0% agarose 
(Gibco BRL, Rockville, USA) gels in Tris-borate (TBE) or Tris-acetate (TAE) buffer 
and purified with GeneClean II kit (Bio 101, Inc. Vista, CA, USA). DNA sequencing 
was performed with dideoxy chain termination method using ABI Big Dye terminator 
kit (Applied Biosystems, Foster City, USA) and analyzed using an Automatic 
Sequencer ABI 377 (Applied Biosystems). 
Total RNA was extracted from bacteria using RNeasy Mini Kit (Qiagen, 
Hilden, Germany) after pre-treatment with RNAprotect reagent (Qiagen) according to 
manufacturer’s instructions. RT-PCR was carried out using Access RT-PCR System 
(Promega) in Mg2+-free buffer containing 5 µg template RNA, 200 µM (each) dNTPs, 
1 µM of each primer, 1 mM MgSO4, 0.1 U Tfl DNA polymerase and 0.1 U AMV 
reverse transcriptase in a total volume of 10 µl. Cycling parameters include a reverse 
transcription step at 48oC for 45 min, followed by PCR of 1 cycle (2 min, 94oC), 30 
cycles (30 s, 94oC; 30 s annealing at the respective temperatures; 1 min/kb product 
length, 68oC) and a final extension at 68oC for 7 min. Conventional RT-PCR is an 
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end-point assay, and precise quantitation suffers from the plateau effect during the 
later stages of the PCR reaction. Furthermore, the interpretation of the results obtained 
is ambiguous. Therefore, extra caution was to be taken when interpreting data. 
Alternatively, competitive RT-PCR or real-time PCR could be used to determine gene 
expression levels. 
 
2.4. PCR primer design and amplification 
Primers used in this study are described in Table 3. VectorNTITM suite 7 was 
used to design the primers. Primer pairs used for PCR amplification comprises of a 
forward (F) primer that was identical to the sense strand (5’→3’), and a reverse (R) 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.5. Bacterial conjugation 
Plasmids were delivered to B. pseudomallei KHW by triparental mating as 
described by de Lorenzo and Timmis (de Lorenzo and Timmis, 1994). Briefly, donor and 
recipient strains and also the helper strain E. coli HB101(pRK600) were grown at 37oC 
overnight in 5 ml LB supplied with appropriate antibiotics. The cells were subcultured 
(1:100) the next day in 2 ml of LB. When the OD600 was about 0.9, the cells were 
harvested, washed and resuspended in 200µl LB. Donor and helper cells (100µl each) 
were mixed and incubated for 30 min at room temperature. Recipient cells (200µl) were 
added and the mixture was spot-inoculated onto the surface of pre-warmed LB agar 
plates. After overnight incubation at 37oC, the cells were scraped off and were 
resuspended in 1ml 0.9% NaCl. Serial dilutions were plated on LB medium containing 
200µg /ml kanamycin and 100µg/ml streptomycin to counter select against donor, helper 
and untransformed recipient cells. The second round of selection is 200µg/ml kanamycin 
and 5% sucrose, which selects against those KHW colonies carrying the extra-
chromosomal vector containing sacB or colonies whereby the entire vector DNA was 
inserted via a single crossover recombination event. 
 
2.6. Construction and screening of the B. pseudomallei DNA 
library  
Genomic clones carrying the genes encoding bpeAB-oprB were identified from a 
genomic library of B. pseudomallei ATCC 23343 (American Type Culture Collection, 
Manassas, Va.), using 32P-radiolabeled B. cepacia ceoA- and ceoB-specific DNA probes 
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(Amersham Biosciences, Little Chalfont, UK), which were generated with the primers 
pairs ceoA3F/ceoA4R and ceoB6F/ceoB4R, respectively (Table 3). CeoA and ceoB 
probes shared 56% and 64% identity with bpeA and bpeB DNA sequences respectively. 
This was done prior to the completion of genome sequencing of B. pseudomallei by the 
Sanger institute. The genomic library was constructed by using partially digested Sau3AI 
genomic DNA and XhoI-digested arms of bacteriophage λGem-12 (Promega, Madison, 
WI.). DNA manipulation techniques, plaque hybridization, and extraction of 
bacteriophage DNA were performed as described by Sambrook and Russell (Sambrook 
and Russell, 2001), while the extraction of bacterial genomic DNA was done by the 
method described by Pitcher et al (Pitcher et al., 1989).  
The bpeR-bpeAB-oprB contig was assembled from sequences of the ceoB clone 
obtained by a combination of subcloning into pBluescriptII (Stratagene, La Jolla, CA) 
and primer walking (Figure 6). Plasmid DNA was purified from overnight cultures with a 
Qiaprep Spin Miniprep kit (Qiagen, Hilden, Germany). PCR was performed in a PTC-
100 Peltier thermal cycler (MJ Research, Waltham, MA.) in Mg2+-free buffer containing 
100 ng of template DNA, 200 µmol (each) deoxynucleoside triphosphate, 50 pmol of 
each primer, 1.5 mM MgSO4, and 0.5 U of Tth polymerase (Biotools, Madrid, Spain) in a 
total volume of 50 µl. The cycling parameters included 1 cycle at 94°C for 3 min, 
followed by 30 cycles at 94°C for 30 s (with 30 s of annealing at the respective 
temperatures; 1 min/kb of product length at 72°C) and a final extension at 72°C for 10 
min. DNA sequencing was performed with an ABI BigDye (version 3) dye terminator 
kit, and the DNA sequence was analyzed with an automatic sequencer (model 377; 





Figure 6. Organization of bpeR-bpeA-bpeB-oprB genes in B. pseudomallei and the 
locations of primers for (i) sequence determination, (ii) cloning of the full-length bpeAB 
for trans complementation, and (iii) verification of the allelic exchange. The thin dotted 
lines illustrate the allelic exchange involved in the construction of KHW∆bpeAB. Solid 
arrows and their numbers indicate the locations of the primers listed in Table 2, while the 
predicted promoters for bpeAB-oprB are represented by the thick dotted arrows. The 
divergently transcribed bpeR is indicated by the stippled arrow. The probes generated 
with the PCR primers listed in Table 2 are indicated as solid bars at the bottom. 
 
2.7. Construction of KHW∆bpeAB and KHWbpeR::Km 
The bpeAB deletion was generated in B. pseudomallei KHW, a virulent clinical 
isolate, by the homologous gene replacement strategy described previously (Chua et al., 
2003). Briefly, bpeA (1.2 kbp) and bpeB (1.3 kbp) PCR products, obtained with primer 
pairs AcrAHisF-AcrAHisR and AcrB3’3716-AcrB3’R1, respectively, were digested with 
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ClaI, which cleaved the bpeA and bpeB fragments internally. A 271-bp bpeA 5’ fragment 
and a 989-bp bpeB 3’ fragment were recovered after electrophoresis in 1% agarose with 
the GeneClean II kit (Bio 101, Inc., Vista, CA) and ligated with T-tailed plasmid pGEM-
T (Promega) to yield pGEM-T∆bpeAB. Next, ClaI-linearized pGEMT∆bpeAB was made 
blunt ended before ligation with an end-filled 2.3-kbp EcoRI fragment containing the 
kanamycin resistance gene cassette from pUTKm (GenBank accession number 
AF102233), yielding pGEMT∆bpeABKm.  
A 3.5-kbp ApaI-SpeI fragment containing the 5’ bpeA, 3’ bpeB, and kanamycin 
resistance cassette from pGEMT∆bpeABKm was made blunt ended and inserted into 
SmaI-linearized pJQ200mp18, yielding pJQ200∆bpeABKm. pJQ200∆bpeABKm was first 
introduced into E. coli DH5αλpir by electroporation with a MicroPulser instrument (Bio-
Rad, Hercules, CA) and then mobilized into B. pseudomallei KHW by triparental mating 
with E. coli HB101(pRK600) as the helper strain, as described by de Lorenzo et al. (de 
Lorenzo and Timmis, 1994). Exconjugants were plated on LB agar containing 
kanamycin, streptomycin, and 5% (w/v) sucrose to select for recombinants, which had 
undergone allelic exchange. The chromosomal deletion of bpeAB was confirmed by PCR 
with primers AcrABpro and AcrB3’R1 (Table 3; Figure 6) and Northern blotting. The 2.3 
kbp kanamycin resistance cassette from pUTKm and a 1.6 kbp fragment from B. 
pseudomallei generated by PCR with primers AcrA3’F3 and AcrB5’R3 were used as 
probes for the Northern blotting. A 521-bp 16S ribosomal DNA PCR product, generated 




The bpeR insertion mutant was generated in B. pseudomallei KHW using the 
homologous gene replacement strategy as described previously (Chan et al., 2004). The 
631bp bpeR product was amplified using the primers AcrRHisF and AcrRHisR, and 
ligated with T-tailed pGEM-T (Promega) yielding pGEM-TbpeR. Next, NarI-linearized 
pGEM-TbpeR was made blunt-ended before ligating with a 2.3 kbp end-filled EcoRI 
fragment containing the kanamycin-resistance cassette from pUTKm, yielding pGEM-
TbpeR::Km. DNA fragments with 3’ recessed or overhanging ends were converted to 
blunt ends using T4 DNA polymerase (Promega).  
A 3 kbp ApaI-SpeI fragment containing the bpeR and kanamycin resistance 
cassette from pGEM-TbpeR::Km was made blunt-ended and inserted into SmaI-
linearized pJQ200mp18, yielding pJQ200bpeR::Km. pJQ200bpeR::Km was first 
introduced into E. coli DH5αλpir by electroporation using MicroPulser (BioRad) and 
then mobilized into B. pseudomallei KHW by triparental mating using E. coli HB101 
(pRK600) as helper strain (de Lorenzo and Timmis, 1994). Recombinants which had 
undergone allelic exchange were selected on LA containing kanamycin, streptomycin and 
5% (w/v) sucrose and were designated KHWbpeR::Km. The bpeR null mutation was 
verified by PCR using primers AcrRHisF and AcrRHisR, and by RT-PCR.  RT-PCR of 
16sRNA using primers 16SF2 and 16SR2 was included as a control for the amount of 




2.8. Complementation of KHW∆bpeAB mutant with wild-type 
bpeAB and KHWbpeR::Km with wild-type bpeR  
It is important to show that the introduction of wild-type copies of the bpeAB and 
bpeR genes in trans could restore the phenotypes of KHW∆bpeAB and KHWbpeR::Km 
to wild-type. A 4.9-kbp full-length bpeAB PCR product, amplified from KHW genomic 
DNA by use of the Expand Long Template PCR system (Roche Diagnostics GmbH, 
Mannheim, Germany) and primers AcrABpro and AcrB3’R1 (Table 3), was blunt ended 
with T4 DNA polymerase and was ligated with SmaI-linearized pUCP28T, yielding 
pUCP28TbpeAB (Table 2). pUCP28TbpeAB was first introduced into DH5αλpir by 
electroporation and was subsequently mobilized into KHW∆bpeAB by conjugation, as 
described above.  
Complementation of the KHWbpeR::Km mutant was performed by cloning the 
promoter-containing 1.5 kbp bpeR PCR product, amplified from KHW genomic DNA 
using primers AcrRHisF and AcrA5’R, and made blunt-ended, into SmaI-linearized 
pUCP28T, yielding pUCP28TbpeR (Table 2). pUCP28TbpeR was mobilized into 
KHWbpeR::Km via triparental mating as described previously.  
 
2.9. Construction of promoter-lacZ fusions 
The broad host range vector, pCYY carrying a promoterless lacZ cassette was 
used to construct bpeRpromoter-lacZ and bpeABpromoter-lacZ fusions as described by Chan et 
al. (Chan and Chua, 2005). pCYY was derived by ligating a 6.2 kbp EcoRI-SalI  
promoterless lacZYA cassette from pMC1403 to EcoRI-SalI linearized mini-CTX1. An 
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868 bp intergenic fragment, comprising the upstream regulatory sequences of bpeR and 
bpeAB, as well as the ATG initiation codons, was obtained by PCR using primers 
AcrABpro and AcrA5’R and DNA from KHW. Opposite orientations of the blunt-ended 
PCR product when ligated to SmaI digested pCYY, yielded the bpeABpromoter-lacZ fusion 
(pCYYbpeAB) and the bpeRpromoter-lacZ fusion (pCYYbpeR). Transcriptional expression 
of bpeAB and bpeR were determined by measuring β-galactosidase activities in B. 
pseudomallei strains harbouring the reporter plasmids.  
 
2.10. Western Blots  
Total bacterial proteins were prepared by adding 1 ml of lysis buffer (8M Urea, 
0.1M NaH2PO4, 0.01M Tris-Cl, pH 8) to cell pellets harvested from 5 ml overnight broth 
culture. 5 µg aliquots were resolved by 4% stacking / 12% resolving sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis and then blotted onto a nitrocellulose 
membrane (Amersham Biosciences). Western blot was performed as described by 
Towbin et al (Towbin et al., 1979) by using 20 mM Tris-HCl (pH 7.5)–500 mM NaCl–
0.05% Tween 20 (TBST) containing 10% (w/v) skim milk as the blocking reagent and a 
1:2,000 dilution of rabbit polyclonal anti-BpeA or anti-BpeR antibodies as the primary 
antibody. Membranes were blocked fro 24 h at room temperature, with gentle shaking. 
Antisera against BpeR and BpeA were prepared by immunizing New Zealand white 
rabbits intramuscularly with 500 µg each of His-tagged recombinant BpeR and BpeA per 
dose. Booster doses were given every 28 days after the initial dose, and the serum was 
collected 1 month after the final booster injection. After incubating with the primary 
antibody for 1 h, the membrane was washed three times with TBST. The protein bands 
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were detected after adding alkaline phosphatase-conjugated goat anti-rabbit 
immunoglobulin G (1:10,000 dilution, Promega) for 1 h, followed by washing and 
immersion in Western Blue stabilized substrate for alkaline phosphatase detection reagent 
for 1 min (Promega).   
 
2.11. Northern Blots  
BpeAB and bpeR probes for Northern blotting were generated by PCR by using 
primers AcrA3’F3 and AcrB5’R3; AcrRHisF and AcrRHisR respectively. The PCR 
products were [α-32P]-dCTP labelled by using Ready-to-Go DNA labelling beads 
(Pharmacia Biotech Inc., Uppsala, Sweden). Ten µg of each total RNA was used for 
Northern blotting according to a procedure described by Sambrook et al (Sambrook and 
Russell, 2001). Briefly, the RNA was resolved on a 1% w/v agarose formaldehyde gel 
and then blotted onto a nylon membrane (Amersham Biosciences) by capillary transfer 
using 20X SSPE as transfer buffer. The RNA was fixed onto the membrane by UV 
irradiation and pre-hybridised for 1 h in a 5 ml solution containing final concentrations of 
5X SSPE, 50% (v/v) formamide, 5X Denhardt’s solution and 0.5% (w/v) SDS. Denatured 
salmon sperm DNA (100µg) and radiolabeled DNA probe (500µg) was added to the 
membrane and hybridised for 16 h. The membrane was washed twice in 20 ml 2X SSPE, 
0.1% (w/v) SDS for 15 min before a final wash in 20ml 1X SSPE, 0.1% (w/v) SDS for 
30 min. All hybridisation and washing were carried out at 42oC.  The membrane was then 




2.12. MIC and MBC determinations 
MIC determinations were carried out in 96-well microtiter plates by a standard 
broth microdilution method (Wayne, 2003). Muller-Hinton broth (MHB; 5 ml; Becton 
Dickinson) was inoculated with 50 µl of an overnight culture, and the mixture was 
incubated for 4 h at 37°C with shaking. After adjustment of the culture with MHB to a 2 
McFarland nephelometer standard (~5 x 108 cells/ml), the culture was further diluted 
100-fold before inoculation of 10 µl into 100 µl of MHB, yielding a final inoculum 
density of ~5 x 105 cells/ml. Bacterial growth was determined 24 h after incubation at 
35°C. The minimal bactericidal concentration (MBC) was determined by plating serially 
diluted cultures from the MIC test medium. The MBC was defined as the lowest 
concentration of antibiotic required to kill 99.9% of the inoculum. All antibiotics were 
purchased from Sigma Chemical Co. (St. Louis, Mo.). 
 
2.13. Erythromycin accumulation assay 
The efflux of erythromycin was studied by monitoring the intracellular levels of 
[14C]-erythromycin (NEN, Boston, MA.) in intact cells. Overnight cultures (10 ml each) 
of KHW, KHW∆bpeAB, and KHW∆bpeAB(pUCP28TbpeAB) were washed three times 
in LB medium and were resuspended in equal volumes of fresh antibiotic-free LB 
medium before inoculation 50 µl into 10 ml of antibiotic-free LB medium (optical 
density at 600 nm [OD600], ~0.05). [14C]-erythromycin (final concentration, 0.1 µg/ml) 
was added to the culture at early log phase (OD600, ~0.5), and 1 ml aliquots were 
removed at 30 min intervals. The cells were washed three times in 1 ml of cold 0.9% 
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(w/v) NaCl containing 1 µg of erythromycin per ml, air dried, and solubilized in 2 ml of 
scintillation cocktail (Amersham Biosciences) for liquid scintillation counting with an 
LS6500 multipurpose scintillation counter (Beckman Instruments Inc., Fullerton, CA). 
The effect of carbonyl cyanide m-chlorophenylhydrazone (CCCP; Sigma) on macrolide 
efflux was tested by adding CCCP at 20 µM (final concentration) to the culture for 10 
min at 37°C prior to the addition of [14C]-erythromycin. 
 
2.14. Bioassays  
2.14.1. β-galactosidase assay 
β-galactosidase assay was performed as described by Miller (Miller, 1972). 10 ml 
AB medium (Clark and Maaloe, 1967) containing 25 µg/ml tetracycline, 20 mM glycerol 
and 0.2% (w/v) casamino acids, was inoculated with overnight culture (1:100) of B. 
pseudomallei KHW or its isogenic mutants, harbouring, either pCYYbpeAB, pCYYbpeR 
or pSYI. β-galactosidase activities and cell densities (OD600) were determined at various 
time intervals during the culture. 0.1 ml of bacterial culture was used for the β-
galactosidase assay and the enzyme activity was expressed as Miller Units.  For assays 
involving the addition of exogenous compounds, typically a 5 ml bacterial culture was 
inoculated with overnight culture (1:50) and the compounds are added to the culture at 
OD600∼ 0.1. β-galactosidase activity was determined after 4 h incubation at 37oC, i.e. in 
early exponential phase growth. 0.1ml AB medium was used as reagent blank and the 




2.14.2. Siderophore production 
Siderophore production was determined using the chrome azurol (CAS) assay 
described by Yang et al (Yang et al., 1991). Briefly, 0.1 ml of 24 h-old bacterial culture 
was added to 0.9 ml CAS solution (pH 5.6) and equilibrated for 2 h before reading 
absorbance at 630 nm. Siderophore activity was expressed as the change in OD630 
readings (∆OD630) between the test samples and the sample blank, and was normalized 
for cell density by expressing as a ratio of ∆OD630 to OD600. 
 
2.14.3. Phospholipase C activity 
Phospholipase C activity was determined by the enzymatic hydrolysis of p-
nitrophenylphosphorylcholine (NPPC, Sigma) to phosphatidylcholine and p-nitrophenol 
(Kurioka and Matsuda, 1976). Briefly, 10 µl of bacterial culture supernatant from 20 h-
old culture was mixed with 90 µl of NPPC reagent (250mM Tris-HCl, pH 7.2; 0.1mM 
ZnSO4; 10mM NPPC and 40% (w/w) sorbitol) and the release of p-nitrophenol was 
detected by reading OD405 after 1 h incubation at 37oC. All assays were performed in 
triplicates. 
 
2.15. Biofilm formation 
Biofilm formation was assayed by the ability of cells to adhere to the wells of 96-
well microtitre plates made of PVC using a modification of a previously reported 
protocol (O'Toole and Kolter, 1998). 100 µl of a diluted (OD600 ~ 0.05) overnight 
bacterial culture in AB medium containing 0.2% (w/v) casamino acids and 20 mM 
glycerol was added into each well of a 96-well microtitre plate. After 20 h incubation at 
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30oC, and washing twice with distilled water to remove planktonic cells, 125 µl of 1% 
(w/v) crystal violet (Sigma) was added.  After 15 min at room temperature and three 
rounds of washing with distilled water, 300 µl of 95% (v/v) ethanol was added to 
solubilize the stain and the extent of biofilm formation was determined by reading the 
absorbance of the solution at 595 nm. The assay was performed in triplicates. 
 
2.16. Detection of autoinducer production 
2.16.1. Detection of autoinducer production using a reporter strain, 
E. coli JB525 
The production of homoserine lactones (HSLs) by the B. pseudomallei strains was 
detected by cross streaking against indicator strains, E. coli JB525 as described 
previously (Song et al., 2005). The bacteria were cross-streaked onto LA and observed 
after incubating at 28oC for 20 h.   
Intracellular HSLs were extracted from total bacterial lysate obtained by 
subjecting the bacterial cells to 5 cycles of freeze-thaw. Briefly, 5 ml overnight bacterial 
culture in AB media containing 0.2% (w/v) glucose and 0.2% (w/v) casamino acids were 
adjusted to OD600 ~ 1.5. Five millilitres of these diluted cultures were centrifuged at 3000 
rpm for 15 min and the pellet resuspended in 1 ml AB media. The cells were 
permeabilized by freezing at –80oC for 3 min and rapid thawing at 37oC for 1 min. This 
was repeated for a total of 5 times and the lysates harvested from the cell debris by 
centrifuging at 13,400rpm for 15 min. The lysates were passed through a Spin-X column 
(Costar, Broadway, MA) to remove any residual cell debris before loading 50 µl onto 
wells in LA spotted with 2 µl of indicator strain. Extracellular HSLs were detected by 
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directly inoculating 50 µl of overnight bacterial culture supernatants onto LA containing 
indicator strain. Fluorescence was visualized under UV light at 254 nm and image 
captured onto Vilber Lourmat documentation system after incubation at 28oC for 20 h. 
HSLs will diffuse passively through the agarose support matrix towards the indicator 
strain. This assay allows semi-quantitative determinations of the amounts of intracellular 
and extracellular HSLs in B. pseudomallei.  
 
2.16.2. Detection of autoinducer production by Reversed-Phase 
High Performance Liquid Chromatography (RP-HPLC) 
Radiolabeled HSLs were prepared from 5 ml overnight bacterial broth culture in 
AB media containing 20 mM glycerol by adding 5 µCi of L-[1-14C] methionine (Sigma) 
into the culture and incubated at 37oC, with shaking for another 30 min (Conway et al., 
2002). Extracellular radiolabeled HSLs were prepared from the culture supernatant, 
whilst intracellular HSLs were extracted from permeabilized cell pellet obtained after 
centrifugation at 3000 rpm for 15 min. The pelleted cells were permeabilized by the 
freeze-thaw method as described earlier to release intracellular radiolabeled HSLs. 
Radiolabeled HSLs were extracted from the filtered supernatant using 5 ml of acidified 
ethyl acetate (0.01% v/v glacial acetic acid in ethyl acetate). The inorganic phase (top 
layer) was removed and HSLs from the organic phase (bottom layer) was re-extracted 
with another 5 ml of acidified ethyl acetate. The combined extract was dried using a 
rotary evaporator at 35oC, dissolved in 200 µl of 20% ethanol, and then filtered through a 
0.22 µm filter for RP-HPLC analysis.  
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Reversed-phase HPLC was used to separate and analyse the HSLs produced by B. 
pseudomallei. 100µl of samples were injected into the 200mm (length) by 4.6mm 
(diameter) C18 column (Agilent Series 1100 Hypersil ODS, particle size 5 mm; Palo 
Alto, CA). Elution was done using 50% v/v methanol-water for 10 min, followed by a 
linear gradient from 50% v/v to 90% v/v methanol in water for 25 min and finally 90% 
v/v methanol for 10 min.  Two millilitre fractions were collected at a flow rate of 1 ml 
per min. Radiolabeled HSLs in the fractions were detected with Radiomatic 500TR 
Radioisotope HPLC detector (Perkin-Elmer). 
 
2.17. Spermidine accumulation assay 
The efflux of spermidine was studied by monitoring the intracellular levels of 
[14C]-spermidine (Sigma) in intact cells. Overnight cultures (5 ml each) of KHW and its 
isogenic mutants were washed three times in AB medium and were resuspended in equal 
volumes of fresh AB medium containing 0.2% (w/v) glucose, and 10 mM 
cyclohexylamine before inoculation of 50 µl into 5 ml of the same medium (optical 
density at 600 nm [OD600], ~0.05). [14C]-spermidine (final concentration, 5 µM) was 
added to the culture at early log phase (OD600, ~0.5), and 0.2-ml aliquots were removed 
at 1 h intervals for determination of radioactivity. The cells were washed three times in 1 
ml of cold 0.9% (w/v) NaCl containing 50 µΜ of spermidine per ml, air dried, and 
solubilized in 2 ml of scintillation cocktail (Amersham Biosciences) for liquid 
scintillation counting with an LS6500 multipurpose scintillation counter (Beckman 
Instruments Inc.). After 4 h, exogenous [14C]-spermidine was removed from the 
remaining cultures through three rounds of washing in fresh AB media containing 0.2% 
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(w/v) glucose and 10 mM cyclohexylamine. The cells were resuspended in equal volume 
of the same media and further incubated at 37oC. Intracellular level of radiolabeled 
spermidine was measured thereafter at 2 h and at 4 h. Cyclohexylamine is a potent 
inhibitor of spermidine synthase and was added to block any de novo synthesis of 
spermidine within cells (Bitonti et al., 1982).  
 
2.18. Cell invasion and cytotoxicity assays 
Bacterial invasion of A549 and THP1 cells was performed as described by 
Elsinghorst (Elsinghorst, 1994) except for the following modifications. Tetracycline (50 
µg/ml) was added to kill extracellular bacteria instead of gentamicin, as KHW is resistant 
to gentamicin. Mid-log phase bacteria in LB medium (OD600 = 0.6) was washed and 
resuspended in an equal volume of 0.85% (w/v) NaCl.  Twenty-five µl aliquots of the 
bacterial suspension were added to each well of a 24-well tissue culture plate containing 
1 x 105 mammalian cells per well (MOI = 100). After 2 h incubation at 37°C in the 
presence of 5% CO2, the cells in each well were washed thrice with phosphate-buffered 
saline (PBS) before adding 1.5 ml of fresh culture medium containing tetracycline (50 
µg/ml).  After a further 2 h incubation to kill extracellular bacteria, the wells were again 
washed thrice with PBS and the mammalian cells lysed using 1 ml of 0.1% Triton X-100 
(Sigma).  Serial dilutions of the cell lysate were then plated on LA. The numbers of 
internalized bacteria were quantified 2 h after infection. The assays were performed in 
triplicates.  
The cytotoxic effects of bacteria on mammalian cells were evaluated by 
measuring the release of lactate dehydrogenase (LDH) enzyme using Cytotoxicity 
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Detection kit (Roche, Mannheim, Germany). Mid-log phase bacterial cells were added to 
A549 and THP1 cells (105 cells/well) cultured in 24-well plates in Dulbecco’s Modified 
Eagle’s medium (Sigma) and RPMI-1640 (Sigma), respectively, supplemented with 10% 
(v/v) fetal bovine serum (Sigma), at a multiplicity of infection (MOI) of 100.  
Tetracycline (50 µg/ml) was added after 1 h incubation at 37oC, 5% CO2, and the cells 
were incubated for another 4 h. LDH activity was determined in 100 µl aliquot of the 
centrifuged supernatant obtained from each well.   
 
2.19. Screening of putative BpeAB-OprB inhibitors 
2.19.1. Checkerboard titration assay of pump inhibitor MC-
207,110 
Interactions between streptomycin, gentamicin, or erythromycin and MC-207,110 
(Phe-Arg-β-naphthylamide dihydrochloride; Sigma) were assessed by a checkerboard 
titration assay in a 96-well microtiter plate, as described by Lomovskaya et al 
(Lomovskaya et al., 2001). The antibiotics were tested at 12 two-fold serial dilutions 
(2,048 to 0 µg/ml,), while MC-207,110 was tested at 7 two-fold serial dilutions (40 to 
0.625 µg/ml, including 0 µg/ml). 0.2 ml of LB medium containing 5 x 105 cells/ml was 
added to each well, and the plate was incubated for 24 h at 35°C. 
 
2.19.2. Rapid screening assay of potential pump inhibitors 
This assay is a modification of MIC determination by broth microdilution method 
as described by Wayne (Wayne, 2003) and the checkerboard titration assay as described 
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by Lomovskaya et al (Lomovskaya et al., 2001). This easier and simpler assay was 
developed for rapid screening of a variety of potential pump inhibitors that could 
abrogate BpeAB-OprB function. The inhibitors tested were summarised in Table 4. All 
chemicals were from Sigma and were kindly given by Prof. Khoo Hoon Eng (No.s 1-17) 
and Dr. Lam Yulin (No.s 18-21) from departments of Biochemistry and Chemistry, 
respectively, National University of Singapore.  
 
Table 4. List of adenosine analogues tested for inhibition of BpeAB-OprB function 
No. Name Molecular weight 
1 (-)-N6-(2-phenylisopropyl)-adenosine 385.4 
2 (-)-N6-(R-phenylisopropyl)-adenosine 385.4 
3 (-)-N2-(2-phenylisopropyl)-adenosine 385.4 
4 2-chloroadenosine 301.7 
5 2’-deoxyadenosine 251.2 
6 5’-(N-cyclopropyl)carbocamidoadenosine 320.3 
7 5’-(N-ethylcarboxamido)-adenosine 308.3 
8 α,β-methleneadenosine 5’-diphoshate 425.2 
9 Adenosine-5’-o-thiomonophosphate 375.1 
10 Adenosine-5’-o-(2-thiodiphosphate) 461.1 
11 Adenosine-5’-o-(3-thiotriphosphate) 547 
12 N6-(L-2-phenylisopropyl)-adenosine 385.4 
13 N6,2-(4-aminophenyl)ethyl-adenosine 386.41 
14 N6-cyclohexyladenosine 349.4 
15 N6-O21-dubutyryladenosine 3’:5’-cyclic 
monophosphate 
491.3 
16 2-fluoroadenine a-β-D-arabinofuranoside 285.2 
17 6-mercaptopurine 170.19 
18 2-amino-6-mercatopurine (6-thioguanine) 167.19 
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19 5-Fluorouracil 130.08 
20 5-fluoro-2’deoxyuridine 246.19 
21 Cytosine-β-D-arabinofuranoside 243.22 
 
Muller-Hinton broth (MHB; 5 ml; Becton Dickinson) was inoculated with 50 µl of 
an overnight culture, and the mixture was incubated for 4 h at 37°C with shaking. After 
adjustment of the culture with MHB to a OD600 of approximately 0.1 (~1 x 108 cells/ml), 
the culture was further diluted 20-fold before inoculation of 10 µl into 100 µl of MHB, 
yielding a final inoculum density of ~5 x 105 cells/ml. Interactions between erythromycin 
and the pump inhibitors were assessed by a checkerboard titration assay in a 96-well 
microtiter plate, as described by Lomovskaya et al (Lomovskaya et al., 2001). 
Erythromycin was tested at 0.5X MIC concentration (64 µg/ml), while the inhibitors 
were tested at 7 two-fold serial dilutions (40 to 0.625 µg/ml, including 0 µg/ml). The 
plate was incubated for 24 h at 35°C. Bacterial growth was determined 24 h after 
incubation at 35°C. The compounds tested were classified as a potential pump inhibitor if 










Chapter 3: Results 
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3.1. Putative RND pumps in B. pseudomallei 
In silico genome analysis identified 8 putative RND efflux pumps in B. 
pseudomallei, of which 6 are located on chromosome 1, the remaining two on 





Figure 7. Putative RND pumps in B. pseudomallei. The orientation and genes that 
made up an RND efflux system are represented by arrows. Black and grey arrows 
represent RND and adjacent genes respectively. Gene homologues/identities are labelled 
within the arrows whilst the model organism is in parenthesis. MFP - membrane fusion 
protein, RND – resistance-nodulation-division, OMP – outer membrane protein. In silico 
genome analysis and annotation was performed by homology and conserved domain 
search using a database created by our laboratory (Xie, 2003). 
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The genes of most of the RND efflux systems identified are organized into 
operons, which encode a membrane fusion protein (MFP), an inner membrane protein 
(IMP), an outer membrane protein (OMP) and an upstream transcriptional regulator 
(Figure 7). The tripartite components of the RND efflux pump traverse both the inner and 
the outer membranes and forms a channel, which facilitates direct passage of the 
substrate from the cytoplasm and periplasm into the external medium. Exceptions to this 
genetic organization include (1) the genes on chromosome 1 at nucleotide positions 
2690327 to 2694717 which encodes a putative permease belonging to the major 
facilitator superfamily instead of an OMP and also does not encode any adjacent 
transcriptional regulator; (2) the genes on chromosome 1 nucleotide positions 1462491 to 
1471563, which does not encode any OMP, but has 2 genes encoding for IMPs 
homologous to the AcrB/AcrD/AcrF family of efflux pump in Yersinia pestis; and (3) the 
operon on chromosome 1 at nucleotide positions 322945 to 328601 which lacks an  
upstream transcriptional regulator. 
 
3.2. Biochemical properties of BpeAB-OprB 
3.2.1.bpeR-bpeAB-oprB encodes an RND efflux pump and its 
repressor 
The identification of operons encoding RND efflux pumps in B. pseudomallei 
began when the genome sequencing of B. pseudomallei was still in progress. Thus, we 
took the approach to screen a genomic library of B. pseudomallei ATCC23343 using the 
B. cepacia ceoA and ceoB PCR fragments as probes. Two genomic clones were identified 
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from the genomic library constructed as described in section 2.6. The DNA sequences 
from one of the clones were assembled into a contig of 7,597 bp containing four open 
reading frames (ORFs). The ORFs were mapped to nucleotide positions 941806 to 
949450 on chromosome 1 of the recently completed B. pseudomallei strain K96243 
genome sequence (www.sanger.ac.uk ). The sequences were highly identical except a 49-
nucleotide GC-rich insert at positions 944037 to 944084 of the K96243 chromosome 1. 
The four ORFs were named bpeR (636 bp), bpeA (1,209 bp), bpeB (3,201 bp) and oprB 
(1,599 bp), respectively. bpeR encodes a 211-amino-acid (aa) repressor protein of the 
TetR family; bpeA a 402-aa periplasmic linker protein; bpeB a 1,066-aa inner membrane 
protein; and oprB a 532-aa outer membrane protein. It is interesting to note that the GC-
rich insert found in K96234 is located at the 3’end of bpeA and has the ability to form 
very stable hairpin loop structure (∆G = -29.47 kcal/mol, Figure 8). 
 
Figure 8. Schematic representation of hairpin loop structure found in K96243 at 
nucleotide positions 944037 to 944084. The hairpin loop is stabilized by 3 hydrogen 
bonds formed between guanine and cytosine residues on the DNA (represented by ≡).  
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Several homologues of the RND family of efflux pumps are identified from a 
search of the National Center for Biotechnology Information protein databases containing 
protein sequences from all non-redundant GenBank CDS translations, Protein Databank 
(PDB), SwissProt, Protein Information Resource (PIR) and Protein Research Foundation 
(PRF) with the BLASTX program. The BpeA, BpeB, OprB, and BpeR protein sequences 
were used as queries and were analyzed by multiple amino-acid sequence alignment. 
BpeA shared 54, 52, 42, and 22% amino acid similarities with AcrA (E. coli), MexA (P. 
aeruginosa), AmrA (B. pseudomallei), and CeoA (B. cepacia), respectively (Appendix 
IV), while BpeB shared 65, 62, 49, and 40% amino acid similarities with AcrB (E. coli), 
MexB (P. aeruginosa), AmrB (B. pseudomallei), and CeoB (B. cepacia), respectively 
(Appendix V). The OprB protein shared 18, 52, and 28% amino acid similarities with 
TolC (E. coli), OprM (P. aeruginosa), and OpcM (B. cepacia), respectively (Appendix 
VI); and BpeR shared 60, 57, and 41% amino acid similarities with AcrR (E. coli), AmrR 
(B. pseudomallei), and MexR (P. aeruginosa), respectively (Appendix VII). AcrAB-
TolC, MexAB-OprM, AmrAB-OprA, and CeoAB-OpcM are RND efflux pumps of E. 
coli, P. aeruginosa, B. pseudomallei, and B. cepacia, respectively.  
The translated sequence of BpeB shows a secondary structure with 12-
transmembrane helical domains and two large periplasmic loops between transmembrane 
segments 1-2 and 7-8, which is characteristic of an inner membrane component of the 
RND family (Figure 9, Table 5) (Putman et al., 2000b; Moller et al., 2001). Multiple 
sequence alignment of inner membrane proteins of other RND pumps showed four highly 
conserved motifs (A-D)s (Saier et al., 1994; Paulsen et al., 1996). These conserved 
motifs were also found in loop 1 and transmembrane domains 3, 6, and 11 of BpeB 
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(Table 6). Putative promoter regions were identified at 15 and 10 bp upstream from the 




Figure 9. Schematic representation of BpeB transmembrane topology. BpeB shows 
the characteristic structure of an inner membrane component of the RND family with 12-
transmembrane helical domains (1-12) and 2 large periplasmic loops (A and D) between 
transmembrane segments 1-2 and 7-8. These 2 large periplasmic loops are thought to 
contain the amino acid residues responsible for substrate recognition. 
  
84
Table 5. Proposed model for transmembrane topology of BpeB using TMPred 
Version 2 (Hofmann and Stoffel, 1993) 
 
TMS From sequence To sequence Length Scorea Orientation 
1 9 28 20 2788 Intra- to extra-cellular 
2 343 359 17 1580 Extra- to intra-cellular 
3 385 406 22 2128 Intra- to extra-cellular 
4 438 458 21 2325 Extra- to intra-cellular 
5 474 497 24 2352 Intra- to extra-cellular 
6 540 556 17 2573 Extra- to intra-cellular 
7 793 811 19 835 Intra- to extra-cellular 
8 873 891 19 2503 Extra- to intra-cellular 
9 898 917 20 1755 Intra- to extra-cellular 
10 924 945 22 913 Extra- to intra-cellular 
11 973 994 22 2085 Intra- to extra-cellular 
12 1006 1026 21 2448 Extra- to intra-cellular 





























































































































































































































































































































































































































































































































































3.2.2. Construction of isogenic B. pseudomallei mutants 
3.2.2.1. Construction of KHW∆bpeAB and pUCP28bpeAB for trans 
complementation  
An isogenic derivative of KHW containing deletion in bpeAB was constructed 
using the suicide vector pJQ200mp18, which carried a counter-selectable marker, 
sacB, which encodes a sucrose inducible lethal product (Quandt and Hynes, 1993). 
Thus, recombinants that carried the mutation by gene replacement via a double 
crossover rather than via a single crossover resulting in plasmid insertion into the 
chromosome will be selected in the presence of sucrose. Any exconjugants harbouring 
the intact pJQ200mp18 vector, whether extrachromosomal or inserted into the 
chromosome, would be sensitive to sucrose-induced cell death.  
PCR and Northern blotting were performed to verify the mutation in 
KHW∆bpeAB and that the bpeAB deletion resulted in a null mutation. PCR yielded a 
4.9-kbp fragment from KHW and a 3.5-kbp fragment from KHW∆bpeAB, consistent 
with a 3.7-kbp chromosomal deletion of bpeA-bpeB and replacement with a 2.3-kbp 
kanamycin resistance cassette (Figure 10a). The insertion of the kanamycin cassette in 
the bpeA-bpeB deletion was also confirmed by DNA sequencing of the PCR product 
obtained from KHW∆bpeAB chromosomal DNA with primer AcrABpro, as described 
above. PCR with pUCP28TbpeAB isolated from complemented KHW∆bpeAB and 
primers pUCP28TF and pUCP28TR (Table 3) produced a 5.3-kbp product, which was 
consistent with the presence of a full-length bpeAB gene product (5 kb), including 300 
bp of flanking plasmid DNA (Figure 10b). Northern blot analysis also confirmed no 
bpeAB was expressed in KHW∆bpeAB (Figure 11). Complementation of the mutation 
in KHW∆bpeAB in trans using pUCP28TbpeAB, which carried the full-length bpeAB 
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sequence, restored bpeAB mRNA expression (Figure 11). No increase in the level of 
mRNA expression was detected in the complemented mutant compared to that in the 
wild type, even though pUCP28T was a multicopy plasmid (Figure 11). Similar 
results were observed when experiment was repeated. 
Figure 10. PCR verification of bpeAB deletion and complementation in KHW. 
PCR amplifications were done on total DNA of wild type KHW (Lane 1) and, 
KHW∆bpeAB  (Lane 2), as well as plasmid preparations from KHW∆bpeAB 
(pUCP28TbpeAB) (Lane 3) using primer pairs AcrABpro and AcrB3’R1 (A); and 
pUCP28TF and pUCP28TR (B). 
  
Figure 11. Northern blot analysis of bpeB mRNA expression in wild-type B. 
pseudomallei KHW, KHW∆bpeAB mutant, and the complemented KHW∆bpeAB 
mutant. 10 µg of total RNA was resolved on 1% agarose gel, blotted onto 
nitrocellulose membrane and probed with 32P-radiolabelled AcrA3’F3-AcrB5’R3-
generated partial bpeAB PCR product (Table 2).  A mixture of 0.5 µg each of full-
length bpeAB, bpeB and 16sRNA PCR products were loaded as a positive control 
(lane 1) and 10 µg each of total RNA from KHW∆bpeAB (lane 2), wild-type KHW 




The expression of bpeA and bpeR in KHW, KHW∆bpeAB and KHW∆bpeAB 
(pUCP28TbpeAB) was also verified by RT-PCR. bpeAB and bpeR expression was 
detected in KHW and the KHW∆bpeAB (pUCP28TbpeAB) (Figure 12, Lanes 1 and 
3), but no bpeAB expression in the KHW∆bpeAB mutant (Figure 12. Lane 2).  
 
 
Figure 12. Detection of bpeA and bpeR expression in KHW and its isogenic 
mutants by RT-PCR. Five micrograms of total RNA isolated from wild type 
parental strain KHW (lane 1), KHW∆bpeAB mutant (lane 2), 
KHW∆bpeAB(pUCP28TbpeAB) (lane 3), KHWbpeR::Km (lane 4), 
KHWbpeR::Km(pUCP28TbpeR) (lane 5) and KHW(pUCP28TbpeR) (lane 6) were 
used. Lane M is 1 kb plus size marker (Gibco-BRL, Carlsbad, CA). The bands 
corresponding to bpeA, bpeR and 16SrRNA RT-PCR products are indicated on the 
right. The primers used for RT-PCR of bpeA, bpeR and 16SrRNA are AcrAHisF-
AcrAHisR; AcrRHisF-AcrRHisR; and 16SF2-16SR2 respectively.  
 
3.2.2.2. Construction of bpeR insertion mutant KHWbpeR::Km and 
pUCP28TbpeR for trans complementation   
An isogenic derivative of KHW in which the bpeR gene was disrupted by 
insertion of a kanamycin-resistance cassette was constructed by using the suicide 
vector pJQ200mp18. Verification of the mutation was obtained by PCR using primers 










from KHW and KHWbpeR::Km, respectively. This result is consistent with the 
disruption of bpeR by the insertion of a 2.3-kbp kanamycin-resistance cassette (Figure 
13). The absence of bpeR expression in the bpeR null mutant was verified by RT-PCR 
using primers AcrRHisF and AcrRHisR (Figure 12, Lane 4). Overexpression of 
bpeAB in the bpeR null mutant was also detected using the primers AcrAHisF and 
AcrAHisR (Figure 12, Lane 4). 
Successful complementation of the bpeR mutation by the introduction of 
pUCP28TbpeR was verified by both PCR (Figure 13) and RT-PCR (Figure 12, Lane 
5) as described above. PCR, using total DNA isolated from the complemented 
KHWbpeR::Km produced a 631 bp product, which was consistent with the presence 










Figure 13. PCR verification of bpeR deletion and complementation in KHW. 
PCR amplifications were done on total DNA of wild type KHW (Lane 1), 
KHWbpeR::Km (Lane 2), KHWbpeR::Km(pUCP28TbpeR) (Lane 3) and 





3.2.3. Anti-microbial substrates of the B. pseudomallei BpeAB-OprB 
efflux pump 
The susceptibilities of KHW and KHW∆bpeAB to a variety of anti-microbial 
agents were compared in an attempt to identify the substrates of the B. pseudomallei 
BpeAB pump. Table 7 summarizes the MICs and MBCs of the different anti-
microbial agents for KHW, KHW∆bpeAB, and trans-complemented mutant 
KHW∆bpeAB(pUCP28TbpeAB).  
 
Table 7. Susceptibilities of B. pseudomallei KHW, the deletion mutant 
KHW∆bpeAB and the complemented mutant, KHW∆bpeAB (pUCP28TbpeAB), 
to anti-microbial agents 












































































































































































































































aND, not determined;  bSDS, sodium dodecyl sulfate 
 
The parental strain, KHW, was resistant to a variety of antibiotics and agents, 
including aminoglycosides, macrolides, polymyxins, β-lactams, ethidium bromide 
and sodium dodecyl sulfate. KHW also showed intermediate resistance to DNA 
intercalators like crystal violet, and acriflavine. Deletion of bpeAB resulted in about 
1,000-fold increased susceptibility to the aminoglycosides gentamicin and 
streptomycin and the macrolide erythromycin, and a smaller increase in susceptibility 
to acriflavine. KHW∆bpeAB remained resistant to another aminoglycoside 
(spectinomycin) and to other macrolides (clarithromycin and oleandomycin), 
demonstrating that BpeAB was able to recognize a wide range of substrates, and still 
discriminate between substrates of similar structures.  
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Complementation of KHW∆bpeAB, using the plasmid pUCP28TbpeAB, 
restored resistance to the gentamicin, streptomycin, erythromycin, and acriflavine to 
wild-type levels, although the trans-complemented mutant was significantly more 
resistant to erythromycin (more than 1000-fold) and slightly more resistant to 
gentamicin than the wild type (Table 7). The complemented strain was equally 
susceptible to spectinomycin, streptomycin, clarithromycin, oleandomycin, 
ceftazidime, doxycycline, tetracycline, chloramphenicol, rifampin, and acriflavine 
when compared to the parental strain, KHW. Since pUCP28T is a multicopy number 
plasmid (copy number = 10; West et al., 1994), the anti-microbial susceptibility 
profile of the complemented bpeAB mutant suggests that overexpression of BpeAB 
did not affect the anti-microbial susceptibility of B. pseudomallei significantly. The 
complementation assay also demonstrated that either the deletion mutation in 
KHW∆bpeAB did not exert a polar effect on oprB, or another outer membrane efflux 
pump component could compensate for the OprB function that is lacking in 
KHW∆bpeAB. 
 
3.2.4. Efflux of [14C]-erythromycin by BpeAB 
A threefold higher intracellular accumulation of [14C]-erythromycin (~3.0 ng/ 
OD600 unit) was observed in KHW∆bpeAB when compared to KHW and the 
complemented KHW∆bpeAB mutant (0.8 ng/ OD600 unit) 3 h after exposure to 0.1 
µg/ml exogenous [14C]-erythromycin, thus demonstrating the involvement of BpeAB 
in the efflux of erythromycin (Figure 14). The restoration of intracellular levels of 
erythromycin to wild-type level in the complemented mutant, 
KHW∆bpeAB(pUCP28TbpeAB), further supports the role of BpeAB in the efflux of 
erythromycin (Figure 14). Finally, addition of 20 µM of a proton conductor, CCCP, 
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resulted in rapid intracellular accumulation of [14C]-erythromycin to about 6 ng/OD600 
unit after 3 h both in the wild type and bpeAB mutant, thus confirming that BpeAB is 
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Figure 14. Intracellular accumulation of [14C]-erythromycin in B. pseudomallei 
KHW, KHW∆bpeAB, and complemented KHW∆bpeAB mutant, in the presence 
and absence of 20 µM CCCP.  Closed symbols showed accumulation in CCCP-
treated samples, whereas open symbols show accumulation in untreated samples. 
Symbols: ■, wild-type parental strain, KHW; ▲, KHW∆bpeAB; ●, complemented 




3.3. Occurrence of BpeAB-OprB efflux pumps in clinical, 
animal and environmental B. pseudomallei isolates 
Next, we addressed the clinical significance of the BpeAB-OprB efflux pump 
by determining its presence and function in clinical, animal and environmental 
isolates of B. pseudomallei. Firstly, we used Northern blot analysis to detect bpeR  
(631 bp) expression in 26 randomly selected human, animal and soil isolates using 
radiolabeled PCR product generated with primers AcrRHisF and AcrRHisR as a 
probe. One human isolate (H11) showed reduced bpeR expression whilst a monkey 
isolate (ATCC15682) did not express bpeR (Figure 15A, lanes 16 and 21 
respectively). Both isolates H11 and ATCC15682 also do not contain the bpeA gene 
(1.2 kbp, Figure 15B) and did not produce any BpeA protein (32kD, Figure 15C).   
Table 8 lists the antibiograms of all the 26 isolates. The antibiograms of 
isolates KHW, H11 and ATCC15682 were similar with respect to gentamicin, 
streptomycin and erythromycin, and all three isolates were more resistant to these 
antibiotics than the other 23 isolates (Table 8). Although the number of samples used 
was limited, it could be concluded that (1) BpeAB-OprB is a common efflux pump 
found in the majority of B. pseudomallei isolated from clinical, animal and 
environmental samples, and (2) none of these isolates developed antimicrobial 
resistance through acquiring a null mutation in the bpeR gene, which would have 





Figure 15. Screening of B. pseudomallei isolates with altered bpeR and bpeA 
expression.  (A) Detection of bpeR mRNA by Northern blot, (B) detection of bpeA 
genomic DNA by PCR using primers AcrAHisF and AcrAHisR, and (C) detection of 
BpeA by Western blot using anti-BpeA polyclonal antibodies. The identities of 
bacterial samples tested are indicated in Table 8.   
 
Table 8. Susceptibilities of clinical, animal and environmental isolates to 
erythromycin, streptomycin and gentamicin  













1 KHW Human 128 1024 1024 1024 128 512 
2 ATCC23343 Human 64 256 128 128 64 256 
3 H1 Human 64 256 128 128 64 256 
4 H2 Human 64 256 128 128 64 256 
5 H3 Human 64 256 1024 1024 128 512 
6 H5 Human 64 256 128 128 64 256 
7 H6 Human 64 256 128 128 64 256 
8 H7 Human 128 1024 128 128 64 256 
9 A153 Animal 64 256 128 128 32 128 
10 A413 Animal 64 256 128 128 64 256 
11 A488 Animal 64 256 64 128 64 256 
12 A490 Animal 64 256 128 128 64 256 
13 S77/96 Soil 64 512 256 256 128 512 
14 H8 Human 64 256 128 128 64 256 
15 H9 Human 64 256 128 128 64 256 
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16 H11 Human 256 256 1024 1024 64 64 
17 H10 Human 32 256 32 32 32 256 
18 H12 Human 64 256 128 128 64 256 
19 H13 Human 64 256 128 128 64 256 
20 H14 Human 64 256 128 128 64 256 
21 ATCC15682 Animal 128 128 256 256 256 256 
22 A561 Animal 64 256 128 128 64 256 
23 A612 Animal 64 256 128 128 64 256 
24 EY9 Animal 128 1024 256 256 64 1024 
25 EY10 Animal 128 512 512 512 64 256 
26 S78/96 Soil 64 512 256 256 128 512 
 
3.4. Regulation of bpeAB-oprB expression 
3.4.1. BpeR functions as a local repressor of bpeAB-oprB operon 
bpeR, which lies upstream of the bpeAB-oprB operon and is divergently 
transcribed, encodes a putative repressor belonging to the TetR family of repressors. 
In order to study the local regulation of bpeAB-oprB expression by BpeR, we first 
constructed a bpeR null mutant, KHWbpeR::Km by insertional mutagenesis.  RT-PCR 
data in Figure 12 showed that bpeR was not expressed in the insertional mutant, 
KHWbpeR::Km (Lane 4). The absence of BpeR resulted in a corresponding increase 
in bpeA expression, thus demonstrating the role of BpeR as a repressor of the bpeAB-
oprB operon (Figure 12, lanes 4).  Expression of bpeR in KHWbpeR::Km was 
restored by trans complementation using pUCP28TbpeR which carried the complete 
bpeR gene (Figure 12, lane 5). Additionally, the RT-PCR data from 
KHW(pUCP28TbpeR) and KHWbpeR::Km(pUCP28TbpeR) whereby bpeR was 
overexpressed in the wild-type strain and the bpeR mutant, respectively, resulted in 
complete inhibition of bpeA expression (Figure 12, lanes 5 and 6).  
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The physiological function of BpeR on antibiotic efflux by BpeAB-OprB 
pump was evaluated by determining the MICs and MBCs of antibiotic substrates of 
the BpeAB-OprB efflux pump in KHW, KHW∆bpeAB, KHWbpeR::Km, as well as 
the respective complemented mutants. The antibiotic substrates used in this study 
were gentamicin, streptomycin and erythromycin, which were previously shown to be 
substrates of the BpeAB-OprB pump (Section 3.2.3; Chan et al., 2004).  The data in 
Table 9 showed that the MIC values for streptomycin, erythromycin and gentamicin, 
respectively, were 2-, 4- and 16-fold higher in the bpeR mutant when compared to the 
wild type. Overexpression of bpeR in KHWbpeR::Km and KHW had the same effect 
of significantly increasing their susceptibility to all three antibiotics. The MIC and 
MBC values of all three antibiotics tested on KHWbpeR::Km(pUCP28TbpeR) and 
KHW(pUCP28TbpeR) were equivalent to that of KHW∆bpeAB (Table 9). This data 
shows a positive correlation with the observed down-regulation of bpeA expression in 
the complemented bpeR mutant in Figure 12.  We therefore conclude that (1) bpeR 
functions as a transcriptional repressor of the bpeAB-oprB operon and (2) 
overexpression of bpeR significantly potentiates the susceptibility of B. pseudomallei 
to the commonly used anti-microbials gentamicin, streptomycin and erythromycin. 
The restoration of BpeR repressor function by complementation using pUCP28TbpeR 
also verified that the increased anti-microbial resistance of KHWbpeR::Km was due to 
the bpeR mutation and not due to polar effects of the insertional mutation on 























































































































































































































































































































3.4.2. BpeAB-OprB is an inducible efflux system 
Transcriptional expression of bpeAB and bpeR were determined by measuring 
β-galactosidase activities in B. pseudomallei strains harbouring the reporter plasmids 
pCYYbpeAB and pCYYbpeR.  Erythromycin was previously identified as a substrate 
of the BpeAB-OprB pump (Chan et al., 2004).  Using a time-course promoter assay, 
bpeAB-oprB was demonstrated to have a low basal expression, which was inducible 
in the presence of 0.1X MIC (or 10 µg/ml) erythromycin (Figure 16A).  The induction 
of bpeAB expression by erythromycin showed a linear dose-dependent relationship 
(Figure 16B).  Basal expression of bpeAB was 2.5-fold higher in KHWbpeR::Km 
when compared to the wild-type KHW. Interestingly, although the basal bpeAB 
expression was higher in KHWbpeR::Km, it was still inducible in the presence of 
0.1xMIC erythromycin to a final level similar to that observed in KHW (Figure 16A).  
This result suggested that although BpeR repressor interacts with the bpeAB-oprB 
regulatory region to regulate its basal expression, another ligand-sensitive regulatory 
protein could also interact, perhaps at an adjacent site, to control inducible expression 
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Figure 16. Induction of bpeAB-lacZ expression by erythromycin. (A) Effect of 
bpeR mutation on the basal and inducible expression of bpeAB in KHW and 
KHWbpeR::Km. β-galactosidase activities expressed from bpeABpromoter-lacZ fusion, 
pCYYbpeAB, were determined in KHW (circles) and KHWbpeR::Km (triangles).  
Open symbols represent basal expression of bpeAB whilst closed symbols represent 
bpeAB expression after addition of 0.1X MIC erythromycin (or 10 µg/ml). (B) Dose-
dependent induction of bpeAB expression in KHW(pCYYbpeAB).  β-galactosidase 
activities were assayed 4 h after addition of erythromycin.  Error bars represent 
standard deviations of triplicate β-galactosidase determinations for one typical 
experiment. Where error bars are not shown, the standard deviation was within the 
size of the symbol. 
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The expression of bpeRpromoter-lacZ could also be induced in the presence of 
0.1X MIC of erythromycin using KHW(pCYYbpeR), but unlike bpeABpromoter-lacZ 
expression, the induction of bpeRpromoter-lacZ expression was delayed, occurring only 
after 6 h of exposure to erythromycin (Figure 17). Our data thus provide evidence that 
the BpeR repressor interacts with the bpeAB-oprB regulatory region to regulate 
bpeAB expression.  
Figure 17. Induction of bpeR-lacZ expression in wild-type KHW during early 
exponential phase in the presence of 0.1X MIC erythromycin (or 10 µg/ml). β-
galactosidase activities were expressed from bpeRpromoter-lacZ fusion, pCYYbpeR, in 
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3.4.3. Expression of bpeAB-oprB is growth phase regulated 
The expression of bpeAB at different growth phases of the bacterium was 
studied next as it was recently shown that MexGHI-OpmD multi-drug efflux pump in 
P. aeruginosa controls growth, antibiotic susceptibility and virulence via 4-quinolone-
dependent cell-to-cell communication (Aendekerk et al., 2005). The expression of 
bpeAB was low from lag until mid-log phases, but gradually increased from mid-log 
phase to reach maximum at stationary phase (Figure 18A). This data was further 
verified by RT-PCR which showed that bpeAB expression was detectable from the 
onset of culture, but increased from 12 h onwards to reach maximum in stationary 
























Figure 18. Growth phase-dependent expression of bpeAB in wild-type KHW. (A) 
β-galactosidase activities were expressed from pCYYbpeAB in KHW. Solid lines 
represent β-galactosidase activity in Miller units, while dotted lines represent cell 
density (OD600). Error bars represent standard deviations of triplicate cell density and 
β-galactosidase determinations for one typical experiment. Where error bars are not 
shown, the standard deviation was within the size of the symbol. (B) Verification of 
growth phase-dependent expression of bpeA and bpeR in wild-type cells by RT-PCR.   
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3.4.4. Expression of bpeR is inducible upon entry into stationary 
phase 
In comparison, bpeR expression was low from the lag to late-log phases, and 
was induced only during the early stationary phase to maximum expression during the 
late stationary phase (Figure 19). RT-PCR results also showed that the expression of 
bpeR was negligible until 12 h of culture and reached maximum after 24 h culture 






















Figure 19. Induction of bpeR expression upon entry into stationary phase in wild-
type KHW. β-galactosidase activities were expressed from pCYYbpeR in KHW. 
Solid lines represent β-galactosidase activity in Miller units, while dotted lines 
represent cell density (OD600). Error bars represent standard deviations of triplicate 
cell density and β-galactosidase determinations for one typical experiment. Where 
error bars are not shown, the standard deviation was within the size of the symbol. 
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3.5. Effect of BpeAB-OprB function on quorum sensing in 
B. pseudomallei 
3.5.1. Addition of exogenous acyl-HSLs advances bpeAB-lacZ 
expression to early exponential phase 
The growth phase-dependent expression of bpeAB-oprB led us to question if 
there is a link between BpeAB-OprB efflux function and the process of quorum 
sensing which is also growth phase-dependent. Quorum sensing regulates the cell 
density-dependent expression of virulence in many bacteria. It is therefore plausible 
that the expression of bpeAB and bpeR might be regulated by quorum sensing or 
BpeAB-OprB function may have an effect of the expression of genes involved in 
quorum sensing, i.e. the autoinducer synthases. The B. pseudomallei quorum sensing 
systems produce several autoinducers such as N-octanoyl-DL-homoserine lactone 
(C8-HSL), N-decanoyl-DL-homoserine lactone (C10HSL), 3-hydroxy-C8-HSL, 3-
hydroxy-C10HSL, and 3-oxo-N-tetradecanoyl-DL-homoserine lactone (3-oxo-
C14HSL) during stationary phase cultures (Ulrich et al., 2004; Valade et al., 2004; 
Song et al., 2005).  To investigate whether the expression of bpeAB-lacZ in wild-type 
KHW could be advanced to early exponential phase (8-12 h) by the addition of 
cognate autoinducers, 100 nM C8-HSL or 100 nM C10HSL was added to KHW 
cultured in AB medium containing glucose and casamino acids. Maximum expression 
of bpeAB-oprB typically obtained during stationary phase culture (24 h) could be 
prematurely advanced to 12 h by the addition of C8-HSL (Figure 20A).  Addition of 
C10-HSL was less effective in advancing the expression of bpeAB (Figure 20B). This 
suggests that bpeAB expression might be regulated by quorum sensing.  The 
advancement of bpeAB expression in KHW to early exponential phase (4 h) was 
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dependent on the dose of C8-HSL added, but required at least 80 nM C8-HSL to 
achieve the level of bpeAB expression typically observed in stationary phase (∼250 
Miller Units) (Figure 19C). bpeAB expression could not be induced if the 
concentration of C8-HSL was <60 nM (Figure 20C). This is in contrast to the very 
low concentrations of C8-HSL (0.1 nM) and C10-HSL (1 nM), required to induce the 
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Figure 20. Advancement of growth phase-dependent induction of bpeAB 
expression by exogenous C8-HSL and C10-HSL.  (A) Growth (OD600) of KHW in 
the presence ({) or absence () of 100 nM C8-HSL.  Also shown are the β-
galactosidase activities (Miller units) representing bpeAB expression from 
pCYYbpeAB during early growth phase (up to 12 h) in the absence (grey bars) or 
presence (black bars) of C8-HSL. (B) Growth (OD600) of KHW in the presence ({) or 
absence () of 100 nM C10-HSL. β-galactosidase activities (Miller units) 
representing bpeAB expression in the absence (grey bars) or presence (black bars) of 
C10-HSL. (C) Dose dependent induction of bpeAB expression in KHW at early 
exponential phase by C8-HSL. C8-HSL was added to 5-ml bacterial culture (OD600~ 
0.1), approximately 2 h after inoculation. β-galactosidase activities were determined 
after 4 h incubation at 37oC. β-galactosidase activities (Miller units) representing 
bpeAB expression in the absence (grey bars) or presence (black bars) of C8-HSL 
Error bars represent standard deviations of triplicate β-galactosidase determinations 
for one typical experiment.   
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3.5.2.  Extracellular production of acyl-HSLs is dependent on 
BpeAB-OprB function  
There is also evidence suggesting that multi-drug efflux pumps may be 
involved in the efflux of autoinducers (Evans et al., 1998; Pearson et al., 1999). We 
tested if BpeAB-OprB was similarly involved in B. pseudomallei autoinducer 
production by cross-streaking the B. pseudomallei wild type and mutant strains 
against the reporter strain, E. coli JB525 carrying the plasmid pJBA132. Expression 
of the luxI promoter-GFP fusion in E.coli JB 525(pJBA132) was induced in the 
presence of C6-HSL, 3-oxo-C6-HSL, C8-HSL, 3-oxo-C8-HSL, C10-HSL and 3-oxo-
C10-HSL (Andersen et al., 2001).  Interestingly, no autoinducer production was 
detected when KHW∆bpeAB and the bpeR overexpressing strains, 
KHW(pUCP28TbpeR) and KHWbpeR::Km(pUCP28TbpeR)  when cross-streaked 
against the reporter strain (Figure 20). Fluorescence was detected on the reporter 
strain when cross streaked against KHWbpeR::Km, KHW and the complemented 
bpeAB mutant, KHW∆bpeAB (pUCP28TbpeAB), with no observable difference in 




Figure 21. Production of HSLs by the B. pseudomallei KHW and its isogenic 
mutants, KHW∆bpeAB, and KHWbpeR::Km, the complemented mutants, 
KHW∆bpeAB(pUCP28TbpeAB) and KHWbpeR::Km(pUCP28TbpeR) and bpeR-
overexpressing parental strain, KHW(pUCP28TbpeR).  Vertical streaks represent the 
E. coli JB525 reporter strain harbouring the luxR-luxIpromoter-GFP plasmid whilst the 
horizontal streaks represent (A) KHW, (B) KHW∆bpeAB mutant, (C) KHW∆bpeAB 
(pUCP28T-bpeAB) complemented mutant, (D) KHWbpeR::Km mutant, (E) 




3.5.3. Growth phase-dependent expression of the autoinducer 
synthase, BpsI, is dependent on BpeAB-OprB function 
Since a reduction in autoinducer production in KHW∆bpeAB might be the 
result of either an absence of autoinducer efflux or a repression of autoinducer 
synthase activities, the expression of bpsI, a luxI homolog, in KHW and its isogenic 
mutants were measured (Song et al., 2005). It was recently reported that B. 
pseudomallei has 3 luxIR homologs, which produce a variety of HSLs, including C8-
HSL, C10-HSL, 3-hydroxy-C8-HSL, 3-hydroxy-C10HSL and 3-oxo-C14HSL (Ulrich 
et al., 2004). BpsI synthesizes mainly C8-HSL (Song et al., 2005).  
Wild-type B. pseudomallei KHW entered stationary phase after 15 h culture in 
AB medium containing 20 mM glycerol and 0.2% (w/v) casamino acids (Figure 22A). 
In comparison, the doubling time in KHW∆bpeAB was almost twice as long and 
stationary phase was attained only after 27 h of culture. We introduced the bpsIpromoter-
lacZ plasmid, pSYI, into both KHW and KHW∆bpeAB to study the effect of BpeAB-
OprB on bpsI expression. In the bpeAB mutant, bpsIpromoter-lacZ expression was 
significantly lower that that of KHW or the entire duration of culture, finally attaining 
about half the level of that in KHW. In KHWbpeR::Km, which had functional 
BpeAB-OprB, the growth properties and levels of bpsIpromoter-lacZ expression after 30 
h of culture were similar to those in KHW. Thus, the absence of growth phase-
dependent expression of bpsI in the bpeAB mutant was indeed a consequence of the 
defective efflux pump (Figure 22A). We have also cultured the bpeAB-null mutant 
under conditions similar to those described for Figure 22, but in the presence of 100 
nM C8-HSL, and observed that the growth of the bpeAB-null mutant was not restored 
to wild-type level (Figure 22B). The inability to restore bpsIpromoter-lacZ expression in 
KHW∆bpeAB to wild-type levels even in the presence of exogenous 100 nM C8-HSL 
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suggests that intracellular concentrations of C8-HSL might already be high, possibly 
due to impaired efflux. This accumulation of C8-HSL in the bpeAB mutant might 


















































Figure 22. Effect of BpeAB-OprB on growth-phase-dependent expression of 
bpsIpromoter-lacZ. The plasmid pSYI carrying bpsIpromoter-lacZ was introduced into 
KHW, KHW∆bpeAB, and KHWbpeR::Km, respectively, to study the effect of 
BpeAB-OprB on the expression of the autoinducer synthase BpsI. (A) Aliquots of the 
bacteria cultured in AB medium containing 20 mM glycerol, 0.2% casamino acids, 
and 25 µg/ml tetracycline were assayed at different time intervals from the onset of 
culture (0 h) to stationary phase (30 h). Solid lines represent the cell densities of 
KHW(pSYI) (), KHW∆bpeAB(pSYI) ({), and KHWbpeR::Km (pSYI) (♦), 
respectively, while β-galactosidase activities are represented as bars [KHW(pSYI), 
black bars; KHW∆bpeAB(pSYI), grey bars; and KHWbpeR::Km (pSYI), striped 
bars]. (B) Growth curve of bpeAB-null mutant in the presence (solid lines) and 
absence (dotted lines) of 100 nM C8-HSL. (C) β-galactosidase activities (Miller units) 
representing bpsI expression in KHW∆bpeAB at early exponential phase in the 
absence (black bars) or presence (grey bars) of C8-HSL. All measurements were done 
in triplicates; the means and standard errors are shown.  
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The possibility that BpeAB-OprB might have affected autoinducer production 
as a consequence of its involvement in the efflux of an intermediary metabolite that 
had an impact on autoinducer synthase expression and thus autoinducer production 
was investigated. The amounts of intracellular and extracellular autoinducers 
produced by the wild-type B. pseudomallei and its isogenic pump mutants were 
compared before and after membrane permeabilization by freeze-thawing using E. 
coli JB525 as a reporter strain (Figure 23). Autoinducers were synthesized by all the 
B. pseudomallei strains tested, but the efflux of these autoinducers was significantly 
reduced in the strains where the BpeAB-OprB function was impaired. Extracellular 
autoinducers was undetectable in KHW∆bpeAB mutant, KHWbpeR::Km 
(pUCP28TbpeR) complemented mutant and KHW(pUCP28TbpeR) before membrane 
permeabilization but was detectable after several rounds of freeze-thawing to 




Figure 23. Detection of intracellular and extracellular acyl-HSLs in B. 
pseudomallei and its isogenic mutants, KHW∆bpeAB, and KHWbpeR::Km, the 
complemented mutants, KHW∆bpeAB(pUCP28TbpeAB) and 
KHWbpeR::Km(pUCP28TbpeR) and bpeR-overexpressing parental strain, 
KHW(pUCP28TbpeR). Each dot below the wells was spotted with 2 µl of E. coli 
JB525 reporter strain harbouring the luxR-luxIpromoter-GFP plasmid. Fifty µl of 
intracellular HSLs, extracted from total bacterial lysate by subjecting the cells to 5 
cycles of freeze-thaw, were loaded onto wells A. Extracellular HSLs were detected by 
directly inoculating 50 µl of overnight bacterial culture supernatants into wells B. B. 
cepacia was used as a positive control in this experiment. 
 
3.5.4. BpeAB-OprB is involved in the active efflux of C8-HSL   
Extracellular [14C]-radiolabeled acyl-HSLs were extracted from culture 
supernatants KHW and its isogenic mutants, whilst intracellular HSLs were prepared 
by lysing the cell pellet by freeze-thaw method as described in section 2.16.1 to 
release intracellular radiolabeled HSLs. The ethyl-acetate extracted HSLs were then 
analysed by Reversed-phase High Performance Liquid Chromatography (RP-HPLC). 
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Seven major peaks with [14C]-label were detected in both the extracellular and 
intracellular extracts from KHW (Figure 24). Peaks 2 and 3 were identified as C8-
HSL and C10-HSL, respectively, according to their retention volumes, when 
compared to standards, from previous work done in our lab. Liquid-chromatography-
mass-spectometry (LC-MS) analyses done by A/Prof Zhang Lianhui from Institute of 
Molecular and Cell Biology (IMCB) suggested the identities of peaks 2 and 3, as well 
as identified peak 7 as 3-oxo-C14-HSL. Peak 1 is likely to be [14C]-methionine and 
not an HSL. We failed to detect any 3-OH-C8-HSL and 3-OH-C10-HSL, which 
should be detected before peak 2 and between peaks 2 and 3, repectively, although 
these 2 HSLs were reported to be produced in B. pseudomallei (Ulrich et al., 2004; 
Valade et al.). 
In contrast, only 2 and 4 peaks were detected in the cytoplasm of 
KHW∆bpeAB and KHWbpeR::Km, respectively (Figure 24A). Whilst both the bpeAB 
and bpeR null mutants produced C8-HSLs (Figure 24A, peak 2), the results showed 
that only the bpeAB mutant was unable to efflux this autoinducer into the extracellular 
medium (Figure 24B). The intracellular level of C8HSL in KHW∆bpeAB was also 
two-fold lower when compared to wild-type KHW as well as KHWbpeR::Km, 
probably due to the negative feedback of intracellular C8-HSL on the expression of 
autoinducer synthase.  
The deletion of bpeR, which led to an overexpression of bpeAB (Figure 12, 
lane 4) also resulted in a reduction in the variety of HSLs produced. KHWbpeR::Km 
produced only 4 peaks of HSLs compared to 7 peaks in wild-type KHW. 
Approximately 20% more C8-HSL was detected in the extracellular medium of 
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Figure 24. RP-HPLC analyses of intracellular (A) and extracellular (B) HSLs in 
KHW and its isogenic mutants, KHW∆bpeAB, and KHWbpeR::Km. Radiolabeled 
HSLs were prepared from 5 ml overnight bacterial broth culture incubated with 5 µCi 
of L-[1-14C] methionine (Sigma) for 30 min prior extraction. Extracellular 
radiolabeled HSLs were prepared from the culture supernatant, whilst intracellular 
HSLs were extracted from permeabilized cell pellet by the freeze-thaw technique. 
Dotted line represents HSLs produced by wild-type KHW (), solid lines represent 




3.6. Impact of BpeAB on B. pseudomallei virulence 
3.6.1. BpeAB function is a requirement for cell invasion by B. 
pseudomallei 
Since quorum sensing regulates the expression of virulence, the effect of the 
BpeAB function on the invasion of human lung carcinoma cells (A549) and human 
macrophage cells (THP-1) by wild type B. pseudomallei and its isogenic mutants 
were investigated. Bacterial invasion of both A549 and THP-1 cells was attenuated by 
more than 100-fold in KHW∆bpeAB when compared to the wild type (Table 10).  
Exogenous addition of 100 nM C8-HSL to the cell culture medium restored the 
invasiveness of KHW∆bpeAB to wild-type KHW levels. Thus the BpeAB function is 
required for cell invasion by B. pseudomallei. Secondly, the attenuation of cell 
invasion in the pump mutant, KHW∆bpeAB, is probably due to its impaired quorum 








































































































































































































































































































































































































































































































3.6.2. Overexpression of BpeR repressor blocks cell invasion by B. 
pseudomallei 
The absence of autoinducer production in the bpeR-overexpressing strains, 
KHW(pUCP28TbpeR) and KHWbpeR::Km(pUCP28TbpeR), demonstrates that 
quorum sensing can be inhibited by overexpressing bpeR (Figure 21E and 21F). Since 
quorum sensing regulates the expression of virulence, the effect of bpeR 
overexpression on the invasion of human lung carcinoma cells (A549) and human 
macrophage cells (THP-1) was also investigated. Bacterial invasion of both A549 and 
THP-1 cells was significantly attenuated in bpeR-overexpressing strains, 
KHWbpeR::Km(pUCP28TbpeR) and KHW(pUCP28TbpeR) (Table 10). The data 
demonstrates that overexpression of the BpeR repressor could attenuate B. 
pseudomallei virulence by blocking cell invasion more effectively than deletion of 
BpeAB pump function. The invasiveness of KHW∆bpeAB was reduced by about 100-
fold, as compared to wild type, whereas an overexpression of bpeR in KHW reduced 
the invasiveness by 10,000-fold.  
 
3.6.3. BpeAB function is required for cell killing by B. pseudomallei   
Interestingly, the absence of a functional BpeAB pump not only reduced the 
pathogen’s invasiveness but also its cytotoxic effect on THP-1 and A549 cells (Table 
11).  The results showed that a functional BpeAB pump is essential to invade and kill 
mammalian cells as the effects were restored with a functional copy of bpeAB as seen 
in the complemented KHW∆bpeAB (Table 11). The cytotoxic effect of both 
KHW∆bpeAB, as well as the bpeR-overexpressing strains, KHWbpeR::Km 
(pUCP28T-bpeR) and KHW(pUCP28T-bpeR), on both A549 and THP-1, were 
significantly reduced (Table 11).  44% of A549 cells and 42% of THP-1 cells were 
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killed after exposure to KHW for 4 h. The cytotoxicity of KHW∆bpeAB, 
KHWbpeR::Km(pUCP28TbpeR) and KHW(pUCP28TbpeR) to A549 was 
significantly attenuated to 3%, 11% and 6%, respectively, whilst the cytotoxicity of 
these strains to THP-1 cells was completely blocked (Table 11). Addition of 
exogenous C8-HSL could only partially restore the cytotoxicity of KHW∆bpeAB, 
KHWbpeR::Km(pUCP28TbpeR) and KHW(pUCP28TbpeR). 
The cytotoxicity towards A549 cells was fully restored to wild-type level 
when the KHW∆bpeAB mutant was complemented in trans with pUCP28TbpeAB, 
but its cytotoxicity towards THP-1 cells was only partially restored in the 
complemented mutant.  The bpeR mutation had no effect on the cytotoxicity of KHW. 
The data showed that the BpeAB function is required for the cytotoxicity of B. 
pseudomallei towards A549 and THP-1 cells, and the attenuated virulence of the 














































































































































































































































































































































































































3.6.4. BpeAB function affects production of virulence factors 
(siderophore and phospholipase C) 
The production of putative virulence factors, such as siderophore and 
phospholipase C in B. pseudomallei, is affected by quorum sensing (Song et al., 2005).  
Extracellular production of siderophore and phospholipase C in B. pseudomallei KHW 
is maximal during the stationary phase cultures (Song, 2003). In order to gain further 
insight into the interaction of BpeAB function and virulence, we then investigated the 
effect of BpeAB function on the production of siderophore and phospholipase C. 
Siderophore production was reduced by 50% in the KHW∆bpeAB mutant, but 
by only 30% in the strains overexpressing bpeR (Figure 25A). The reduction of 
phospholipase C (PLC) production in the bpeAB mutant and the strains overexpressing 
bpeR was more significant when compared to wild-type, where about 80% reduction 
in PLC activity was observed (Figure 25B). 
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Figure 25. Effect of BpeAB on siderophore and phospholipase C production in B. 
pseudomallei. Siderophore activities and phospholipase C activities were measured in 
KHW, KHW∆bpeAB, KHW∆bpeAB complemented with pUCP28TbpeAB, 
KHWbpeR::Km, KHWbpeR::Km complemented with pUCP28TbpeR, and KHW 
harbouring pUCP28TbpeR, respectively. (A) Optimal siderophore production in B. 
pseudomallei is dependent on the BpeAB function, and overexpression of bpeR in 
KHWbpeR::Km(pUCP28TbpeR) and KHW(pUCP28TbpeR) reduced siderophore 
production. Siderophore activities were assayed in the supernatants of 24-h-old 
cultures and were determined by measuring the differential in OD630 readings between 
the test and the sample blank. The values shown have been normalized for cell density 
by being expressed as a ratio of ∆ OD630/ OD600. (B) Optimal PLC secretion by B. 
pseudomallei KHW is dependent on BpeAB, and overexpression of bpeR in 
KHWbpeR::Km(pUCP28TbpeR) and KHW(pUCP28TbpeR) inhibited PLC secretion. 
PLC activities were determined in the supernatants of 24-h cultures, and the values 
shown have been normalized for cell density by being expressed as a ratio of ∆ OD410/ 





3.7. Impact of BpeAB function on biofilm formation  
In B. pseudomallei, biofilm was formed on polyvinylchloride surfaces during 
the stationary phase (Song, 2003). The B. pseudomallei quorum-sensing mutants 
(KHWbpsI::Km and KHWbpsR::Km) showed reduced biofilm formation when 
compared to the wild-type parental strain (Song, 2003).  Since quorum sensing was 
significantly impaired in the B. pseudomallei bpeAB mutant, we were interested to find 
out if biofilm formation, which is regulated by quorum sensing, might be affected by 
the BpeAB efflux function. Biofilm formation was reduced by 60% in the bpeAB 
mutant and about 50-60% in the strains overexpressing bpeR (Figure 26). 
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Figure 26. Effect of BpeAB on biofilm formation in B. pseudomallei. Optimal 
biofilm formation is dependent on BpeAB. Biofilm formation was significantly 
reduced in KHW∆bpeAB and KHW overexpressing bpeR. Each bar is the average 




3.8. Other physiological functions of BpeAB-OprB 
3.8.1. Expression of bpeAB-lacZ is unaffected by stress conditions 
 In. E. coli, one of the functions of AcrAB-TolC is to protect the cells from 
environmental stress such as bile salts (Thanassi et al., 1997), and organic solvents 
(White et al., 1997), suggesting that multi-drug transporters play a role in protecting 
the membrane integrity or energy state of the cell. In the case of BpeAB-OprB, the 
expression of bpeAB was induced by the substrates recognized by the pump, but not 
by environmental stress such as osmolarity, acidic or alkaline pH, and ethanol, Thus, 
unlike the E. coli AcrAB-TolC, the primary role of BpeAB-OprB appears to be for the 
efflux of amphiphatic antibiotics from the cells, but not salts, H+ or ethanol (Figure 
27).  













Figure 27. The expression of bpeAB-lacZ in the presence of antibiotic substrates 
and under physiological stress. The antibiotic substrates, erythromycin, gentamicin 
and streptomycin induced the expression of bpeAB-lacZ, but not conditions such as 
acidic or alkaline pH, high osmolarity or ethanol. Black bars represent basal β-




3.8.2 Expression of bpeAB-lacZ is induced by intermediates of the 
methionine utilization pathway, 5’-S-methyl-5’-thioadenosine 
(MTA) and spermidine 
The occurrence of multiple RND efflux pumps in gram-negative bacterial 
pathogens, including B. pseudomallei, suggests that these pumps could be involved in 
the efflux of a broad range of structurally unrelated physiological substrates. It is 
plausible that over-expression of bpeAB-oprB might result in the efflux of a metabolite 
that could have an impact on the expression of genes encoding autoinducer synthases, 
thus affecting the production of HSLs. Autoinducers involved in quorum sensing in 
many gram-negative bacteria are N-acyl-HSLs. When in high enough concentration, 
these molecules can bind to and activate a transcriptional activator, or LuxR homolog, 
which in turn induces expression of target genes (De Kievit and Iglewski, 2000). 
HSLs, which are derived from S-adenosylmethionine, are synthesized by LuxI-type 







Figure 28. Homoserine lactone (HSL) and AI-2 biosynthesis in gram-negative 
bacteria.  Autoinducer synthases form HSLs from S-adenosylmethionine (SAM) and 
specific acyl carrier proteins (Acyl–ACPs). These reactions also produce MTA, which 
is detoxified by the Pfs enzyme yielding MTR and adenine. SAM also functions as a 
methyl donor in many cellular reactions, resulting in the formation of another toxic 
compound, S-adenosylhomocysteine (SAH). SAH is detoxified by SAH hydrolase to 
homocysteine and adenosine as well as by the enzyme Pfs, yielding S-
ribosylhomocysteine (SRH), which in some bacteria is further processed by the LuxS 
enzyme to yield SRH and subsequently to homocysteine and AI-2, another quorum 
sensing autoinducer.   
 
 Analysis of the B. pseudomallei K96243 genomic sequence showed that B. 
pseudomallei does not encode any luxS homolog. Instead, SAH appears to be 
detoxified by hydrolysis into adenosine and homocysteine. In other bacterial genomes, 
the occurrence of LuxS and SAH hydrolase is also mutually exclusive (Winzer et al., 
2002). Therefore, although yet to be verified experimentally, we assume B. 
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pseudomallei does not produce any AI-2. The gene encoding SAH is located on 
chromosome 1 of the B. pseudomallei genome, nucleotide positions 3906275 to 
3907693. Thus, metabolic pathway intermediates whose intracellular concentrations 
that might impinge on HSL synthesis through product inhibition are MTA, MTR, SAH 
and SRH. Due to the unavailability of SRH, only the effects of MTA, MTR and SAH 
on BpeAB-OprB were investigated. For this study, MTR was synthesised from MTA 
according to the protocol described by Schlenk et al (Schlenk et al., 1973). Both MTA 
and MTR could induce bpeAB-lacZ expression 4 h after their addition to the culture 
media. In contrast, bpeAB-lacZ expression was undetectable after the addition of SAH 
(Figure 29). This showed that the intermediary metabolites like HSLs that are derived 


























Figure 29. Induction of bpeAB-lacZ expression by intermediary metabolites 
derived from SAM. Expression of bpeAB-lacZ, determined by introducing 
pCYYbpeAB into KHW, was induced in the presence of MTA, as well as MTR but 
not by SAH. All the test compounds were added at a final concentration of 0.2 µM. 




 Besides HSL synthesis, the bulk of MTA in the bacterium is produced during 
polyamine biosynthesis (Williams-Ashman et al., 1982; Pegg, 1988). Thus the amount 
of MTA produced from polyamine biosynthesis might be significant for the induction 
of bpeAB-oprB expression. This led us to investigate if polyamines might be the 
physiological substrates of BpeAB-oprB. 
 
 
Figure 30. Pathway for the biosynthesis of polyamines and generation of MTA in 
E. coli. In E. coli, S-adenosylmethionine (SAM) is first decarboxylated and then the 
propylamine group is transferred to form the polyamine spermidine (Sekowska et al., 
2000). MTA is the co-product of the polyamine synthase reactions. 
 
Polyamines are polycationic compounds that are present in all biological 
materials and have been implicated in a wide variety of biological reactions, including 
DNA, RNA and protein synthesis (Tabor and Tabor, 1985). The most common 
polyamines in bacteria are putrescine and spermidine. Although polyamines are 
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essential for normal growth and have important physiological roles, their specific 
molecular functions in vivo are still largely unclear. In E. coli, mutant strains that do 
not contain any polyamines can still grow indefinitely, although the rate is only about 
30% of the rate observed after polyamine addition into the culture medium (Hafner et 
al., 1979).  The induction of bpeAB-lacZ expression in B. pseudomallei KHW by the 
polyamines, putrescine and spermidine, was studied. Exogenous addition of 1 mM 
putrescine did not induce expression of bpeAB-lacZ in KHW, but the same 























Figure 31. Induction of bpeAB-lacZ expression by exogenous polyamines, 
spermidine and putrescine. Expression of bpeAB-lacZ was determined in B. 
pseudomallei KHW carrying the plasmid pCYYbpeAB. Putrescine and spermidine 
were added at a final concentration of 1 mM. Black and grey bars represent β-
galactosidase activities before and after addition of polyamines, respectively. β-




The involvement of the BpeAB-OprB pump in the efflux of spermidine was 
verified using [14C]-labelled spermidine. 5 µM radiolabeled spermidine (Amersham 
Biosciences, Buckinghamshire, UK) was added to early log-phase bacterial culture in 
the presence of 10 mM cyclohexylamine, a spermidine synthase inhibitor, so as to 
inhibit intracellular de novo biosynthesis of spermidine. [14C]-spermidine was 
accumulated in KHW and all its isogenic mutants 2 h after its addition into the 
cultures, with no significant differences (p≤0.05) in the amounts accumulated (Figure 
32A). Since this might be due to the attainment of similar steady state levels between 
the different strains due to prolonged exposure to the exogenous spermidine, the 
experiment was repeated by removing exogenous [14C]-spermidine and then 
measuring the intracellular levels of [14C]-spermidine at 2 h intervals in media without 
spermidine (Figure 32B and C).  
Two hours after removal of exogenous spermidine, the amount of spermidine 
accumulated in wild-type KHW and the complemented KHW∆bpeAB mutant 
remained high (~ 50nM/OD600), whereas very little intracellular [14C]-spermidine was 
detected in the bpeAB deletion mutant (~10nM/OD600) (Figure 32B). Unexpectedly, 
the spermidine level in bpeR mutant is 3-fold higher than in wild type KHW, and 
intracellular spermidine level in the complemented bpeR mutant was comparable to 
wild-type (Figure 32B). The intracellular levels of spermidine in KHW and all its 
isogenic mutants subsequently returned to a very low level of between 8 to 15 nM, 4 h 
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Figure 32. Intracellular accumulation of [14C]-spermidine in B. pseudomallei 
KHW and its isogenic mutants, in the presence of 10 mM cyclohexylamine. (A) 
Intracellular accumulation of radiolabeled spermidine occurred 4 hours after addition 
of 5 µM [14C]-spermidine to the culture media containing 10 µM cyclohexylamine. 
After the removal of exogenous [14C]-spermidine from the bacterial cells through three 
rounds of washing in fresh AB media containing 0.2% (w/v) glucose and 10mM 
cyclohexylamine, the cells were resuspended in equal volume of the same media and 
further incubated at 37oC. Intracellular levels of radiolabeled spermidine were 
measured after (B) 2 hours and (C) 4 hours. Student’s t-test was performed to 
determine if there was a statistically significant difference (p≤0.05) between the mean 
intracellular [14C]-spermidine levels in the wild-type KHW and its isogenic mutants.  
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 E. coli K12 mutants deficient in the enzymes for polyamine synthesis, such as 
spermidine synthase and S-adenosylmethionine decarboxylase, do not synthesize 
putrescine or spermidine and grow at only one-third the rate of wild-type E. coli 
(Hafner et al., 1979). We also observed a slower growth rate in the B. pseudomallei 
bpeAB deletion mutant (Figure 22A). Intracellular spermidine levels was also very 
much reduced in the bpeAB deletion mutant when compared to wild-type (data not 
shown). This suggests that spermidine biosynthesis might be impaired in the bpeAB 
mutant. The gene encoding spermidine synthase is speE. We studied speE expression 
by RT-PCR using primers SpeE1 (5’ GCCGCCTTGAGCACCACC 3’) and SpeE2 (5’ 
TCGCTGTTCTCGCACGA 3’). The results, however, showed no significant 
difference (p≤0.05) in levels of speE expression between KHW and its isogenic 
mutants KHW∆bpeAB, KHW∆bpeAB complemented with pUCP28TbpeAB, 
KHWbpeR::Km complemented with pUCP28TbpeR, and KHW harbouring 




Figure 33. Detection of spermidine synthase expression in KHW and its isogenic 
mutants by RT-PCR. 5 µg of total RNA from KHW (lane 1) and its isogenic mutants 
KHW∆bpeAB (lane 2), KHW∆bpeAB(pUCP28TbpeAB) (lane 3), KHWbpeR::Km 
(lane 4), KHWbpeR::Km(pUCP28TbpeR) (lane 5), and KHW(pUCP28TbpeR) (lane 
6) were used for RT-PCR to detect speE expression using Access RT-PCR System as 
described in section 2.3. Primer pairs SpeE1 (5’ GCCGCCTTGAGCACCACC 3’) and 
SpeE2 (5’ TCGCTGTTCTCGCACGA 3’) produced a 642 bp speE product, whilst 
primer pairs 16SF2 and 16SR2 (Table 3) produced a 521 bp 16SrDNA product.  
 
3.9. MTA and spermidine exhibit bacteriostatic properties 
on B. pseudomallei in vitro  
MTA exerts a potent feedback inhibition of polyamine synthase reactions at 
low µM concentrations (Raina et al., 1982) and in E. coli, spermidine accumulation 
resulted in a decrease in cell viability (Fukuchi et al., 1995). The growth inhibitory 
effects of MTA and spermidine were thus investigated in KHW and its isogenic 
mutants by employing the technique used in MIC and MBC determinations as 
described in section 2.10.  
The parental strain, KHW, was sensitive to 4 µM MTA as well as 2 µM SAH 
but resistant to more than 1 mM MTR and 10 mM spermidine (Table 12). Deletion of 
bpeAB reversed the growth effects of all the compounds tested as it became resistant to 
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MTA (more than 250-fold) and SAH (more than 500-fold) but sensitive to MTR (more 
than 250-fold) and spermidine (more than 500-fold). KHW∆bpeABKm 
(pUCP28TbpeAB) and KHWbpeR::Km behaved like wild-type KHW whereas 
KHWbpeR::Km (pUCP28TbpeR) behaved the same as bpeAB deletion mutant. This 
again confirmed the phenotype of bpeR insertional mutant to be identical to bpeAB 
complement, which a mutation in bpeR resulted in an overexpression of bpeAB, 
whereas an overexpression of bpeR as seen in KHWbpeR::Km(pUCP28TbpeR) 
resulted in a repression or no bpeAB expression, just like bpeAB deletion mutant. It 
was interesting to note that MTA and SAH had the same effects on the bacteria 
compared to MTR and spermidine. 
 
Table 12. Susceptibilities of B. pseudomallei KHW and its isogenic mutants to 
intermediate compounds derived from homoserine lactone (HSL) biosynthesis 
pathways and the polyamine, spermidine. 
Test compounds MTA MTR SAH Spermidine 
















KHW 4  >1000 >1000 >1000 2  >1000  > 10  > 10 
KHW∆bpeABKm >1000  >1000 4  >1000 >1000 >1000  < 20  > 10 
KHW∆bpeABKm 
(pUCP28TbpeAB) 
2  >1000 >1000 >1000 2  >1000  > 10  > 10 
KHWbpeR::Km 4 >1000 >1000 >1000 4  >1000  > 10  > 10 
KHWbpeR::Km 
(pUCP28TbpeR) 




3.10. Screening of putative inhibitors of BpeAB-OprB 
Antibiotic resistance by active efflux of toxic compounds out of cells is a 
general mechanism by which bacteria protect themselves against the adverse effects of 
their environments. Antibiotics that are used in clinical settings are among these toxic 
compounds, and extrusion of antibiotics from bacterial cells significantly decreases 
their clinical utility (Lawrence and Barrett, 1998). Therefore an inhibitor of efflux 
pumps could potentially improve the clinical performance of antibiotics by enhancing 
the anti-microbial susceptibility of the bacterial pathogens. An inhibitor of BpeAB-
OprB, in this case, is also likely to have an additional beneficial effect of inhibiting 
quorum sensing and the expression of virulence determinants in B. pseudomallei. The 
number of commercially available efflux pump inhibitors is very limited and several 
potential ones are being evaluated by pharmaceutical companies. 
 
3.10.1 . Effect of a broad-spectrum efflux pump inhibitor (MC-
207,110) on BpeAB-OprB  
The potentiating effect of the broad-spectrum efflux pump inhibitor MC-
207,110 on the anti-microbial substrates of the B. pseudomallei BpeAB-OprB pump 
was assessed by checkerboard assays, in which the MICs of erythromycin and 
streptomycin were determined in the presence of different concentrations of MC-
207,110 (Lomovskaya et al., 2001). MC-207,110 was selected because of its effect on 
potentiating the susceptibility of P. aeruginosa to fluoroquinolones, an antibiotic that 
is a substrate of the P. aeruginosa MexAB-OprM, MexCD-OprJ and MexEF-OprN 
efflux pumps (Lomovskaya et al., 2001). MC-207,110 was shown to be active against 
MexAB-OprM, MexCD-OprJ and MexEF-OprN in P. aeruginosa, as well as AcrAB-
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TolC in E. coli. When this compound, MC-207,110 was used, the intrinsic resistance 
of wild-type P. aeruginosa to levofloxacin decreased 8-fold, while in strains over-
expressing these pumps, susceptibility was increased up to 64-fold. MC-207,110 is 
also able to decrease the frequency of emergence of P. aeruginosa strains with 
clinically relevant levels of resistance to fluoroquinolones. The addition of MC-
207,110 at concentrations up to 40 µg/ml, did not potentiate the anti-microbial 
activities of erythromycin and streptomycin in B. pseudomallei. MC-207,110 alone 
also did not have any anti-microbial activity. 
 
3.10.2 Effects of adenosine analogues on BpeAB-OprB  
Since MTA could induce bpeAB expression and inhibit the growth of wild-type 
KHW, it therefore is a potential substrate of the BpeAB-OprB pump. It is plausible 
that analogues of adenosine might function as competitive inhibitors of the pump. We 
thus screened a number of adenosine analogues, which are used in the clinical setting 
for treatment of cancer (Table 4). These include drugs like 6-mercaptopurine, and 5-
fluorouracil commonly used for cancer therapy. The assay studied the interactions 
between erythromycin and the pump inhibitors assessed by a checkerboard titration 
assay in a 96-well microtiter plate, as described by Lomovskaya et al. (Lomovskaya et 
al., 2001). Erythromycin was tested at 0.5X MIC concentration (64 µg/ml), while the 
inhibitors were tested at 7 two-fold serial dilutions (40 to 0.625 µg/ml, including 0 
µg/ml). None of the analogues, however, exert a potentiating effect on the 
susceptibility of KHW to erythromycin as bacterial growth was not inhibited even in 













4.1. Identification of the B. pseudomallei bpeAB-oprB 
operon 
Antibiotic efflux mechanisms are highly recognised as a major factor in the 
intrinsic and acquired antibiotic resistance of a number of significant human 
pathogens, including P. aeruginosa and B. cepacia (Nikaido, 1998b). Several tripartite 
efflux systems coded on the chromosome play important roles in these types of 
antibiotic resistance in many gram-negative bacteria. Each system consists of a 
cytoplasmic membrane component of the resistance-nodulation-division family 
presumed to function as a transporter, an outer membrane component presumed to 
form channels, and a membrane fusion protein presumed to link the two membrane 
proteins (Nikaido, 1998a). Sequencing of the B. pseudomallei K96243 genome was 
recently completed at the Sanger Centre, UK in late March 2003, and annotation of the 
genome is in progress. B. pseudomallei K96243 was isolated from a 34-year-old 
female melioidosis patient in Thailand but our study was focused on a local virulent 
clinical isolate, KHW. Our studies on the bpeR-bpeA-bpeB-oprB genes will contribute 
towards validation and annotation of the genomic information of B. pseudomallei.   
Multiple alignments of amino acid sequences revealed a number of strongly 
conserved amino acid sequence motifs throughout the multi-drug transporters of the 
RND family. The conservation of these motifs suggested that they play an important 
structural and functional role in the transporter (Putman et al., 2000b). These 
conserved sequences are characteristics of RND transporters and can be used to 
identify members of this family in B. pseudomallei genome. The B. pseudomallei 
bpeR-bpeAB-oprB operon encodes a repressor of the TetR family (BpeR) and a three-
component anti-microbial efflux system comprising a periplasmic linker protein 
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(BpeA), an inner membrane protein (BpeB), and an outer membrane protein (OprB). 
Multiple-amino-acid-sequence alignments with homologues and secondary structure 
prediction showed that BpeAB-OprB pump belongs to the RND superfamily of 
transporters, which are known to have extremely broad substrate specificities. The 
large periplasmic loops of RND transporters, located between transmembrane 
segments 1,2 and 7,8, are believed to be involved in multi-drug recognition and efflux 
(Tikhonova et al., 2002; Eda et al., 2003; McKeegan et al., 2003), whereas the two-
arginine residues in motif C may play a functional role in the binding and transport of 
charged drugs and/or translocation of protons (Putman et al., 2000b).  
 It is interesting to note that the bpeAB-oprB sequences were highly identical 
between K96243 and ATCC 23343 except a 49-nucleotide GC-rich insert at positions 
944037 to 944084 of the K96243 chromosome 1. This GC-rich insert is located at the 
3’end of bpeA and has the ability to form very stable hairpin loop structure (Figure 8), 
which might affect the expression of bpeB. However, a comparison between ATCC 
23343 and K96243 showed that there are no significant differences in the MIC values 
of gentamicin, streptomycin and erythromycin, which are substrates of BpeAB-OprB 
(Simpson et al., 1999).  
 
4.2. Anti-microbial substrates of the B. pseudomallei BpeAB 
efflux pump  
The functions of BpeR and BpeAB in antibiotic resistance in B. pseudomallei 
were characterized by the construction of insertional and deletion mutants in bpeR and 
bpeAB respectively. KHWbpeR::Km and KHW∆bpeAB were isogenic derivatives of 
the wild-type parental strain, KHW. The phenotypes attributable to the bpeR and 
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bpeAB mutations were verified by trans complementation using the plasmids carrying 
copies of the wild-type bpeR and bpeAB, respectively. 
Among the 8 putative RND efflux pumps (Figure 7) present in B. pseudomallei 
is AmrAB-OprA that conferred resistance to aminoglycosides and macrolides (Moore 
et al., 1999). Both the BpeAB-OprM pump and the AmrAB-OprA pump share some 
similarities with respect to substrate specificity but are distinct in their chromosomal 
locations and amino acid sequences. Both pumps efflux the aminoglycosides 
gentamicin and streptomycin, and the macrolide erythromycin. The efflux of 
kanamycin, which is also a substrate of the AmrAB-OprA pump, could not be 
compared because KHW∆bpeAB was kanamycin resistant. Although both pumps have 
some substrates in common, their substrates differed in that B. pseudomallei strains 
which had either amrA or amrB deletions displayed increased susceptibilities to a 
wider range of aminoglycosides and macrolides, including gentamicin, kanamycin, 
streptomycin, spectinomycin, tobramycin, neomycin, erythromycin, and 
clarithromycin (Moore et al., 1999). The B. pseudomallei bpeAB deletion, in contrast, 
resulted in increased susceptibility to erythromycin, streptomycin, and gentamicin but 
not to spectinomycin and clarithromycin. Although this was likely to be attributed to 
differences in the substrate specificities of these two pumps, it was also possible that 
the inactivation of the BpeAB pump in KHW∆bpeAB might have consequentially 
upregulated the AmrAB-OprA pump, resulting in the higher levels of efflux of 
clarithromycin and spectinomycin from this strain. However, limited data on the 
inducibility of the AmrAB-OprA pump showed that it is not inducible by its substrate, 
and it is difficult to explain how the efflux of clarithromycin and spectinomycin could 
be selectively affected by this upregulation (Moore et al., 1999). A study on the effect 
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of the bpeAB deletion in a strain that already lacks amrAB in order to elucidate 
whether these pumps have an additive effect on aminoglycoside and macrolide 
resistance in B. pseudomallei would be useful, since additive or multiplicative effects 
on drug resistance have been reported for P. aeruginosa, which has multiple efflux 
pumps with overlapping substrate specificities (Lee et al., 2000). 
The data on the susceptibility of the complemented KHW∆bpeAB strain to 
anti-microbials showed that, apart from erythromycin, multiple copies of bpeAB did 
not increase the level of resistance of B. pseudomallei to any of the anti-microbials 
tested. Coupled with the absence of any significant increase in the level of bpeAB 
mRNA expression in the complemented mutant, this would suggest that the expression 
of bpeAB is tightly regulated, perhaps by an abundance of the BpeR repressor. The 
successful complementation of the bpeAB mutation in trans with a plasmid carrying 
full-length bpeAB genes showed that the bpeAB deletion in KHW∆bpeAB did not have 
a polar effect on oprB expression, or alternatively, another outer membrane efflux 
pump component could compensate for the absence of OprB in KHW∆bpeAB. For 
instance, the OprM outer membrane component is shared by MexAB and MexXY in 
P. aeruginosa, and TolC is shared by AcrAB and AcrEF in E. coli (Poole, 2001a). 
Although B. pseudomallei is intrinsically resistant to a number of antibiotics, it is also 
highly susceptible to many others, including piperacillin, ceftazidime, tetracycline, 
doxycycline, and chloramphenicol; but the choice of anti-microbials for effective 
treatment of melioidosis remains limited. Combinations of chloramphenicol, 
doxycycline, and trimethoprim-sulfamethoxazole, which have been used previously to 
treat confirmed cases of acute severe melioidosis (Chaowagul, 2000), were ineffective 
because of their bacteriostatic rather than bactericidal properties and their potential 
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toxicities. At present, ceftazidime-containing regimens, imipenem, and amoxicillin-
clavulanate are the preferred therapies for acute melioidosis; but the emergence of 
chloramphenicol- and ceftazidime-resistant strains, which are fully virulent is a cause 
for concern (Dance et al., 1989). The use of a combination of quinolones, such as 
ciprofloxacin, and macrolides has also been suggested for melioidosis therapy because 
ciprofloxacin could penetrate phagocytic cells and the macrolide could reduce or 
inhibit biofilm formation, both mechanisms of which are relevant for the treatment of 
melioidosis relapses (Vorachit et al., 1993; Vorachit et al., 1995; Vorachit et al., 
2000).  
The contribution of BpeAB-OprB, as well as AmrAB-OprA, to the intrinsic 
resistance of B. pseudomallei to the anti-microbials gentamicin, streptomycin, and 
erythromycin would explain why aminoglycoside–β-lactam combinations, which are 
commonly used to treat suspected cases of community-acquired sepsis in many parts 
of the world, would be ineffective for the treatment of melioidosis (Poole et al., 
1993b; Nikaido, 1998a; Moore et al., 1999; Lee et al., 2000; Masuda et al., 2000). It is 
noteworthy that in the complemented KHW∆bpeAB mutant that carried multiple 
copies of bpeAB, the overexpression of BpeAB did not affect the organism’s 
susceptibilities to the antibiotics of therapeutic importance, such as chloramphenicol, 
doxycycline, tetracycline, and ceftazidime, although the level of resistance to 
erythromycin was increased in the complemented mutant (Table 7).  
 
4.3. The effects of CCCP on the intracellular accumulation 
of [14C]-erythromycin in B. pseudomallei  
Multi-drug efflux by gram-negative bacteria is an energy-dependent process 
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that is driven by the proton motive force (PMF) (Putman et al., 2000b). An increase in 
the intracellular level of accumulation of erythromycin by B. pseudomallei KHW was 
expected when CCCP, a proton conductor, which dissipates the PMF, was added 
(Figure 14). However, it was unexpected that KHW∆bpeAB, which had a higher 
intracellular level of erythromycin than KHW, would also respond likewise when it 
was treated with CCCP. This finding that the effect of CCCP was not completely 
abolished in the bpeAB knockout mutant suggested that BpeAB is not the only 
mechanism of resistance in B. pseudomallei. This could be explained if another PMF-
dependent system recognizes the same substrates as BpeAB, and is also sensitive to 
CCCP. A possible candidate is the AmrAB-OprA pump previously characterized by 
Moore et al, 1999 (Moore et al., 1999). Whether AmrAB-OprA and BpeAB-OprB 
function additively in the efflux of aminoglycosides and macrolides in B. pseudomallei 
could be addressed by using an isogenic derivative with deletions in both amrAB and 
bpeAB.  
Another explanation might be that erythromycin, which is a weak base (pKa of 
8.8), was excluded from the cytoplasm due to the pH gradient across the energized 
cytoplasmic membrane of KHW∆bpeAB; and spontaneous influx occurred when the 
PMF was dissipated by CCCP, which would account for the observed increase 
(Sanchez et al., 1997). 
4.4. Occurrence of BpeAB-OprB efflux pumps in clinical, 
animal and environmental B. pseudomallei isolates 
Analysis of bpeAB-oprB expression in 26 local isolates of B. pseudomallei 
from clinical, animal and environmental samples, showed that BpeAB-OprB is present 
in most of these isolates.  None of the isolates over-expressed BpeAB-OprB and none 
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showed significant increase in multi-drug resistance to gentamicin, erythromycin and 
streptomycin. The two isolates, H11 and ATCC15682, that showed either reduced or 
no bpeR expression, also had concomitant null mutations in bpeA. The comparable 
antibiograms of H11, ATCC15682 and KHW with respect to gentamicin, streptomycin 
and erythromycin, supports the notion that two or more drug efflux pumps may have 
additive effects on the MICs of common effluxed substrates as in the case of P. 
aeruginosa (Llanes et al., 2004).  Another RND efflux pump in B. pseudomallei, 
which shares similar substrates as BpeAB-OprB is AmrAB-OprA (Moore et al., 
1999). 
 
4.5. Regulation of bpeAB-oprB expression 
4.5.1. Local regulation of bpeAB-oprB gene expression by BpeR 
 BpeR contains the conserved helix-turn-helix structure 
(SLADIAQHAGVTRGAIYWHFA) of TetR family of repressors and is responsible 
for DNA binding to operator sites and inhibits transcription of genes. Given the 
homology of the deduced bpeR gene product to a number of TetR family of regulatory 
proteins and its close proximity to the BpeAB-oprB operon, it seemed reasonable to 
expect that BpeR might regulate the expression of bpeAB-oprB operon.  
Several lines of evidence point to the fact that BpeR is the local regulator for 
bpeAB-oprB:  
(A) RT-PCR analyses showed that the bpeR mutant, KHWbpeR::Km, had elevated 
bpeA expression, which means the transcriptional inhibition of bpeA was lifted upon 
abolishment of BpeR function (Figure 12, lanes 4). Also, in both KHW and 
KHWbpeR::Km, which harboured the multicopy plasmid, pUCP28TbpeR, resulted in 
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complete inhibition of bpeA expression (Figure 6, lanes 5 and 6).   
(B) The MIC values for streptomycin, erythromycin and gentamicin, respectively, 
were 2-, 4- and 16-fold higher in the bpeR mutant when compared to the wild-type 
(Table 9). Over-expression of bpeR in KHWbpeR::Km and KHW both had the same 
effect of significantly increasing their susceptibilities to all three antibiotics. This 
could be explained by an up-regulation of bpeAB-oprB expression in the absence of 
functional BpeR, as well as a down-regulation of bpeAB-oprB expression in the 
presence of higher levels of BpeR (Figure 12).   
(C) The construction of bpeABpromoter–lacZ fusion in KHW showed that BpeAB-OprB 
efflux system is inducible by its substrate, erythromycin. A low basal expression of 
bpeAB-oprB was observed in wild-type B. pseudomallei. The basal expression of 
bpeAB-oprB was about 3.5-fold higher in the bpeR mutant when compared to the wild-
type and this consequently resulted in its relatively higher MIC and MBC values for 
gentamicin, streptomycin and erythromycin (Table 9). We have also observed a delay 
in the erythromycin-induced expression of bpeRpromoter-lacZ expression in wild-type 
cells, compared to that of bpeABpromoter-lacZ expression (Figure 17). This supports the 
view that the BpeR repressor interacts with its ligand to regulate bpeAB-oprB 
expression as well as its own expression. Induction of bpeRpromoter-lacZ expression in 
wild-type cells by erythromycin is also suggestive of a protein ligand interaction 
between the BpeR repressor and erythromycin, which releases the repression of 
bpeAB-oprB expression as well as bpeR expression. It appears that an adjacent site, 
which may be responsive to a different ligand-sensitive regulatory protein, may also 
be involved in regulating the inducible expression of the bpeAB-oprB operon. This yet 
unknown BpeR-independent mechanism might explain why, in the bpeR mutant 
  
148
background, bpeAB expression was elevated but not constitutively maximal (Figure 
16). A more direct evidence to show that BpeR acts as a repressor of bpeAB-oprB is to 
perform a gel-shift or DNA foot-printing assay. Nonetheless, a proposed mechanism 
for the regulation of bpeAB-oprB operon by BpeR is shown in Figure 34.  
It was however, unexpected that the bpeAB-oprB expression in the bpeR 
mutant could be further induced by erythromycin to comparable levels as the wild-
type parental strain. This could be explained if another transcriptional regulator, which 
recognizes erythromycin as a ligand and binds to a different site in the bpeAB-oprB 
regulatory region is involved. Alternatively, a repressor protein of another RND pump 
(e.g. AmrR), which may use erythromycin as a ligand could share the bpeAB-oprB 
regulatory region. Two promoters were shown to transcribe the P. aeruginosa mexAB-
oprM operon – one of which was regulated by MexR repressor, but the other was not 
(Evans et al., 2001). The induction of bpeAB-oprB expression by erythromycin in the 
bpeR null mutant will be useful to demonstrate that bpeAB-oprB expression can occur 




Figure 34. Negative regulation of bpeAB-oprB by BpeR. (A) In the absence of 
inducers (substrates), BpeR blocks bpeAB-oprB expression. It accomplishes repression 
by binding to the operator (ObpeAB) site upstream from bpeAB-oprB, blocking 
transcription by RNA polymerase from the promoter (PbpeAB). An operator sequence 
made up of inverted repeats was identified at 3 to 23 bp upstream from the start codon 
of bpeAB-oprB that overlaps the promoter site located at 15 bp upstream of bpeAB-
oprB. (B) Derepression occurs when appropriate substrates bind to BpeR, causing a 
conformational change in the protein that lowers the repressor’s affinity for ObpeAB.  
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4.5.2. Global regulation of bpeAB-oprB gene expression 
  The expression of bpeAB-oprB is growth phase-dependent and that of bpeR is 
inducible upon entry into stationary phase. This suggested that either the bpeAB-oprB 
expression is (1) regulated by quorum sensing, (2) inducible by a metabolite that 
accumulates with cell density and which is a substrate of the pump, or (3) is inducible 
by a transcriptional regulator which controls the expression of genes at stationary 
phase. Expression of mexAB-oprM in P. aeruginosa is similarly growth phase 
dependent, and the regulation of its growth phase-dependent expression does not 
involve the MexR repressor (Evans and Poole, 1999). The P. aeruginosa autoinducer, 
C4-HSL, could induce the expression of mexAB-oprM without the involvement of 
MexR (Sawada et al., 2004).  The addition of 50 µM C4-HSL to mexR null mutants 
resulted in rapid increase in mexAB-oprM expression. Interestingly, this enhancement 
of mexAB-oprM expression was cancelled by the introduction of plasmid-borne MexT 
(Sawada et al., 2004). Thus, there seems to be cross-talk among the regulators of RND 
pumps in P. aeruginosa whereby an upstream regulator of one RND efflux pump 
operon can also regulate the expression of another RND pump.  
We have shown that bpeAB-oprB expression could be induced by exogenous 
autoinducers, suggesting that BpeAB-OprB might be involved in the efflux of 
autoinducers. An impairment of this efflux in the bpeAB-null mutant or the bpeR-
overexpressing strains would therefore result in an accumulation of autoinducers, 
which would then exert a negative feedback on the expression of the autoinducer 
synthase. This would explain the attenuated virulence phenotype of the bpeAB-null 
mutant and the bpeR-overexpressing strains. Three pairs of luxIR homologs and two 
other luxR homologs have been identified in B. pseudomallei. Together they are 
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responsible for the production of several acyl-homoserine lactone autoinducers: C8-
HSL, C10-HSL, 3-hydroxy-C8-HSL, 3-hydroxy-C10-HSL, and 3-oxo-C14-HSL 
(Ulrich et al., 2004; Valade et al., 2004; Song et al., 2005).  Using early-exponential-
phase cultures when bpeAB-oprB expression was low, we showed that the induction of 
bpeAB-oprB expression could be advanced to the exponential phase by the exogenous 
addition of 100 nM C8-HSL or C10-HSL to the culture medium. It is noted that the 
response of bpeAB-oprB expression to such high concentrations of exogenous C8-HSL 
or C10-HSL might not necessarily imply that bpeAB-oprB expression is directly 
regulated by quorum sensing, as the acyl-HSLs could have activated a stationary-
phase transcriptional regulator.  
The induction of the bpeAB operon by various structurally toxic compounds 
such as acyl-HSLs, MTA, MTR and spermidine, suggests that it might be regulated by 
a generic stress response mechanism. In bacteria, alterations in gene expression are 
often controlled at the transcriptional level through changes in associations between 
the catalytic core of RNA polymerase and the different sigma factors present in a 
bacterial cell (Borukhov and Nudler, 2003). Associations between different sigma 
factors and core RNA polymerase essentially program the ability of the RNA 
polymerase holoenzyme to recognize different promoter sequences and express 
different sets of target genes (Boor, 2006). The σs subunit of DNA dependent RNA 
polymerase is a master regulator in a complex regulatory network that governs the 
expression of many inducible genes: (i) in stationary phase and (ii) by different 
environmental stresses in exponential phase. Physiologically, σs plays the role of a 
general stress sigma factor and acts predominantly as a positive effector (Hengge-
Aronis, 1996; 1999; Loewen et al 1998).  
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In P. aeruginosa, RpoS, the alternative sigma factor (σs) responsible for the 
switching-on of gene expression at stationary phase, is involved in the expression of 
40% of quorum-controlled genes (Schuster et al., 2004). rpoS expression is activated 
by quorum sensing, and among target genes regulated by both quorum sensing and 
RpoS are probable RND efflux transporters (Latifi et al., 1996; Schuster et al., 2004). 
BpeAB-oprB might also be regulated by σs in B. pseudomallei. Acyl-HSL can also 
induce the expression of rpos in E. coli (Huisman and Kolter 1994). Therefore, it is 
plausible that metabolites that have an effect on acyl-HSLs synthesis (such as MTA, 
MTR and perhaps spermidine), might affect the availability of σs and thus regulate 
bpeAB-oprB expression in B. pseudomallei.  
Since the expression of rpoS in B. pseudomallei is also growth phase-
dependent (Subsin et al., 2003), it is therefore difficult to distinguish if the induction 
of bpeAB-oprB expression at stationary phase is due to activation by RpoS regulons 
and/or quorum sensing regulons. In order to ascertain this satisfactorily, it would be 
necessary to study the effect of exogenous C8-HSL and C10-HSL on the expression of 
bpeAB-oprB in a quorum sensing-deficient or rpos-deficient genetic background. Such 
a mutant with null quorum sensing phenotype is difficult to construct because of the 







4.6. Role of BpeAB-OprB in quorum sensing  
Although we observed that bpeAB expression could be activated by exogenous 
autoinducers, it was more responsive to C8-HSL than to C10-HSL, and only at high 
concentrations of C8-HSL (>80 nM). Likewise, it was recently reported that the 
expression of P. aeruginosa mexAB-oprM was differentially enhanced by the 
exogenous addition of C4-HSL and 3-oxo-C12-HSL (Maseda et al., 2004), although 
its expression was not regulated by the LasIR quorum-sensing system (Evans and 
Poole, 1999). We have also identified a las/lux box motif in the intergenic region 
between bpeR and bpeAB-oprB, but the function of this has not been studied. It could 
perhaps be addressed by studying the effect of exogenous C8-HSL and C10-HSL on 
bpeAB-oprB expression in a null quorum-sensing genetic background. 
Our data showed that autoinducer production is significantly reduced when 
BpeAB-OprB function is impaired and this reduction in autoinducer production 
seemed to be at the level of autoinducer synthesis, as the expression of the autoinducer 
synthase was impaired in the bpeAB mutant (Figure 22). Additionally, the absence of 
autoinducer production in the bpeR-overexpressing strains, KHW(pUCP28TbpeR) and 
KHWbpeR::Km(pUCP28TbpeR), demonstrates that quorum sensing can be inhibited 
by overexpressing bpeR (Figure 21E and 21F). Quorum sensing (QS) is a cell-density-
dependent communication system utilized by gram-negative bacteria that incorporates 
HSLs for the coordination of gene expression (Fuqua et al., 1994; Fuqua et al., 2001). 
Functional QS networks have been identified in numerous gram-negative bacterial 
pathogens, such as B. cepacia (Baldwin et al., 2004), P. aeruginosa (Brint and 
Ohman, 1995; Latifi et al., 1996; Dong et al., 2005) and B. pseudomallei (Ulrich et al., 
2004; Valade et al., 2004; Song et al., 2005). These QS systems had been shown to 
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both positively and negatively regulate various putative virulence factors, thus 
contributing to bacterial pathogenicity in animal models. When expressed at high 
levels, BpeR was not only able to render the bacteria more susceptible to the 
antibiotics (erythromycin, streptomycin and gentamicin) that are commonly used for 
treatment of suspected cases of community-acquired sepsis, but also inhibited HSL 
production. Thus, overexpression of BpeR is potentially useful for the therapy of 
melioidosis.  
It is interesting that in KHWbpeR::Km, which had up-regulated bpeAB 
expression, bpsI expression was no longer growth phase-dependent, but remained low 
up to early stationary phase (>18 h) and then increased to wild-type levels thereafter. 
This was in contrast to bpsI expression in the KHW∆bpeAB mutant, which remained 
low even during the stationary phase. This again points to BpeR being involved in the 
regulation of bpeAB-oprB expression.  
We have also ascertained that bpsI expression was not inducible in the bpeAB-
null mutant which was cultured in the presence of 100 nM exogenous C8-HSL for up 
to 6 h. This could be explained if intracellular levels of C8-HSL was high enough in 
the bpeAB mutant to exert a negative feedback inhibition on its bpsI expression 
regardless of the exogenous C8-HSL. The efflux of C8-HSL by BpeAB-OprB was 
subsequently confirmed by HPLC analyses of extracellular HSL from the B. 
pseudomallei culture supernatants. KHW∆bpeAB could produce C8-HSL but could 
not efflux this autoinducer into the extracellular medium (Figure 24). However, the 
intracellular C8-HSL level in bpeAB mutant was comparable to that of wild-type 
(Figure 24A), therefore the negative feedback inhibitory effect on bpsI expression is 
most probably due to the supply of exogenous C8-HSL that leads to high intracellular 
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C8-HSL concentration in the mutant. It is unclear how the syntheses of other HSLs are 
affected in KHW∆bpeAB. It could be that the reduced intracellular synthesis of C8-
HSL in the bpeAB mutant and the lack of efflux of this autoinducer into the 
extracellular medium had an impact on the synthesis of the other HSLs. Therefore, 
C8-HSL might be the key autoinducer in quorum sensing of B. pseudomallei that 
regulates the expression of other autoinducer synthases and the synthesis of other 
HSLs. 
Surprisingly, fewer 14C-labeled peaks were detected in the intracellular and 
extracellular extracts from KHWbpeR::Km, which overexpress BpeAB-OprB when 
compared to wild type. KHWbpeR::Km produced 20% more C8-HSL in the 
extracellular medium than the wild type although its intracellular level of C8-HSL was 
comparable to that of wild-type (Figure 24). Thus, the BpeAB-OprB pump might be 
involved in the efflux of an intermediary metabolite that impacted on other 
autoinducer synthase expressions and thus autoinducer production. It was assumed 
that all autoinducers diffuse freely into bacterial cells, as demonstrated using 
radiolabeled N-3-oxo-hexanoyl homoserine lactone (3OC6-HSL), which freely 
diffused into and out of V. fischeri and E.  coli cells (Kaplan and EP, 1985; Pearson et 
al., 1997). Pearson et al (Pearson et al., 1999) also demonstrated an involvement of 
the MexAB-OprM pump in active efflux of 3OC12-HSL in P. aeruginosa using 
radiolabeled 3OC12-HSL. Unlike 3OC12-HSL, C4-HSL, which had a shorter acyl 
group, diffused freely across the bacterial membranes. It was proposed that the length 
and/or degree of substitution of the N-acyl side chain determined whether HSLs are 
freely diffusible or require active efflux. 
Growth impairment was observed in the KHW∆bpeAB mutant compared to 
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KHW, both when cultured in AB medium supplemented with glycerol and casamino 
acids and when cultured in LB medium. The KHW∆bpeAB mutant had a longer 
doubling time and attained stationary phase only after 24 h although microscopic 
examination of the negatively stained cells by transmission electron microscopy 
showed size and length similar to those of KHW cells. The failure to restore the 
growth impairment of the bpeAB-null mutant to wild-type levels in the presence of 
100 nM C8-HSL suggests that the cause of the growth defect of the bpeAB-null mutant 
was probably not regulated by C8-HSL. It is also plausible that there was an 
accumulation in the KHW∆bpeAB mutant of a metabolite which is a physiological 
substrate of the BpeAB-OprB efflux pump and which has an impact on cell division. 
Polyamines, whose biosynthesis shares the same pathway as that of acyl-HSLs, are 
plausible candidates (Tabor and Tabor, 1985; Parsek et al., 1999). The intracellular 
level of polyamines, which is tightly regulated, is an important control of cell division 
in E. coli (Inouye and Pardee, 1970).  
 
4.7. Impact of BpeAB-OprB on virulence 
In P. aeruginosa, certain studies have suggested a relationship between efflux 
and virulence. For example, it has been reported that MexAB-OprM exports HSLs that 
are involved in quorum sensing and consequent regulation of the expression of a 
variety of virulence determinants (Pearson et al., 1999). Another study strongly 
suggested that invasion determinants are predominantly exported by P. aeruginosa via 
MexAB-OprM as a mexAB-oprM deletion strain was compromised in its ability to 
invade kidney epithelial cells (Hirakata et al., 2002). This same relationship was 
investigated in B. pseudomallei so as to better understand the role of efflux in bacterial 
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pathogenesis. The role of BpeAB-OprB in B. pseudomallei on the invasion of and the 
cytotoxic effects on human lung epithelial (A549) and macrophage (THP-1) cells were 
investigated. The impairment of the BpeAB-OprB pump either by the bpeAB-null 
mutation or by overexpression of bpeR had a dramatic effect on virulence attenuation 
of B. pseudomallei. These strains showed significant impairment in cell invasion of 
human lung epithelial (A549) and macrophage (THP-1) cells (Table 10). The data 
demonstrates that overexpression of the BpeR repressor attenuate B. pseudomallei 
virulence by blocking cell invasion more effectively than deletion of BpeAB pump 
function alone. The invasiveness of KHW∆bpeAB was reduced by about 100-fold, as 
compared to wild type, whereas an overexpression of bpeR in KHW reduced the 
invasiveness by more than 10,000-fold. This showed that BpeR plays a role in the 
regulation of the expression of a wider variety of virulence determinants than BpeAB-
OprB. BpeR might regulate the expression of these virulence genes directly and/or 
through quorum sensing.  
The cytotoxic effect of these strains on A549 and THP-1 was also significantly 
attenuated (Table 11). The partial restoration of cytotoxicity of the KHW∆bpeAB 
mutant and the bpeR-overexpressing strains, KHWbpeR::Km(pUCP28TbpeR) and 
KHW(pUCP28TbpeR), by the addition of exogenous C8-HSL supports the notion that 
the BpeAB-OprB efflux function is important for optimal autoinducer synthesis. This 
also implicate that BpeAB-OprB role in cell killing is not only on quorum sensing-
regulation of virulence factors, but by other unknown mechanisms independent of 
autoinducers. The partial restoration of cytotoxicity of KHW∆bpeAB mutant and the 
bpeR-overexpressing strains is because the addition of C8-HSL can only restore the 
virulence determinants regulated by quorum sensing but not those regulated by other 
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mechanisms. It is possible that the addition of exogenous C8-HSL, which failed to 
induce bpsIpromoter-lacZ expression in the bpeAB mutant (Figure 22C), may have a 
positive effect on the expression of the other luxIR homologs in the efflux-impaired B. 
pseudomallei. Such an effect could have restored the invasiveness of these efflux-
impaired strains. It remains unclear why the addition of exogenous C8-HSL 
autoinducer to the culture medium was able to partially restore the cytotoxic effect of 
the bpeAB mutant and bpeR-overexpressing strains towards THP-1 cells but had no 
effect on the cytotoxic effect of the same strains towards A549 cells.  
It is also interesting that, in the identification of new regulators that modulate 
quorum sensing in P. aeruginosa, a mutation in a probable RND-like efflux 
transporter was found to significantly down-regulate the quorum-sensing-dependent 
lecA::lux expression (Diggle et al., 2002). Diggle et al (2002) identified a novel global 
regulator (MvaT) involved in the modulation of cell density-dependent gene 
expression in P. aeruginosa and proposed that quorum sensing regulation of virulence 
gene expression is linked with the growth phase and the metabolic state of the cell. 
Our study has shown that the BpeAB-OprB function is important for optimal 
production of virulence factors such as siderophore and phospholipase C. The BpeAB-
OprB function is thus an important virulence determinant of B. pseudomallei.  
 
4.8. Impact of BpeAB-OprB on biofilm 
 The nature of biofilm structure and the physiological attributes of biofilm 
organism confer an inherent resistance to anti-microbial agents. Mechanisms 
responsible for resistance in biofilm may be one or more of the following: (A) delayed 
penetration of the antibiotic through the biofilm matrix (Suci et al., 1994), (B) altered 
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growth rate of biofilm organisms (Evans et al., 1990), (C) other physiological changes 
due to biofilm mode of growth (Adams and McLean, 1999). So far, there is no 
evidence to show that RND efflux pumps play a role in the development of antibiotic 
resistance in biofilms. P. aeruginosa strains that lack MexAB-OprM were resistant to 
ciprofloxacin in biofilms (Brooun et al., 2000). Our study has shown that BpeAB-
OprB function is required for optimal formation of biofilm, however its role in 
antibiotic resistance of biofilms remains to be proven. One approach is to determine 
the susceptibility of sessile cells in B. pseudomallei biofilms to anti-microbials.  
 
4.9. Physiological roles of BpeAB-OprB 
4.9.1. Chemoprotection 
Organisms produce antibiotics to compete for a particular niche and to survive. 
For example, Ascomycetes (Penicillium) produces penicillin. Penicillin kills bacteria 
by interfering with cell wall biosynthesis and is effective only against bacteria cell 
walls due to the peptidoglycan (protein-sugar complex) that is a major component of 
the cell wall (Sneader, 1985). Plant and fungi have different cell wall structures and 
therefore is ineffective against Ascomycetes. It is interesting to note that in B. 
pseudomallei genome, there are fourteen gene clusters encoding possible antibiotic, 
surfactant, and siderophore biosynthesis pathways (Holden et al., 2004), of which 3 of 
them encode for putative antibiotic synthesis proteins. These genes are located on 
chromosome 1, nucleotide positions 1253037 to 1252138 and 2687326 to 2685503; 
and on chromosome 2, nucleotide positions 1607728 to 1605305. If these genes were 
expressed and functional in B. pseudomallei, one would wonder how the organism 
remains unaffected by the toxic effects of these antibiotics. One mechanism could be 
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the antibiotic is highly specific and effective against “enemies” as in the case of 
penicillin. In B. pseudomallei, it will be interesting to study if the toxic effects of these 
antibiotics produced could be kept to a minimum by the efflux pumps and whether 
BpeAB-OprB might play a role in this. We have shown that BpeAB-OprB pumps out 
the antibiotics – streptomycin, gentamicin and erythromycin. Antibiotics are produced 
are part of the vast range of natural products known as secondary metabolites. 
Secondary metabolites tend to be formed during stationary phase and are often 
excreted into the medium (Hammond and Lambert, 1979). Expression of bpeAB-oprB 
was growth phase-regulated, whereby the expression of bpeAB-oprB followed closely 
the shape of the growth curve (Figure 18A). This suggests that BpeAB-OprB might 
play an important role during the late stages of growth, such as the extrusion of 
secondary metabolites. 
 
4.9.2. BpeAB-OprB acts as a metabolic relief valve to alleviate toxic 
effects of MTA and spermidine metabolism 
As can be inferred from Figure 30, MTA is located at a crossroad in cellular 
metabolism. MTA is a metabolic product of S-adenosylmethionone in polyamine 
biosynthesis, and can be recycled to methionine by a number of organisms including 
B. subtilis and K. pneumoniae (Furfine and Abeles, 1988; Sekowska and Danchin, 
1999). Besides its role as a metabolic intermediate, MTA may play relevant regulatory 
functions in the cell. Some of these functions include exerting a potent feedback 
inhibition on spermidine and spermine synthase and ornithine decarboxylase at low 
µM concentrations (Raina et al., 1982). Therefore, there must be some mechanisms 
that prevent the build-up of intracellular MTA. One of the mechanisms includes rapid 
  
161
recycling of MTA where it is salvaged to methylthioribose (MTR) and adenine by the 
enzyme MTA nucleosidase encoded by pfs (Figure 30). In E. coli, MTR is excreted 
(Schroeder et al., 1973; Sekowska et al., 2000), whereas in K. pneumoniae, MTA is 
recycled to yield methionine using the key enzyme MTR kinase (Figure 35) (Furfine 
and Abeles, 1988). However, in B. pseudomallei genome, we identified a gene 
encoding for MTA/SAH nucleosidase on chromosome 1, nucleotide positions 
2357084-2356296 but failed to identify any gene encoding for MTR kinase, 
suggesting that MTR could be the final product of this pathway. It is plausible that 
MTA and/or MTR might be effluxed by BpeAB-OprB as MTA and MTR could 
induce bpeAB-lacZ expression in KHW.  
 
Figure 35. The methionine salvage pathway via methylthioadenosine (MTA) in K. 
pneumoniae. MTA is produced as a by-product of polyamine biosynthesis and is 
rapidly cleaved to produce methylthioribose (MTR) and adenine by MTA/SAH 
nucleosidase. MTR is then phosphorylated by the key enzyme MTR kinase and 




Polyamines are necessary for normal cell growth in microorganisms (Cohen, 
1998). The polyamine content of cells is tightly regulated by biosynthesis, 
degradation, uptake and excretion (Pegg, 1988; Igarashi and Kashiwagi, 1999). It has 
been reported that high intracellular spermidine levels in E. coli, has no effect on the 
growth but causes a decrease in cell viability (Fukuchi et al., 1995), whereas low 
intracellular spermidine level slows down the growth of E. coli (Hafner et al., 1979) 
and P. aeruginosa (Bitonti et al., 1982).  More exogenous spermidine accumulated in 
wild-type KHW and the complemented KHW∆bpeABKm mutant than in the bpeAB 
deletion mutant (Figure 32B). Thus, spermidine seems not to be a substrate of BpeAB-
OprB, but perhaps another intermediate in the spermidine metabolic pathways might 
be responsible for the induction of bpeAB-oprB expression in the presence of 
exogenous spermidine. The gene encoding the B. pseudomallei spermidine acetyl-
transferase, speG, was identified on chromosome 1, nucleotide positions 107334 to 
107894. Spermidine acetyltransferase is responsible for the synthesis of the 
compound, N1-acetylspermidine, which decreases spermidine toxicity in cells by 
acetylation of spermidine and rendering it biologically inactive (Fukuchi et al., 1995).  
N1-acetylspermidine could be a substrate of BpeAB-OprB.  
The lower level of intracellular spermidine in the bpeAB deletion mutant might 
account for its slower growth rate (Figure 22A). Similar reduction in growth rate was 
observed in an E. coli mutant that is unable to synthesize putrescine or spermidine 
(Hafner et al., 1979). However, RT-PCR results which showed that spermidine 
synthase, speE gene expression levels was not altered in the bpeAB deletion mutant, 
suggests intracellular spermidine level is regulated at the post translational level, 
probably by degradation or excretion.  
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The intracellular levels of spermidine in KHW and all its isogenic mutants 
subsequently returned to a very low level of between 8 to 15 nM, 4 h after removal of 
exogenous spermidine. This could be the “non-toxic” spermidine level achieved by all 
the mechanisms that regulated its intracellular level.  
 
4.10. Bacteriostatic properties of MTA and spermidine on B. 
pseudomallei 
Methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH) were 
bacteriostatic to wild-type B. pseudomallei, whereas methylthioribose (MTR) and 
spermidine was bacteriostatic only to B. pseudomallei without the BpeAB-OprB 
pump. Since spermidine is unlikely to be a substrate of BpeAB-OprB, one possible 
explanation is that BpeAB-OprB may be involved in the efflux of N1-
acetylspermidine, which is synthesized from spermidine by the enzyme spermidine 
acetylase. In the absence of BpeAB-OprB, N1-acetylspermidine could have 
accumulated to levels resulting in feedback inhibition on spermidine acetyltransferase, 
leading to an accumulation of spermidine, which is toxic to the cells. Polyamine 
content of cells is tightly regulated by biosynthesis, degradation, uptake and excretion 
(Pegg, 1988; Igarashi and Kashiwagi, 1999) and we have shown that the intracellular 
spermidine level in KHW∆bpeABKm was lower than wild type, and that spermidine 
synthase expression was also unaffected in the mutant. Therefore, the deletion of 
bpeAB might inevitably increase activities of other regulatory systems, or other efflux 
pumps, such as AmrAB-OprA, to compensate for the loss of BpeAB-OprB function. 
Contrary to the findings of Fukuchi et al (Fukuchi et al., 1995), intracellular 
accumulation of spermidine was bacteriostatic but not bacteriocidal to B. 
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pseudomallei. We are unable to speculate on the reasons for this difference between E. 
coli and B. pseudomallei.  
 
4.11. Inhibitors of BpeAB-OprB  
BpeAB-OprB is a potential target for therapeutic intervention of melioidosis as 
its inhibition could result in: (A) increased susceptibility to antibiotics commonly used 
to treat suspected cases of community-acquired sepsis, such as gentamicin, 
streptomycin, and erythromycin; (b) virulence attenuation via its negative effect on B. 
pseudomallei quorum sensing and expression of quorum sensing-regulated virulence 
factors such as phospholipase C and siderophore; (c) reduction in biofilm formation. 
The broad-spectrum efflux pump inhibitor MC-207,110, which was active 
against the MexAB-OprM, MexCD-OprJ, and MexEF-OprN pumps of P. aeruginosa, 
did not have any effect on erythromycin or streptomycin efflux by BpeAB-OprM in B. 
pseudomallei (Lomovskaya et al., 2001). It potentiated the anti-microbial effect of the 
fluoroquinolone levofloxacin in P. aeruginosa but not that of fluoroquinolones in B. 
cepacia, a close relative of B. pseudomallei (Lomovskaya, personal communication). 
MC-207,110 was proposed to directly inhibit the Mex pumps in P. aeruginosa. 
Therefore, the inability for MC207,110 to inhibit BpeAB-OprB could be due to 
differences in anti-microbial substrate specificities between BpeAB-OprB and the 
Mex pumps. BpeAB-OprB effluxes the aminoglycoside gentamicin and streptomycin, 
and macrolide erythromycin, whereas MexAB-OprM, MexCD-OprJ and MexEF-
OprN efflux a wider range of anti-microbials which include β-lactams, β-lactam 
inhibitors, fluoroquinolones, tetracycline, chloramphenicol, novobiocin, macrolides, 
trimethoprim etc.  
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The physiological functions of bacterial efflux pumps remain largely unknown. 
The very broad substrate specificities of these efflux pumps makes it difficult to guess 
their physiological substrates and what might inhibit them (Lewis, 2001). As in the 
case of MexAB-OprM in P. aeruginosa, the pump is able to efflux a wide rage of 
structurally unrelated compounds (Poole, 2001a). In B. pseudomallei, we have 
identified erythromycin, streptomycin, gentamicin, methylthioribose (MTR) and 
methylthioadenosine (MTA) substrates of BpeAB-OprB.  Since MTA could induce 
bpeAB expression and inhibit the growth of wild-type KHW, it seems plausible that 
adenosine analogues might function as competitive inhibitors of the pump. None of 
the analogues, however, exert a potentiating effect on the susceptibility of KHW to 
erythromycin as bacterial growth was not inhibited even in the presence of very high 
concentrations (1 mM) of these analogues.  
Table 13 showed the molecular structures of substrates of BpeAB-OprB and 
the adenosine analogues tested as potential pump inhibitors. BpeAB-OprB is able to 
efflux a variety of structurally unrelated compounds, from simple ones like MTR and 
MTR to complex compounds like erythromycin and streptomycin. Adenosine 
analogues tested for their potentiating effect on the susceptibility of KHW to 
erythromycin, differ in their sizes and side chains though retaining the adenosine 
moiety. It was surprising that 2-chloroadenosine and 2-deoxyadenosine, which had 




Table 13. Molecular structures of substrates of BpeAB-OprB and adenosine 


































Chapter 5: Conclusion and Future Studies 
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We have described the identification and characterization of a RND efflux 
system, BpeAB-OprB, in the gram-negative pathogen, B. pseudomallei. BpeAB-OprB 
is only the second RND pump to be described in B. pseudomallei, which encodes 
operons for eight different RND efflux pumps and is intrinsically resistant to multiple 
antibiotics. BpeAB-OprB is responsible for conferring resistance to the 
aminoglycosides gentamicin and streptomycin, and the macrolide erythromycin. Like 
other bacterial RND efflux pumps, the efflux of antibiotic substrates by BpeAB-OprB 
is also dependent on a proton gradient.  
The expression of bpeAB-oprB is regulated in part by an upstream regulator, 
BpeR, which is a member of the TetR family of transcriptional repressors. It is 
plausible that other transcriptional regulator(s) may also act together with BpeR in the 
upstream region of the operon as the expression of bpeAB-oprB in the bpeR null 
mutant remained inducible by erythromycin. Future studies will examine the proteins 
that bind to the regulatory region of the bpeAB-oprB operon using DNA footprinting 
assay and EMSA. Besides BpeR, the growth-phase dependent expression of bpeAB-
oprB suggests that it may also be controlled by global regulators responsible for cell-
density dependent gene expression. Future work will include the verification of the 
role of the putative lux box in the regulatory region of the bpeAB-oprB operon in cell 
density-dependent expression. 
   Apart from antibiotics, the physiological substrates of BpeAB-OprB include 
the quorum sensing autoinducers, MTA and/or MTR, and possibly intermediate(s) in 
the spermidine metabolic pathway. The efflux of autoinducers by BpeAB-OprB had a 
significant impact on B. pseudomallei quorum sensing, which was abolished in the 
bpeAB deletion mutant as well as the bpeR-overexpressing strain. The absence of 
  
169
quorum sensing in these strains resulted in severe attenuation in virulence and affected 
the production of virulence determinants, such as phospholipase C and siderophore.  
Biofilm formation, a process which is quorum sensing-dependent, was also reduced in 
the bpeAB deletion mutant as well as the bpeR-overexpressing strain when compared 
to wild-type.  
Our study has provided evidence that inhibition of BpeAB-OprB function 
could have dual beneficial therapeutic effects of severely attenuating the virulence of 
B.  pseudomallei and increasing its susceptibility to common antibiotics such as 
gentamicin, streptomycin and erythromycin.  In our efforts to identify inhibitors of 
BpeAB-OprB function, we tested several adenosine analogues, which resemble MTA 
in structure. However, none of those tested so far had any potentiation of antimicrobial 
susceptibilities. Future studies will identify genes in metabolic pathways that are 
perturbed by expression profiling the wild-type, bpeAB deletion mutant and the bpeR-
overexpressing strain using DNA microarrays. This information will allow the 
identification of physiological substrates of the efflux pump and subsequently the 
design of analogues for inhibition of BpeAB-OprB function. The broad-spectrum 
pump inhibitor, MC-207,110, also did not have an effect on BpeAB-OprB function.  
Another aspect of future studies would be the validation of the remainder 6 
RND efflux systems identified in B. pseudomallei. This would involve the 
construction of unmarked single and multiple gene knockout mutants. The roles of 
these pumps in antimicrobial resistance will be studied and their physiological 
substrates may be identified using expression profiling as in the case of BpeAB-OprB.  
A comprehensive study of these RND efflux pumps will enable us to understand why 
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Appendix I:  
Recipes 
1. Media and supplements 
1.1. Luria-Bertani (LB) agar or LB broth  
1 % (w/v) bacto-tryptone (Becton Dickinson) 
0.5 % (w/v) yeast extract (Becton Dickinson) 
1% (w/v) NaCl (Sigma) 
pH adjusted to 7 
1.5% (w/v) technical agar – for LB agar (Becton Dickinson) 
Autoclaved at 121oC, 15 PSI for 15 minutes 
 
1.2. Deferrated 10% (w/v) casamino acids 
Casamino acids (BDH) 2g 
Deionized water  20ml 
The casamino acids were dissolved in the deionized water before 20 ml 
of chloroform (Sigma) and 0.6g of 8-hydroxyquinolone (Sigma) was 
added. The solution was mixed vigorously and allowed to equilibrate at 
4oC overnight. The top layer (deferrated CAA) was collected and 
sterilized by passing through a 0.22 µm filter.  
 
1.3. AB media 
1.3.1. Solution A 
(NH4)2SO4 25 g 
Na2HPO4 75 g 
KH2PO4 37.5 g 
NaCl  37.5 g 
Na2SO4 0.1375 g 
H2O  500 ml 
 
1.3.2. Solution B 
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MgCl2.6H2O 0.91 g 
CaCl2.2H2O 0.045 g 
FeCl3.6H2O 0.0018 g 
H2O  500 ml 
  
 Solutions A and B were autoclaved separately at 121oC, 15 PSI for 15 min. 
Two ml of solution A was aseptically added to 8 ml of solution B and topped up to 50 
ml with SDW before use.  
 
2. Buffers 
2.1. DNA gel electrophoresis buffers 
2.1.1. 0.5M EDTA, pH 8 
Na2EDTA.2H20 186.1g 
Deionized H20 800 ml 
PH adjusted to 8 using about 20g of NaOH pellets (EDTA will 
not dissolve until pH was adjusted to about 8) 
Autoclaved at 121oC, 15 PSI for 15 minutes 
 
2.1.2. 10X TAE (Tris-acetate-EDTA) buffer 
Tris base (Sigma)  48.4 g 
Glacial acetic acid (Sigma) 11.4 ml  
0.5M EDTA (pH 8)  10 ml 
Deionized water   800 ml  
pH adjusted to 8.5 before the volume was topped up to 1l with 
deionized water. Working strength for running buffer and gel 
preparation is 1X 
 
2.1.3. 5X TBE buffer (Tris-borate-EDTA) buffer 
Tris base (Sigma) 54 g 
Boric acid (Sigma) 27.5 g   
0.5M EDTA (pH 8) 20 ml  
Deionized water added to 1l. The pH should be at 8.3 and 
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required no adjustment.Working strength for running buffer and 
gel preparation is 0.5X 
 
2.1.4. 6X loading dye 
Bromophenol blue (Sigma)  0.252 g 
Deionized water   60 ml 
Mixed until bromophenol blue was completely dissolved before 
10 ml of glycerol (Sigma) was added. Mixture topped up with 
deionized water to 100 ml after glycerol was thoroughly mixed 
in solution. 
 
2.1.5. 1% (w/v) agarose gel 
Agarose (Gibco BRL)   0.5g 
10X TAE or 5X TBE buffer  50 ml 
Mixture heated in microwave oven at medium heat for 3 minutes 
to totally dissolve agarose, allowed cooling to 50oC before 1 µl of 
5mg/ml ethidium bromide was added and poured into gel tray for 
gel to set.  
 
2.2. CAS Solution 
10 mM HDTMA (Sigma)   6ml 
1mM FeCl3.6H20 in 10mM HCl (Sigma) 1.5ml 
2mM CAS (Sigma)    7.5ml 
The mixture was stirred into 4.307g anhydrous piperazine (Sigma) in 50 
ml deionized water. 6.25ml of 12M HCl (Sigma) was slowly added into 
the above solution drop by drop with constant stirring before the volume 
was topped up to 100ml and the solution was stored in the dark.  
 
2.3. NPPC reagent 
Tris-HCl (Sigma)  250mM 
ZnSO4 (Sigma)  0.1mM 
NPPC (Sigma)  10mM 
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Sorbitol (Sigma)  40 % (w/v) 
 
2.4. DNA extraction buffer (GES buffer) 
Guanidium thiocyanate (Sigma) 5M 
EDTA     100 mM 
Sarkosyl (Sigma)   0.5 % (v/v)  
 
2.5. Northern blot buffers 
2.5.1. 10X MOPS buffer  
MOPS   400mM 
Sodium acetate 100 mM 
EDTA   10 mM 
pH adjusted to 7 with NaOH and treated with 0.1% DEPC before 
autoclaving. 
 
2.5.2. Running buffer (1X MOPS buffer) 
10X MOPS   200 ml 
0.1% (v/v) DEPC water 1800 ml 
 
2.5.3. 20X SSPE 




2.5.4. Loading buffer 
Formamide    36µl 
10X MOPS    8 µl 
37% (v/v) formaldehyde  13 µl 
SDW     5 µl 
Ethidium bromide (10 mg/ml) 5 µl 
Sterile glycerol   4 µl 




2.5.5. Pre-hybridization solution 
20XSSPE    6.25 ml 
Formamide    12.5 ml 
100X Denhardt’s solultion  1.25 ml 
10% (w/v) SDS   0.25 ml 
SDW added to make up volume to 25 ml.  
 
2.5.6. 100x Denhardt’s Solution 
2% (w/v) BSA 
2% (w/v) Ficoll (400,000 mw) 
2% (w/v) polyvinyl pyrollidone (400,000 mw) 
 
2.5.7. 1%(w/v) formaldehyde gel 
One g of agarose was melted in a solution made with 10 ml of 10x 
MOPS and 85 ml SDW. The melted agarose solution was allowed to 
cool to approximately 50oC and 5.4 ml of 37% (v/V) formaldehyde was 
added. This agarose solution was mixed and poured into a gel mould.  
 
2.6. Western blot buffers 
2.6.1. 1.5M-Tris-HCl buffer, pH 8.8 
Trizma base (Sigma) 18.2 g 
Deionised water  80 ml 
The pH was adjusted to 8.8 with concentrated HCl and made up to 
100 ml with deionised water and stored at 4oC. 
 
2.6.2. 0.5M-Tris-HCl buffer, pH 6.8 
Trizma base (Sigma) 6 g 
Deionised water  80 ml 
The pH was adjusted to 6.8 with concentrated HCl and made up to 




2.6.3. 10% (w/v) SDS solution 
Sodium dodecyl sulphate 10g 
Deionized water   100 ml 
Stored at room temperature. 
 
2.6.4. 10% (w/v) ammonium persulphate solution  
Ammonium persulphate 0.1 g 
Deionized water   1 ml 
The solution was always prepared freshly prepared prior to use. 
 
2.6.5. Running buffer 
Trizma base  6.0 g 
Glycine  28.8 g 
10% SDS (w/v)  10 ml  
Deionized water  1l 
Stored at 4oC. 
 
2.6.6. 6X sample loading buffer 
0.5M-Tris-HCl buffer, pH 6.8 2.5 ml 
glycerol    2.0 ml 
SDS 10% solution (w/v)  4.0 ml 
DTT      0.31 g 
bromophenol blue    0.1 mg 
Made up to 10 ml with water. The buffer was stored as 1 ml 
aliquots at -20oC.  
2.6.7. Coomassie Brilliant Blue staining solution.  
Comassie Brilliant Blue R-250 (BioRad)  1.0 g 
Absolute ethanol    250 ml 
Glacial acetic acid    100 ml 
Made up to 1l with deionised water and stored at room 
temperature. 
 
2.6.8. Destaining solution.  
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Absolute ethanol 250 ml 
Glacial acetic acid 100 ml 
Made up to 1l with deionised water and stored at room 
temperature. 
 
2.6.9. Gel preparation (for 2 Mini-Protean gels) 
Composition of the separating and stacking gels in SDS-PAGE. 
Reagents Separating gel (15% T*)  Stacking gel (6% T) 
Acrylamide solution 6 ml 1 ml 
1.5M-Tris-HCl buffer, pH 8.8 5 ml - 
0.5M-Tris-HCl buffer, pH 6.8 - 2.5 ml 
SDS solution 200 µl 100 µl 
Water 8.7 ml  6 ml 
Ammonium persulphate 100 µl 50 µl 
TEMED** 10 µl 5 µl 
*  % T refers to the total acrylamide content. 
** TEMED was added immediately before the casting of the slab gel. 
 
2.7. β−galactosidase assay buffers 
2.7.1. Z-buffer 
Na2HPO4.7H2O   0.06 M 
NaH2PO4.H2O   0.04 M 
KCl    0.01 M 
MgSO4.7H2O   0.001 M 
β-mercaptoethanol  0.05 M 
Adjust to pH 7 
 
2.7.2. 4 mg/ml ONPG 
4 mg/ml in SDW 
Prepare fresh and store in dark. 
 
2.7.3. Stop buffer 
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Implication of the Burkholderia pseudomallei BpeAB-OprB multidrug efflux 
pump on quorum sensing and virulence 
 
Ying Ying CHAN, Theresa May Chin TAN and Kim Lee CHUA  




The BpeAB-OprB pump of Burkholderia pseudomallei is responsible for the efflux of 
the aminoglycosides gentamicin and streptomycin, as well as the macrolide 
erythromycin. Expression of bpeAB-oprB is regulated by an upstream BpeR repressor, 
a member of the TetR family. Over-expression of bpeR in wild-type B.pseudomallei 
resulted in a significant reduction in the expression of BpeAB proteins, whereas a null 
mutation in bpeR had the opposite effect of increasing bpeAB expression in promoter-
lacZ studies. Interestingly, expression of the BpeAB-OprB efflux pump is required for 
the production of quorum sensing autoinducers. Autoinducers could not be detected by 
reporter strains when cross-streaked against the bpeAB mutant and the bpeR over-
expressing strain, but was detected in the wild-type and bpeR null mutant. The 
implication of BpeAB-OprB in virulence was demonstrated by a reduced invasiveness 
and killing of human lung epithelial and macrophage cells by the bpeAB and bpeR 
over-expressing strains as compared to the wild-type and bpeR null mutant. 
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2. 5th Combined Annual Scientific Meeting, 12th – 14th May 2004, Singapore 
 
Expression Of The Burkholderia pseudomallei BpeAB-OprB efflux pump 
 
Ying Ying CHAN, Theresa May Chin TAN and Kim Lee CHUA 




BpeAB-OprB, a multidrug efflux pump of Burkholderia pseudomallei, is responsible 
for the efflux of the aminoglycosides gentamicin and streptomycin and the macrolide 
erythromycin. Expression of bpeAB is inducible by its substrates, but not by stress 
such as ethanol, osmolarity, pH or entry into stationary phase. A divergently 
transcribed gene bpeR, located upstream of the bpeAB-oprB operon, encodes a 
putative repressor belonging to the TetR family. Although a null mutation in bpeR did 
not result in any significant difference in bpeAB expression as compared to the 
parental wild-type, an over-expression of bpeR, however, significantly repressed 
bpeAB expression. The bpeR null mutant was at least twice as resistant to gentamicin, 
streptomycin, and erythromycin when compared to wild-type, whereas over-
expression of bpeR conferred increased susceptibility to the antibiotics. This data 
supports the role of BpeR as a repressor of BpeAB-OprB. A human and an animal 
isolate of B. pseudomallei showed null or reduced BpeR expression.  These isolates 
also contained deletions in bpeAB-oprB and were more susceptible to the antibiotic 
substrates. None of the 26 soil, animal and human isolates tested were more resistant 
to the antibiotics because of an acquired null mutation in bpeR. Interestingly, the BpeR 
repressor also had an effect on bacterial virulence whereby the overexpression of bpeR 





BpeAB-oprB sequence (GenBank Accession no: AY325270) 
DEFINITION  Burkholderia pseudomallei multidrug efflux operon, complete 
            sequence. 
ACCESSION   AY325270 
VERSION     AY325270.1  GI:37588892 
KEYWORDS    . 
SOURCE      Burkholderia pseudomallei 
  ORGANISM  Burkholderia pseudomallei 
            Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales; 
            Burkholderiaceae; Burkholderia; pseudomallei group. 
REFERENCE   1  (bases 1 to 7597) 
  AUTHORS   Chan,Y.Y., Tan,T.M.C., Ong,Y.M. and Chua,K.L. 
  TITLE     BpeAB-OprB, a Multidrug Efflux Pump in Burkholderia pseudomallei 
  JOURNAL   Antimicrob. Agents Chemother. 48 (4), 1128-1135 (2004) 
REFERENCE   2  (bases 1 to 7597) 
  AUTHORS   Chan,Y.Y., Ong,Y.M. and Chua,K.L. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (18-JUN-2003) Biochemistry, National University of 
            Singapore, 8 Medical Drive 117597, Singapore 
FEATURES             Location/Qualifiers 
     source          1..7597 
                     /organism="Burkholderia pseudomallei" 
                     /mol_type="genomic DNA" 
                     /strain="ATCC 23343" 
                     /db_xref="ATCC:23343" 
                     /db_xref="taxon:28450" 
                     /chromosome="1" 
     gene            39..7110 
                     /gene="multidrug efflux operon" 
     gene            complement(39..674) 
                     /gene="bpeR" 
     CDS             complement(39..674) 
                     /gene="bpeR" 
                     /note="BpeR" 
                     /codon_start=1 
                     /transl_table=11 
                     /product="repressor protein" 
                     /protein_id="AAQ94108.1" 
                     /db_xref="GI:37588893" 
                     
/translation="MARRTKEEALATRDRILDAAEHVFFEKGVSHTSLADIAQHAGVT                    
RGAIYWHFASKSELFDAMFDRVLLPIDELKAGTGEPHADPLGRIREILIWCLLGAARD                     
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PQLRRVFSILFMKCEYVADMGPLLQRNREGMRDALRNIEADLAQGVANGQLPADLDTW                     
RATLMLHTLVSGFVRDMLMLPGEIDAERHAEKLVDGCFDMLRTSPAMRKDD" 
     gene            1084..2292 
                     /gene="bpeA" 
     CDS             1084..2292 
                     /gene="bpeA" 
                     /note="BpeA" 
                     /codon_start=1 
                     /transl_table=11 
                     /product="periplasmic linker protein" 
                     /protein_id="AAQ94109.1" 
                     /db_xref="GI:37588894" 
                     
/translation="MRVERVPYRLITVATAAVFLAACGKKESAPPPQTPEVGVVTVQP                     
QPVPVVSELPGRTSAYLVAQVRARVDGIVLRREFTEGSDVKAGQRLYKIDPAPYIAQL                     
NSAKATLAKAQANLATQNALVARYKVLVAANAVSKQQYDDAVAAQGQAAADVGAGKAA                     
VETAQINLGYTDVVSPITGRVGISQVTPGAYVQASQATLMSTVQQLDPVYVDLTQSSL                     
DGLKLRQDIQSGRIKTEGPGAAKVTLILEDGKPYPERGKLQFSDVTVDQTTGSVTIRA                  
IFPNKQRVLLPGMFVRARIEEGVNENAFLIPQIGVTHDPKGQAIAMIVDGKGKVEPRV                     
LVTGGTQGQNWVVESGLQAGDRVIVQGIDKVRPGMTVKAAEAQLPAAAASAAASGAAP                     
SSAAAASSAQ" 
     gene            2308..5508 
                     /gene="bpeB" 
     CDS             2308..5508 
                     /gene="bpeB" 
                     /note="BpeB" 
                     /codon_start=1 
                     /transl_table=11 
                     /product="inner membrane protein" 
                     /protein_id="AAQ94110.1" 
                     /db_xref="GI:37588895" 
                     
/translation="MAKFFIDRPIFAWVIAIILMLAGVAAIFTLPIAQYPTIAPPSIQ                     
ITANYPGASAKTVEDTVTQVIEQQMSGLDNFLYMSSTSDDSGNATITITFAPGTNPDI                     
AQVQVQNKLSLATPILPQVVQQLGLSVTKSSSSFLLVLAFNSEDGSMNKYDLANYVAL                     
HVKDPISRINGVGTVTLFGSQYAMRIWLDPTKLTNYGLTPVDVTSAISAQNVQIAGGQ                     
LGGTPAVPGTVLQATITEATLLQTPEQFGNILLKVNQDGSQVRLKDVAQIGLGGETYN                     
FDTKYNGQPTAALGIQLATNANALATAKAVRAKIDEMSAYFPHGLVVKYPYDTTPFVR                     
LSIEEVVKTLLEGIVLVFLVMYLFLQNLRATIIPTIAVPVVLLGTFAIMSMVGFSINV                     
LSMFGLVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKAMGQITGALVGVALVLS                     
AVFVPVAFSGGSVGAIYRQFSLTIVSAMVLSVLVALILTPALCATILKPIPQGHHEEK                     
KGFFGWFNRTFNSSRDKYHVGVHHVIKRSGRWLIIYLAVIVAVGLLFVRLPKSFLPDE                     
DQGLMFVIVQTPSGSTQETTARTLANISDYLLTQEKDIVESAFTVNGFSFAGRGQNSG                     
LVFVKLKDYSQRQSSDQKVQALIGRMFGRYAGYKDALVIPFNPPSIPELGTAAGFDFE                     
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LTDNAGLGHDALMAARNQLLGMAAKDPTLRGVRPNGLNDTPQYKVDIDREKANALGVT                     
ADAIDQTFSIAWASKYVNNFLDTDGRIKKVYVQSDAPFRMTPEDMNIWYVRNGSGGMV                     
PFSAFATGHWTYGSPKLERYNGISAMEIQGQAAPGKSTGQAMTAMETLAKKLPTGIGY                     
SWTGLSFQEIQSGSQAPILYAISILVVFLCLAALYESWSIPFSVIMVVPLGVIGALLA                     
ATLRGLENDVFFQVGLLTTVGLSAKNAILIVEFARELQQTEKMGPIEAALEAARLRLR                     
PILMTSLAFILGVMPLAISNGAGSASQHAIGTGVIGGMITATFLAIFMIPMFFVKVRA                     
VFSGEKEDADEALRLAHEHMHRDDKPEHGDDAGKKD" 
     gene            5512..7110 
                     /gene="oprB" 
     CDS             5512..7110 
                     /gene="oprB" 
                     /note="OprB" 
                     /codon_start=1 
                     /transl_table=11 
                     /product="outer membrane protein" 
                     /protein_id="AAQ94111.1" 
                     /db_xref="GI:37588896" 
                     
/translation="MKRKHALTALAVALLAAGCTLAPRYERPAAPVSGAFPADGVYAA                    
QPGAAP GARSANGQAAVDIGWREFFVDPRLQRLIEIALKNNRDLRVSVLNVEASRAQY                     
QITRAGLFPTLSGTGTGTIQRTPAGVSITGQPLISRTYNVGVSASWELDLFGRVQSLK                     
DQALAQYFATAQARKAAEISLVASVADQYLTLLSTDDLLQVTQNTLKSARASYDLTKL                     
QFDNGTGSELDLRQAQTVVETALASQQAQARARAQALNALVLLIGEPLPDDLPAGLPL                     
NAQNLLTDIPAGLPSDLLTRRPDIMQAEETLRAANANIGAARAAFFPKISLTSAFGTA                     
SPTLGGLFKAGTAAWSFAPNIALPIFEGGQNIANLDLAHVQKRIEIANYEKAIQSAFR                     
EVSDGLAARGTYDQQIAALERNEHAQQRRYDLSDLRYRNGVDSYLSVLTAQTDLYSAQ                     
HQLISARLARWTNLVDLYRALGGGWLEHCAHKGPATYFHLHTEDGVIENAAWSYEEPS                     
GIANAIRQYVAFDAACVDRIDVTS" 
ORIGIN       
      1   tgcgcgcatg ggagccgttc gccgcgcggc gggcttgctc agtcgtcctt gcgcatcgcg 
      61  gggctcgtgc gcagcatgtc gaagcagccg tcgacgagtt tttccgcatg ccgttcggcg 
      121 tcgatctcgc ccggcagcat cagcatgtcg cgcacgaagc cgctcacgag cgtatgcagc 
      181 atcagcgtcg cacgccacgt gtcgagatcg gcgggcaact ggccgttcgc gacgccctgc 
      241 gcgagatccg cctcgatgtt gcgcagggcg tcgcgcatgc cttcgcggtt gcgctgcagc 
      301 agcggcccca tgtccgcgac gtactcgcac ttcatgaaca ggatgctgaa cacgcgccgc 
      361 aattgcggat cgcgcgcggc gccgagcagg caccagatca ggatttcgcg aatccggccg 
      421 agcgggtccg cgtgcggctc gcccgtgccg gccttcagtt cgtcgatcgg caggagcacg 
      481 cggtcgaaca tcgcgtcgaa gagctcgctc ttgctcgcga agtgccaata gatcgcgccc 
      541 cgcgtgacgc ccgcgtgctg ggcgatgtcg gcgagcgacg tgtgcgatac gcctttctcg 
      601 aagaagacgt gctcggcggc gtcgaggatg cggtcgcgcg tcgcgagcgc ttcctccttc 
      661 gtgcgtctgg ccattcaaca gctcatcgtg tgcaagatcg gggtcgttgc gtgaataata 
      721 agggttgcat cataagcgtc gcactgggcc gcttgcttgg cctgcctgtt gtaaaccttg 
      781 gtaatgtgta agaaattgtg cggcgcatga aggactttta catacattcg tgaatgtata 
      841 tacaatgcca gcttacggcc gaatggcctt cgaggcaatc agttaatatc cgtctctgct 
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      901 gatttccctc ctcattgttg ttccgcgcgc gccgcgcgcg gcggcatccc ggcacggtgg 
      961 tcgcgtgccg ctgttgtatt cgcagtcaag caattcagtt gtccgatccg cgccgcaagg 
     1021 cgcgttcgtg ttgtgtcccc gaggccggca cttatttcat ctagttacaa acgaggtcgc 
     1081 tccatgcgcg tcgaacgggt tccataccgc ttaatcactg tcgcgacggc tgccgttttc 
     1141 ctggccgcgt gcggaaaaaa agaatcggct ccgccccctc aaacgcccga agtcggcgtc 
     1201 gtcaccgtcc agccgcagcc cgtgccggtc gtctccgaac tgccgggccg tacgagcgcc 
     1261 tatctggtcg cgcaggtgcg cgcacgggtc gacggcatcg tgttgcggcg cgagttcacg 
     1321 gaaggcagcg acgtcaaggc cggccagcgc ctgtacaaga tcgatccggc accctatatc 
     1381 gcgcaattga acagcgcgaa ggcgacgctc gcgaaggcgc aggcgaacct cgcgacgcag 
     1441 aacgcgctcg tcgcgcgcta caaggtgctc gtcgccgcga acgcggtcag caagcagcag 
     1501 tacgacgatg cggtggccgc gcaagggcag gcggccgccg acgtgggcgc gggcaaggcc 
     1561 gccgtcgaga ccgcgcagat caacctcggc tatacggatg tcgtctcgcc gatcacgggc 
     1621 cgcgtcggca tctcgcaggt cacgccgggc gcgtacgtgc aggcgagcca ggcgacgctg 
     1681 atgtcgaccg tccagcagct cgatccggtc tacgtcgatc tcacgcagtc gagcctcgac 
     1741 ggcctgaagc tgcgccagga catccagagc gggcgcatca agacggaagg cccgggcgcg 
     1801 gcgaaggtca cgctgattct cgaggacggc aagccgtacc cggagcgggg caagctgcag 
     1861 ttcagcgatg tcacggtcga ccagacgacg ggctcggtca cgatccgcgc gatcttcccg 
     1921 aacaagcagc gcgtgctgct gccgggcatg ttcgtgcgcg cgcgcatcga agagggcgtc 
     1981 aacgagaacg cgttcctcat tccgcagatc ggcgtcacgc acgatccgaa gggccaggcg 
     2041 atcgcgatga tcgtcgacgg caagggcaag gtcgagccgc gcgtgctggt cacgggcggc 
     2101 acgcagggcc agaactgggt ggtcgagagc ggcctgcagg cgggcgaccg cgtgatcgtg 
     2161 cagggcatcg acaaggtgcg cccgggcatg accgtgaagg ccgccgaggc tcaactgccg 
     2221 gccgcggcgg cgagcgcggc cgcgtcgggt gccgcgccgt cgagcgctgc cgccgcgtcg 
     2281 agcgcgcaat aacagggggc ctgtttcatg gcaaagtttt ttatcgatcg cccgatcttc 
     2341 gcgtgggtga tcgccatcat cctgatgctg gccggcgtcg cggcgatctt cacgctgccg 
     2401 atcgcccagt atccgacgat cgcgccgccg tcgatccaga tcaccgcgaa ctacccgggc 
     2461 gcttcggcga agaccgtcga agacaccgtc acgcaggtga tcgagcagca gatgagcggc 
     2521 ctcgacaact tcctgtacat gtcgtcgacg agtgacgact cgggcaacgc gacgatcacg 
     2581 atcacattcg cgccgggcac gaacccggac atcgcgcagg ttcaggtgca gaacaagctg 
     2641 tcgctcgcga cgccgatcct gccgcaggtg gtgcagcagc tcggcctgtc ggtgacgaag 
     2701 tcgagcagca gcttcctgct cgtgctcgcc ttcaactccg aagacggcag catgaacaag 
     2761 tacgacctgg cgaactacgt cgcgttgcac gtgaaggacc cgatcagccg gatcaacggc 
     2821 gtcggcactg tcacgctgtt cggctcgcag tacgcgatgc ggatctggct cgacccgacc 
     2881 aagctcacga actacgggct cacgccggtc gacgtgacga gcgcgatctc cgcgcagaac 
     2941 gtgcagatcg cgggcggcca gctgggcggc acgccggccg tgccgggcac cgtgctgcag 
     3001 gcgacgatca ccgaggcgac gctgctgcag acgcccgagc agttcggcaa catcctgctg 
     3061 aaggtgaatc aggacggctc gcaggtgcgg ctgaaggacg tcgcgcagat cggcctcggc 
     3121 ggcgagacgt acaacttcga cacgaagtac aacggccagc cgaccgccgc gctcggcatc 
     3181 cagctcgcga ccaacgcgaa cgcgctcgcg accgcgaagg cggtgcgcgc gaagatcgac 
     3241 gagatgtcgg cgtacttccc gcacggcctc gtcgtcaagt acccgtacga cacgacgccg 
     3301 ttcgtgcgcc tgtcgatcga ggaagtggtg aagacgctgc tcgagggtat cgtcctcgtg 
     3361 ttcctcgtga tgtatctgtt cctgcagaac ctgcgggcga cgatcatccc gacgatcgcg 
     3421 gtgcccgtcg tgctgctcgg cacgttcgcg atcatgtcga tggtgggctt ctcgatcaac 
     3481 gtgctgtcga tgttcggcct cgtgctcgcg atcggcctgc tcgtcgacga tgcgatcgtc 
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     3541 gtcgtcgaga acgtcgagcg ggtgatggcg gaagagggct tgccgccgaa ggaggcgacg 
     3601 cgcaaggcga tgggccagat cacgggcgcg ctcgtgggcg tggcgctcgt gctgtcggcg 
     3661 gtgttcgtgc cggtggcgtt ctcgggcggc tcggtcggcg cgatctatcg gcagttctcg 
     3721 ctgacgatcg tctcggcgat ggtgctttcc gtgctcgtcg cgttgattct gacgccggcg 
     3781 ctgtgcgcga cgatcctcaa gccgatcccg caagggcatc acgaggagaa gaagggcttc 
     3841 ttcggctggt tcaaccgcac cttcaactcg agccgcgaca agtatcacgt cggcgtccac 
     3901 cacgtgatca agcgctcggg ccgctggctc atcatctatc tcgcggtgat cgtcgcggtc 
     3961 ggcctgctgt tcgtgcgcct gccgaaatcg ttcctgcccg acgaggacca gggcctgatg 
     4021 ttcgtgatcg ttcagacgcc gtcgggctcg acgcaggaga cgaccgcgcg cacgctcgcg 
     4081 aacatttccg actacctgct cacgcaggag aaggacatcg tcgaatccgc gttcacggtc 
     4141 aacggcttca gcttcgcggg ccgcggccag aactcgggcc tcgtgttcgt caagctgaag 
     4201 gactactcgc agcggcagag ctcggaccag aaggtgcagg cgctgatcgg ccggatgttc 
     4261 ggacgctacg cgggctacaa ggacgcgctc gtgattccgt tcaacccgcc gtcgattccc 
     4321 gaactcggca cggcggccgg cttcgacttc gagctgaccg acaacgcggg cctcggccac 
     4381 gatgcgctga tggccgcgcg caaccagttg ctcgggatgg ccgcgaagga tccgacgctg 
     4441 cggggcgtgc gtccgaacgg gctgaacgac acgccgcagt acaaggtcga catcgatcgc 
     4501 gagaaggcga acgcgctcgg cgtgaccgcg gatgcgatcg accagacgtt ctcgatcgcg 
     4561 tgggcgtcga agtacgtgaa caacttcctc gacaccgacg gccggatcaa gaaggtgtac 
     4621 gtgcagtccg acgcgccgtt ccggatgacg ccggaggaca tgaacatctg gtacgtgcgc 
     4681 aacggctcgg gcgggatggt gccgttctcc gcgttcgcga ccggccactg gacctacggc 
     4741 tcgccgaagc tcgagcgcta caacggcatc tcggcgatgg aaatccaggg ccaggccgcg 
     4801 ccgggcaagt cgaccggcca ggcgatgacg gcgatggaga cgctcgcgaa aaagctgccg 
     4861 acgggcatcg gctattcgtg gacggggctg tcgttccagg aaatccagtc gggctcgcag 
     4921 gcgccgatcc tgtacgcgat ctcgatcctc gtcgtgttcc tgtgtctcgc cgcgctgtat 
     4981 gaaagctggt cgatcccgtt ctcggtgatc atggtcgtgc cgctcggcgt gatcggcgcg 
     5041 ctgctcgccg cgacgctgcg cgggctcgag aacgacgtgt tcttccaggt cggcctgctg 
     5101 acgacggtgg ggctgtcggc gaagaacgcg atcctgatcg tcgagttcgc gcgcgagctg 
     5161 cagcaaacgg agaagatggg gccgatcgag gcggcgctcg aggcggcgcg gctgcggctg 
     5221 cgtccgattc tgatgacgtc gctcgcgttc attctcggcg tgatgccgct cgcgatcagc 
     5281 aacggcgcag gctcggcgag ccagcacgcg atcggcaccg gcgtgatcgg cgggatgatc 
     5341 accgcgacgt tcctcgcgat cttcatgatc ccgatgttct tcgtgaaggt gcgggcagtg 
     5401 ttcagcggcg agaaggaaga cgccgacgaa gcgctgcgcc tcgcgcacga gcacatgcac 
     5461 cgtgacgaca agccggagca cggcgacgac gctggcaaga aggactaaca gatgaagcga 
     5521 aaacatgctt tgactgcact cgcagtcgcg ctgctcgccg cgggctgcac gctcgcgccg 
     5581 cgctacgagc gtccggccgc gccggtgtcg ggcgcgttcc ccgccgacgg cgtctatgcc 
     5641 gcgcagccgg gcgccgcgcc cggcgcgcgc agcgcgaacg gccaggcggc cgtcgatatc 
     5701 ggctggcgcg agttcttcgt cgatccgcgc ctgcagcggc tgatcgagat cgcgctgaag 
     5761 aacaaccgcg acctgcgcgt gtcggtgctc aacgtcgagg cgtcgcgcgc gcagtatcag 
     5821 atcacgcgcg cggggctctt cccgacgttg agcggcaccg gcacgggcac gatccagcgc 
     5881 acgccggccg gcgtgtcgat caccggccag ccgctcatct cgcggaccta caacgtcggc 
     5941 gtctccgcgt cgtgggagct cgacctgttc ggccgcgtgc agagcctgaa ggatcaggcg 
     6001 ctcgcgcaat acttcgccac cgcgcaggcg cgcaaggccg cggagatctc gctcgtcgcg 
     6061 agcgtcgccg atcagtacct gacgctgctg tcgaccgacg atctgctgca ggtcacgcag 
     6121 aacacgctga agtcggcgcg cgcgtcctac gatctgacga agctgcagtt cgacaacggc 
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     6181 accggctcgg agctcgacct gcgccaggcg cagacggtgg tcgagaccgc gctcgcgagc 
     6241 cagcaggcgc aggcgcgcgc ccgcgcgcag gcgctcaacg cgctcgtgct gctgatcggc 
     6301 gagccgctgc ccgacgatct gccggccggc ctgccgctca atgcgcagaa cctgctcacc 
     6361 gacattccgg ccgggctgcc gtccgatctg ctcacgcggc gccccgacat catgcaggcc 
     6421 gaggagacgc tgcgcgcggc gaacgcgaac atcggcgcgg cgcgcgcggc gttcttcccg 
     6481 aagatctcgc tcaccagcgc gttcggcacc gcgagcccga cgctcggcgg cctgttcaag 
     6541 gcgggcacgg cggcgtggtc gttcgcgccg aacatcgcgc tgccgatctt cgagggcggg 
     6601 cagaacatcg cgaacctcga tctcgcgcac gtgcagaagc gcatcgagat cgcgaactac 
     6661 gagaaggcga tccagagcgc gtttcgcgag gtgtcggacg ggcttgccgc gcgcggcacg 
     6721 tacgatcagc agatcgcggc gctcgagcgc aacgagcacg cgcagcagcg ccgctacgat 
     6781 ctgtcggacc tgcgctacag gaacggcgtc gacagctatc tgtcggtgct gaccgcgcag 
     6841 acggacctgt attcggcgca gcaccagttg atcagcgcgc ggctcgcgcg ctggacgaac 
     6901 ctcgtggacc tgtatcgcgc gctgggcggc gggtggctcg agcattgcgc gcacaagggg 
     6961 ccggccactt actttcatct gcataccgaa gacggcgtga tcgagaacgc cgcatggagt 
     7021 tacgaggagc cgtccgggat cgcgaacgcg atccggcagt acgtcgcgtt cgatgccgcg 
     7081 tgcgtcgacc gcatcgacgt gacgtcctga cgcggcggtt catcggggga ggcgatcatg 
     7141 gaactgaacg acgcgctgta cattccgctc gcaccgtccg tcgtctggga cgcgctgcag 
     7201 gatctcgcgc tcgtgcgcgc gagcctcgac cattgcgagt cgttttcgcg gctcgcgcgc 
     7261 ggcgagtacg cgctcgcgct gacggtgccg ctcggcccgt tgcgcgcgcg ctacgacgtg 
     7321 cgcgcgcacg tcgtcggcga gcgccacgac gagcccgtgc acacgagacg cacgctgaac 
     7381 ttccgggccc gcgcggacgg catcggcgcg ctgcgcggcc agatcgacgt cgtgctcgcg 
     7441 ccggcggacg acgagcgggg cgcgagccgc cgcgccccga cgacgcggat cgaatacgcg 
     7501 gtatgggcga cggcctccgg cccgctcgcc gagctgccgg ggcggcagat ccagaacgcg 




Multiple amino acid sequence alignment of BpeA from B. pseudomallei with AcrA (E. 






Multiple amino acid sequence alignment of BpeB from B. pseudomallei with AcrB (E. 








Multiple amino acid sequence alignment of OprB from B. pseudomallei with TolC (E. 







Multiple amino acid sequence alignment of BpeR from B. pseudomallei with AcrR (E. 




 BpeR AcrR AmrR MexR 
BpeR 100 38 33 13 
AcrR  100 22 5 
AmrR   100 21 
MexR    100 
 
 
